Characterisation of a novel snRNP protein by Cooper, Michelle
CHARACTERISATION OF A NOVEL SNRNP PROTEIN 
MICHELLE COOPER 
A THESIS PRESENTED FOR THE DEGREE OF DOCTOR 
OF PHILOSOPHY 
UNIVERSITY OF EDINBURGH 
SEPTEMBER 1995 
DECLARATION 
I hereby declare that I alone have composed this thesis and that, except 
where stated, the work presented herein is my own. 
September 1995 
ACKNOWLEDGEMENTS 
Special thanks to Jean for giving me the opportunity to work in her laboratory and 
for her help over the past three years. I would also like to thank every member of the 
Beggs group, past and present, for providing such a fantastic working environment 
and for being good friends. In addition, I am grateful to SIR Frank and Graham 
Brown for their excellent photographic work. 
Lastly, I am indebted to my parents who have given up so much over the years to 
enable me to get this far. Thank you. 
111 
ABSTRACT 
The SDB23 gene of Saccharomyces cerevisiae was isolated in a search for high copy-
number suppressors of mutations in a cell cycle gene, DBF2. SDB23 encodes a 
21,276 Da protein with significant sequence similarity to characterised mammalian 
and yeast snRNP core proteins. Examination of multiple sequence alignments of 
snRNP core proteins with Sdb23p indicates that the amino-termini of all these 
proteins share a number of highly conserved residues, and identifies a novel motif 
characteristic of snRNP core proteins: 
LX9(L'L)XXXGXXXXGXLXXX(DIE)XXMNXXLX[ 1425]Lxx(I/LIV)x(J!L/V)(R!K)Gxx(L'L) 
In contrast, the carboxy-termini of these proteins diverge considerably. An 
exceptionally hydrophilic, asparagine-rich carboxy-terminus distinguishes Sdb23p 
from the characterised snRNP core proteins, which tend to have an abundance of 
arginine and glycine residues. 
Sdb23p is essential for cell growth and is required for nuclear pre-mRNA splicing 
both in vivo and in vitro. Extracts prepared from Sdb23p-depleted cells are unable to 
support splicing and have vastly reduced levels of U6 snRNA. The stability of U 1, 
U2, U4 and U5 spliceosomal snRNAs is not affected by the loss of Sdb23p. 
Overexpression of U6 snRNA can partially compensate for the loss of Sdb23p, 
indicating that one role of this protein is to stabilise free U6. However, the partial 
nature of this suppression would suggest that Ussip has an additional, as yet 
uncharacterised role. 
Antibodies raised against Sdb23p strongly co-immunoprecipitate free U6 snRNA and 
U4/1J6 base-paired snRNAs. The U6 snRNA-specificity of Sdb23p is not determined 
I MA 
by the unique carboxy-terminus of this protein, since a truncated Sdb23 protein 
(Sdb23Ep) lacking the carboxy-terminal ninety three amino acids appears to be 
functional and retains specific association with U6. Highly conserved amino acids 
within the snRNP core protein motif are unlikely to be important for the specificity 
of the polypeptide since they are extremely well conserved throughout the family of 
core proteins. Instead, these residues may be required for the correct folding, stability 
or function of the individual core protein, or for interactions with other snRNP 
proteins. Mutating either of two highly conserved residues within the snRNP core 
protein motif has no gross effect on the functionality of Sdb23p in vivo. However, 
significantly changing the physiochemical nature of both these conserved amino 
acids within the snRNP core protein motif, or introducing individual point mutations 
into Sdb23Ap, can knock out the function of Sdb23p. These results indicate that both 
the snRNP core protein motif and the carboxy-terminus of Sdb23p are functionally 
important. 
Based on in vitro and in vivo characterisation of SDB23, this gene encodes a novel 
U6 snRNA-associated polypeptide, related to the mammalian snRNP core proteins, 
that is essential for nuclear pre-mRNA splicing and U6 snRNA stability. Sdb23p 
appears to represent a previously unidentified class of U6 snRNP-associated core-
like proteins. For this reason, SDB23 has been given the more logical name USSJ (U-





ARS Autonomous Replication Sequence 
ATP Adenosine 5' -triphosphate 
BCIP 5-Bromo-4-Chloro-3-Indolyl Phosphate 
bisacrylamide N, N'-methylene-bisacrylamide 
BLAST Basic Local Alignment Research Tool 
bp Base pair 
BSA Bovine Serum Albumin 
CEN Centromere Sequence 
cDNA Complementary Deoxyribonucleic Acid 
CTP Cytidine 5' -triphosphate 
Da Dalton 
dATP Deoxyadenosine triphosphate 
dCTP Deoxycytidine triphosphate 
ddATP Dideoxyadenosine triphosphate 
ddCTP Dideoxycytidine triphosphate 
ddGTP Dideoxyguanosine triphosphate 
ddTTP Dideoxythymidine triphosphate 
DEPC Diethylpyrocarbonate 
DNA Deoxyribonucleic acid 
DNase Deoxyribonuclease 
dNTP Deoxynucleoside triphosphate 
ds Double-stranded 
DTF Dithiothreitol 
d'lTP Deoxythymidine triphosphate 
dUTP Dideoxyuridine triphosphate 
EDTA Ethylenediaminetetraacetic acid 





HEPES N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid 
IPTG Isopropyl-f-D-thiogalactopyranoside 










MOPS 3-(N-morpholino)propane-sulfonic acid 
NBT Nitroblue tetrazolium 
NP40 Nomdet P40 detergent 
nt Nucleotide 
NTP Nucleoside triphosphate 
0D260 Optical Density at 260 nm 
OLB Oligonucletide Labelling Buffer 
ONIPG O-nitrophenyl--galactosidase 
vi 
ORF Open Reading Frame 
P Plasmid designation 
PAGE Polyacrylamide Gel Electrophoresis 
PBS Phosphate-Buffered Saline 
PCR Polymerase Chain Reaction 
PEG Polyethylene Glycol 
PI Isoelectric Point 
R Resistant 
RNA Ribonucleic Acid 
RNase Ribonuclease 
rRNA Ribosomal Ribonucleic Acid 
S Second(s) 
SDS Sodium Dodecyl Sulfate 
snRNA Small Nuclear Ribonucleic Acid 
snRNP Small Nuclear Riboncleoprotein Particle 
SSC Sodium Chloride/Sodium Citrate Buffer 
TAE Tris/Acetate (buffer) 
TB Tris/Borate (buffer) 
TBE Tris/Borate/EDTA (buffer) 
TBS Tris-buffered Saline 
'FE Tris/EDTA (buffer) 
TEMED N,N, N', N'-tetramethyl-ethylenediamine 
TMG Trimethylguanosine 







YCp Yeast Centromeric Plasmid 
YEP Yeast Episomal Plasmid 
YPDA Yeast/Peptone/Dextrose/Adenine (medium) 
YPGaIA Yeast/Peptone/Galactose/Adenine (medium) 
VIA II 
AMINo Am ABBREVIATIONS 
AMINO ACID THREE LETTER SINGLE LETTER 
ABBREVIATION ABBREVIATION 
Alanine Ala A 
Arginine Arg R 
Asparagine Asn N 
Aspartic Acid Asp D 
Cysteine Cys C 
Glutamic Acid Glu E 
Glutamine Gin Q 
Glycine Giy G 
Histidine His H 
Isoleucine Ile I 
Leucine Leu L 
Lysine Lys K 
Methionine Met M 
Phenylalanine Phe F 
Proline Pro P 
Serine Ser S 
Threonine Thr T 
Tryptophan Trp W 
Tyrosine Tyr Y 
Valine Val V 
viii 
CHAPTER ONE - NUCLEAR PRE-MRNA SPLICING 
INTRODUCTION 	 2 
1.1 NUCLEAR PRE-MRNA SPLICING 2 
1.1.1 Nuclear Pre-mRNA Structure 4 
1.1.2 Splicing Reaction 5 
1.2 SMALL NUCLEAR RIBONUCLEOPROTEINS - SNRNPS 7 
1.2.1 General Composition of SnRNP Particles 8 
1.2.2 Spliceosome Assembly Pathway 8 
1.2.3 UsnRNAs 12 
U snRNA Maturation 12 
SnRNA-Sm Site 13 
1.2.4 Core Sm Proteins 15 
Core Protein Complex Assembly 17 
1.2.5 SnRNP Particle Biogenesis 18 
1.2.6 Particle Specific Proteins 20 
U] snRNP 20 
U2snRNP 21 
U5snRNP 24 
U41U6. U5 tri-snRNP 25 
1.3 NON-SNRNP SPLICING FACTORS 26 
1.4 DYNAMIC REARRANGEMENTS DURING SPLICING 31 
1.5 PROTEIN MOTIFS IN SPLICING FACTORS 34 
RNA Binding Motif 34 
DEAD/H Box Motif 37 
Zinc-Finger like Motif 38 
-transducin 39 
CHAPTER Two - MATERIALS AND METHODS 
2.1 MATERIALS 43 
2.1.1 Chemicals 43 
Chemicals 43 
Enzymes and Antibodies 43 
2.1.2 General Information 43 
Sterilisation 43 
Deionisation of Solutions 43 
2.1.3 Bacteria and Yeast Growth Media 44 
2.1.4 Nutrients and Supplements 46 
2.1.5 Antibiotics 46 
2.1.6 Commonly Used Buffers 47 
2.1.7 Escherichia co/i Strains 48 
ix 
2.1.8 Yeast Strains 49 
2.1.9 Oligonucleotides 50 
2.1.10 Plasmids 53 
2.1.11 Antisera 61 
2.2 MICROBIOLOGICAL METHODS 62 
2.2.1 Growth of Strains 62 
Growth of Bacteria 62 
Growth of Yeast 62 
2.2.2 Strain Preservation 62 
Bacterial Strain Preservation 62 
Yeast Strain Preservation 62 
2.2.3 Sporulation of Yeast 63 
Growth of diploid 63 
Tetrad Dissection 63 
2.2.4 Transformation of E. coli 64 
Preparation of Competent E. coli cells 64 
Transformation of Competent E. coli cells 64 
2.2.5 Yeast Transformations 65 
2.2.6 Growth Curves 66 
2.3 NUCLEIC ACID METHODS 67 
2.3.1 Spectrophotometric Determination of DNA and RNA concentrations 67 
2.3.2 Restriction Digests Of DNA 67 
2.3.3 Precipitation of Nucleic Acids 67 
2.3.4 Agarose Gel Electrophoresis 68 
2.3.5 Isolation of DNA from Agarose Gel Slices 69 
2.3.6 Ligation of DNA 69 
2.3.7 'Filling in' of Recessed 3' Termini 70 
2.3.8 Amplification of DNA using the Polymerase Chain Reaction 70 
General PCR Reaction 70 
PCR on Bacteria Colonies 71 
2.3.9 Labelling DNA Fragments by Random-Priming 71 
Preparation of Probe DNA 71 
Incorporation of Radioactive Label 72 
'PurfIcation' of Random-Primed DNA Probes 72 
2.3.10 End-labelling of Oligonucleotides 73 
PurfIcation' of End-labelled Oligonucleotide Probes 73 
2.3.11 Plasmid DNA Preparations 73 
Small Scale Preparation 73 
Large Scale Preparation 74 
2.3.12 Yeast Genomic DNA Preparation 75 
2.3.13 Southern Blotting Procedures 76 
Transfer of DNA from Agarose Gels to Nylon Membranes 76 
Hybridisation of Randomly-labelled Probes to Nylon Membranes 77 
Membrane Stripping for Reprobing 78 
2.3.14 Total Yeast RNA Preparations 78 
x 
Isolation of RNA 78 
Purification of RNA 79 
2.3.15 Northern Blot Analysis 79 
Denaturing Agarose Gel Electrophoresis 79 
Transfer of RNA from Agarose Gels to Nylon Membranes 80 
Hybridisation of Randomly-labelled Probes to Nylon Membranes 80 
Polyacrylamide Gel Electrophoresis of RNA 80 
2.3.16 DNA Sequencing 82 
Preparation of Single-Stranded Plasmid DNA Templates 82 
Preparation of Double-Stranded Plasmid DNA Templates 82 
Primer Annealing Reactions 83 
(i) 	Single-Stranded Template Reactions 83 
(ii) Double-Stranded Template Reactions 83 
Labelling Reaction 83 
Termination Reaction 84 
2.3.17 Site-directed Mutagenesis 84 
Propagation of Uracil-containing Phagemids 85 
Harvesting Phagemid 85 
Titering Phagemid Stock 86 
Extraction of Phagemid 86 
Synthesis of the Mutagenic Strand 87 
(1) 	Phosphorylation of Mutagenic Oligonucleotide 87 
(ii) Annealing of Mutagenic Oligonucleotide to Template DNA 87 
(iii) 	Synthesis of the Complementary Strand 87 
(iv) 	Transformation of the reaction mix into E. coli DH5aF' 88 
(v) Selection by DNA Sequencing 88 
2.4 PROTEIN METHODS 88 
2.4.1 Quantifying of Total Cellular Protein 88 
2.4.2 Extraction of Total Cellular Protein 88 
Small Scale E. coli Extracts 88 
Large Scale E. coli Extracts 89 
(i) 	Soluble fraction 89 
(ii) Pellet fraction 90 
Yeast Protein Extraction 90 
2.4.3 SDS Polyacrylamide Gel Electrophoresis (SDS-PAGE) 91 
2.4.4 Coomassie Blue Staining of Polyacrylamide Gels 93 
2.4.5 Western Blotting 93 
Electrophoretic Transfer of Proteins onto P VDF Immobilon-P Membrane 93 
Blotting Procedure 93 
2.5 IN VITRO SPLICING REACTIONS 94 
2.5.1 Yeast Splicing Extract 94 
Cell Harvesting and Lysis 94 
Cell Homogenisation 95 
Post-Homogenisation Treatment of Extract 95 
Dialysis 95 
xi 
2.5.2 In vitro Transcription 96 
Preparation of DNA Template 97 
Transcription Reaction 97 
2.5.3 In vitro Splicing Assay 97 
Splicing extract preparation 98 
In vitro splicing reactions 98 
(i) 	RNA Analysis 98 
(ii) Splicing Complexes 99 
2.5.4 Non-Denaturing Gel Electrophoresis of Splicing Complexes 100 
2.5.5 Immunoprecipitations 102 
Immunoprecipitation of Proteins 102 
Immunoprecipitation ofsnRNAs 102 
2.6 IMMUNISATION PROCEDURES 103 
2.6.1 Expression of lacZ and trpE Fusion Protein 103 
Induction of lacZfusion proteins 103 
Induction of trpE fusion proteins 103 
2.6.2 Partial Purification of 3-galactosidase-Sdb23 Fusion Protein 104 
Partial Purification of Fusion Protein 104 
Concentration of Partially Purified -galactosidase-Sdb23 Fusion Protein 104 
2.6.3 Immunisation of Rabbits 105 
Immunisation 105 
Bleeds 105 
2.6.4 Serum Preparation and Storage 105 
2.7 COMPUTER ANALYSIS 106 
CHAPTER THREE - ISOLATION AND CHARACTERISATION OF SDB23 
INTRODUCTION 108 
3.1 ISOLATION OF THE SDB23 GENE 110 
3.1.1 SDB23 Gene Sequence 111 
3.2 SDB23 ENCODES A POLYPEPTIDE WITH Low BUT SIGNIFICANT 
HOMOLOGY TO SNRNP CORE PROTEINS 113 
3.3 SDB23 IS AN ESSENTIAL GENE 115 
3.4 IN Vivo DEPLETION OF SDB23p ARRESTS CELL GROWTH 115 
3.5 IDENTIFICATION OF SDB23 PROTEIN 120 
3.5.1 3-galactosidase-Sdb23 Fusion Protein 120 
3.5.2 Immunoblot Detection of Sdb23 Protein 120 
3.5.3 Anthranilate Synthase-Sdb23 Fusion Protein 121 
DISCUSSION 124 
xl' 
CHAPTER FOUR - SDB23 ENCODES A NOVEL SNRNP PROTEIN 
INTRODUCTION 128 
4.1 SDB23 PROTEIN IS REQUIRED FOR NUCLEAR PRE-MRNA SPLICING 129 
4.2 SD1323p IS REQUIRED PRIOR TO STEP 1 OF SPLICING IN VITRO 130 
4.3 SD1323p is ESSENTIAL FOR THE STABILITY OF U6 SNRNA 133 
4.4 SD1323p IS NOT REQUIRED FOR RNA POLYMERASE III TRANSCRIPTION 138 
4.5 ASSOCIATION OF SDB23p WITH U6 SNRNA 141 
DISCUSSION 144 
CHAPTER FIVE - EXTENSIVE SEQUENCE ANALYSIS IDENTIFIES A NOVEL 
PROTEIN MOTIF: THE SNRNP CORE PROTEIN MOTIF 
INTRODUCTION 148 
5.1 Ussi PROTEIN 149 
5.2 POTENTIAL RNA BINDING SITE 153 
5.3 SEQUENCE ANALYSIS OF CANONICAL SNRNP CORE PROTEINS AND 
Ussi PROTEIN 154 
5.3.1 snRNP Core Protein Motif 158 
5.4 CORE PROTEIN SUBFAMILIES ARE EVOLUTIONARILY CONSERVED 161 
5.5 Ussi PROTEIN REPRESENTS A NOVEL SUBFAMILY OF SNRNP CORE 
PROTEIN 162 
5.5.1 Putative Ussip Homologues 166 
5.5.2 U6-Associating Core-like Proteins 169 
5.6 FUNCTIONAL SIGNIFICANCE OF THE SNRNP CORE PROTEIN MOTIF 169 
DISCUSSION 172 
CHAPTER Six - FUNCTIONAL SIGNIFICANCE OF DOMAIN II AND THE 




6.1 	DOMAIN II OF Ussi PROTEIN IS NOT ESSENTIAL 
	
176 




6.1.2 UsslAp Can Rescue lethality of MCY4 on Glucose Medium 179 
6.1.3 Domain II is Necessary for Efficient Pre-mRNA Splicing In Vivo 182 
6.1.4 Residue(s) in Domain I Confer Usslp-U6 SnRNA Specificity 188 
6.2 FUNCTIONAL SIGNIFICANCE OF THE SNRNP CORE PROTEIN MOTIF 195 
DISCUSSION 209 
CHAPTER SEVEN - POTENTIAL INTERACTIONS BETWEEN Uss1, 
KNOWN Pm' PROTEINS AND U6 SNRNA 
INTRODUCTION 	 213 
7.1 OVEREXPRESSION OF U6 SNRNA CAN PARTIALLY COMPENSATE FOR 
THE Loss OFUSS1p 	 213 
7.2 OvEREXPRESSION OF USSJ ENHANCES THE TEMPERATURE-SENSITIVE 
PHENOTYPE OF KNOWN PRP MUTANTS 	 220 
DISCUSSION 	 224 




NUCLEAR PRE-MRNA SPLICING 
CHAPTER ONE 
	
NucL&R P-MRNA SPLICING 
INTRODUCTION 
The formation of functional, mature messenger ribonucleic acid (mRNA) in 
the nucleus of many eukaryotic cells includes several biochemical events: 
Covalent modification of the 5' end, that is the addition of 7-methyl 
guanosine triphosphate during precursor synthesis, 
methylation of selected adenosine residues, 
cleavage and polyadenylation of the 3' end, and 
splicing, that is the removal of (usually) non-coding intervening 
sequences (introns), and the pairing of adjacent coding sequences 
(exons), to generate the mature mRNA. 
RNA splicing is an essential process in higher eukaryotes for gene organisation and 
expression. The splicing of RNA genes was first suggested over sixteen years ago 
with the discovery of small intervening sequences in adenovirus (Berget et al., 
1977; Chow et al., 1977). Since then introns have been identified in eukaryotic 
genes encoding ribosomal RNAs (rRNA), mRNAs, small nuclear RNAs 
(snRNAs), in archaebacterial tRNAs and in bacteriophage T4. 
This chapter will describe nuclear pre-mRNA splicing in mammalian and yeast 
cells, highlighting the complexity and dynamic nature of this reaction. 
1.1 Nuclear Pre-mRNA Splicing 
In higher eukaryotes many nuclear protein-coding genes are interrupted by 
at least one intron, typically many more. This complexity is best illustrated by the 
human dystrophin gene that spans two megabases of DNA and contains at least 
sixty five introns. As a consequence of accurately and reproducibly recognising 
PA 
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and removing introns, splicing is an important step in regulating gene expression. 
A gene may be switched on or off, or a number of proteins differing in their 
structural domains generated through regulated, alternative pre-mRNA splicing 
(reviewed in Rio, 1993 and references therein). 
Saccharomyces cerevisiae differs from higher eukaryotes in that the number of 
intron-containing genes is rather small and the majority only contain a single 
intron. MA Ta] and the ribosomal protein gene RPL8A are exceptions, each 
containing two small introns. Yeast introns, defined by well conserved sequence 
elements, tend to be located near the extreme 5' end of a nascent transcript. In 
mammalian cells, the 5' cap structure of pre-mRNAs improves splicing in vitro 
(Konarska et al., 1985) and it is possible that the conserved location of introns in 
yeast acts to enhance splicing efficiency, by promoting an interaction between 
components of the splicing machinery and the 5' cap and/or proteins associated 
with the cap. 
S. cerevisiae is a rapidly dividing organism and there tends to be a strong selection 
for a trim genome, facilitated by efficient homologous recombination (Fink, 1987; 
Rodriguez-Medina and Rymond, 1994). Through the combined approaches of 
biochemical analyses and sequence comparisons, it has been estimated that only 
2.5% of non-ribosomal protein yeast genes appear to contain an intron compared 
to approximately 57% of all sequenced ribosomal protein genes (Woolford and 
Warner, 1991; Rodriguez-Medina and Rymond, 1994). Most introns have no 
apparent function, however, many of the yeast intron-containing genes do encode 
essential functions, so accurate splicing is obligatory for cell viability. 
3 
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The mechanism of pre-mRNA splicing has been studied extensively both in yeast 
and mammalian cells through the development of in vitro splicing assays 
(Hernandez and Kellar, 1983; Padgett et al., 1983; Kramer et al., 1984; Lin et 
al., 1985) and by exploiting the amenability of yeast to genetic manipulation 
(reviewed in Ruby and Abelson, 1991; Beggs, 1995). These studies have revealed 
a basic two-step splicing reaction evolutionarily conserved in eukaryotic species 
(Section 1.1.2; reviewed in Kramer, 1995). 
1.1.1 Nuclear Pre-mRNA Structure 
Yeast introns are defined by three short conserved sequence elements: the 
5' splice site; the 3' splice site; and the branch point (Figure 1.1). The importance 
of these sequences has been demonstrated in vitro and in vivo through site-directed 
mutagenesis and analysing the effects of naturally occurring mutations. The 5' and 
3' splice sites are essential for the removal of introns but are insufficient to account 
for the specificity and efficiency associated with splicing. Additional cis-acting 
elements that influence splicing include exon sequences flanking the intron 
(Newman and Norman, 1991; 1992), the position of conserved sequences relative 
to each other, the size of the intron, and the presence of a polypyrimidine-rich 
sequence adjacent to the 3' splice (Mount, 1982). This sequence is generally more 
pronounced in mammals than in yeast, and plays a significant role in promoting 
efficient splicing of mammalian introns. Mammalian introns are defined by the 
same but less well conserved elements, probably reflecting differences between the 
splicing machinery of these two systems. Indeed, transcripts from other organisms 
are not accurately spliced in yeast because their intron sequences are inappropriate 
(Beggs et al., 1980). However, yeast transcripts are spliced in mammalian in vitro 
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5 'ss 
	 Branch point 	 3'ss 
Exoni 1/GU 	 - UACUAAC 	 lAG I Exon 2 
Variable Distance 	 20 - 50 nucleotides 
Yeast 5' ss 	Consensus: AG/GUAUGU 	Yeast 3' ss Consensus: CAGIG 
Mammalian 5 ss Consensus: AG/GURAGU Mammalian 3' ss Consensus: YAGIG 
Figure I.I. Schematic representation of a yeast nuclear pre-mRNA intron indicating the 
positions of the three conserved elements: 5' ss, 5' splice site; 3' ss, 3' splice site; and 
branch point where A is the site of branch formation. Distance between the 5' splice site 
and the branch point is intron-dependent. However, splicing efficiency is affected if this 
distance is less than 45 nucleotides or greater than 700-1000 nucleotides. The branch 
point sequence is typically located 20-50 nucleotides upstream of the 3' splice site. Splice 
site consensus sequences for yeast and mammalian introns are indicated where R=Purine, 
Y=Pyrimidine, and / indicates a splice site. 
The low information content of nuclear pre-mRNA introns is probably 
compensated for by a myriad of trans-acting factors, both proteins and RNAs. 
Extensive, dynamic RNA-RNA and RNA-protein interactions probably permit 
precise recognition and alignment of the splice sites. 
1.1.2 Splicing Reaction 
The basic nuclear pre-mRNA splicing reaction involves two distinct trans-
esterification reactions (Figure 1.2; reviewed in Moore, et al., 1993; Kramer, 
1995). The first step involves cleavage of the pre-mRNA at the 5' splice site, a 
reaction initiated by the direct nucleophilic attack of the 2' hydroxyl group of the 
branch site adenosine residue on the phosphodiester bond at the 5' splice site. This 
results in the formation of a free exon 1 and an intron-exon 2 branched RNA-lariat 
as reaction intermediates. The second step involves cleavage at the 3' splice site as 
a result of a second nucleophilic attack on the phosphodiester bond joining the 3' 
5 
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splice site. This reaction joins exon 1 and exon 2 through a 3'-5' phosphodiester 
bond and releases free, intact intron as an RNA-lariat which is rapidly degraded in 
vivo. 
ATP hydrolysis is required for nuclear pre-mRNA splicing, although the sequential 
trans-esterification reactions are believed to be energy-independent. Splicing is 
dependent upon the formation of a large and highly dynamic ribonucleoprotein 
complex, the spliceosome, formed by the assembly of multiple RNA and protein 
factors onto the pre-mRNA template. Assembly of this complex proceeds in an 
ordered, stepwise manner and a number of distinct complexes reflecting 
spliceosome formation can be resolved in vitro by non-denaturing gel 
electrophoresis and gradient sedimentation (Pikielny et al., 1986; Michaud and 
Reed, 1991). The energy derived from ATP hydrolysis during the splicing reaction 
may be used to drive spliceosome assembly and/or spliceosome rearrangements 
that occur as the reaction proceeds. Additionally, ATP hydrolysis may have a 
proof-reading function, influencing accuracy of splice site selection in a model 
analogous to the ribosome proof-reading mechanism (Burgess and Guthrie, 1993). 
[1 
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Free Exon 1 Exon 2-hUron Lariat 






Figure 1.2. Schematic representation of the catalytic steps of nuclear pre-nRNA splicing. 
Exon sequences (boxes), intron sequence (line) and conserved nucleotides as well as the 
phosphates at the splice sites and hydroxyl group of the branch point adenosine are 
indicated. In step 1 of the reaction, the 5' splice site is cleaved and exon 1 and intron-
exon 2 lariat intermediates are formed. In Step 2, 3' splice site cleavage occurs, the two 
exons are ligated and the intron is released in the form of a lariat for subsequent 
degradation. 
1.2 Small Nuclear Ribonucleoproteins - snRNPs 
Conserved sequences within the primary transcript are not sufficient to 
catalyse the accurate, specific removal of introns. The splicing reaction is 
dependent upon the formation of the spliceosome, a complex of trans-acting 
factors that interact and associate with one another and with the pre-mRNA cis- 
PRE-mRNA 
INTERMEDIATES 
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elements. The major subunits of the spliceosome are five small nuclear 
ribonucleoprotein particles (snRNPs); Ui, U2, U4, U5 and U6. These snRNPs, in 
conjunction with additional protein factors, play critical roles in defining introns 
and folding pre-mRNAs into a conformation suitable for catalysis, and may play 
catalytic roles in the splicing reaction (reviewed in Moore et al., 1993). 
1.2.1 General Composition of SnRNP Particles 
As characterised in metazoans each snRNP, with the exception of U6, is 
composed of a single snRNA transcribed by RNA polymerase II with a 2,2,7-tn-
methlyguanosine cap (TMG-cap), a set of small common core proteins (B, B', Dl, 
D2, D3, B, F and G; in order of decreasing apparent molecular weight) and a 
variable number of snRNP-specific proteins (Table 1.1; reviewed in LUhrmann et 
al., 1990; Kramer, 1995). Unlike the others, U6 snRNA is transcribed by RNA 
polymerase III, has a y-monomethyl cap and does not directly bind the common 
core proteins since it lacks the appropriate structural motif, the Sm site (Section 
1.2.3; Branlant et al., 1982). In yeast Ui, U2 and US snRNAs exist as monomeric 
snRNP particles whereas the majority of U4 snRNA exists base-paired to U6 
snRNA in the same snRNP particle, U4/U6 snRNP (Fortner et al., 1994). 
1.2.2 Spliceosome Assembly Pathway 
The first step in spliceosome assembly involves the ATP-independent 
formation of the commitment complex which contains Ui snRNP and a number of 
non-snRNP protein factors (Figure 1.3; Séraphin and Rosbash, 1989; Rosbash and 
Séraphin 1991). Ui snRNP binds to the 5' splice site through base-pairing between 
a short, conserved sequence at the 5' end of Ui snRNA and a complementary 
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sequence at the 5' splice site. Following assembly of the commitment complex U2 
snRNP stably binds to the branch point sequence of the substrate pre-mRNA. 
Watson-Crick base-pairing between nucleotides near the 5' end of U2 snRNA and 
the UACUAAC sequence leaves the branch point adenosine (A) unpaired and free 
to initiate the first trans-esterification step of splicing (Parker et al., 1987; Query 
et al., 1994). Binding of U2 snRNP to the pre-mRNA is the first ATP-dependent 
step in spliceosome assembly and is promoted by Ui snRNP and other proteins 
within the commitment complex. The subsequent addition of pre-formed 
U4/U6.U5 tri-snRNP complex and numerous non-snRNP factors results in the 
formation of an active splicing complex. This highly simplified scheme for the 
assembly of an active spliceosome is represented diagramatically in Figure 1.3. 
As will be discussed many components are necessary both for the association of 
snRNP particles onto the pre-mRNA and the catalytic steps of splicing (reviewed 
in Moore et al., 1993; Kramer, 1995). The following sections describe in more 
detail some of these components, highlighting the complexity of the individual 
snRNP particles. 
TABLE 1.1 
COMPLEXITY OF MAMMALIAN SNRNP PARTICLES 
SMALL NUCLEAR RNA U! U2 U5 U4 U6 
SIZE 165 188 118 145 107 
(Nucleotides) 
ESTIMATED ABUNDANCE lx 106 5x105 2x105 2x105 4x105 
(Copies/cell) 
CAP STRUCTURE m3GpppA m3GpppA m3GpppA m3GpppA mpppG 
snRNP ASSOCIATED PROTEINS 12S UI 12S 	17S 20S U5 25S 12S U41U6 
U2 U2 U41U6.U5 
0(9kDa) + + 	+ + + + 
F(llkDa) + + + + + + 
E(l2kDa) + + 	+ + + + 
D1(l6kDa) + + + + + + 
D2(165kDa) + + 	+ + + + 
D3(18kDa) + + + + + + 
B(2SkDa) + + 	+ + + + 
B(29kDa) + + + + + + 
C(22kDa) + 
A(34kDa) + 
70K (70 kDa) + 
B"(29.5 kDa) + 	+ 







120 kDa + 
150 kDa + 
160 kDa + 
l5kDa + + 
4OkDa + + 
52kDa + + 
lOOkDa + + 
lO2kDa + + 
llOkDa + + 
ll6kDa + + 
200kDa + + 
2O5kDa + + 
15.5 kDa + 
2OkDa + 
27kDa + 
6OkDa + + 
9OkDa + + 
m3GpppA, 2,2,7 tri-methylguanosine cap; mpppG, y-monomethyl phosphate ester. 
Adapted from Lührmann et al., 1990; Will et al., 1993; Baserga and Steitz, 1993; Kramer, 1995 
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Figure 1.3. Simplified spliceosome assembly pathway depicting the ordered addition of 
snIRNP particles onto the substrate pre-mRNA. Ui snRNP assembles first onto the 5 
splice site forming a commitment complex. This is converted into a prespliceosome by the 
addition of U2 snRNP. U5 snRNP first interacts with the U4/U6 snRNP to form a 
U4/U6.U5 tri-snRNP complex which then associates with the U1-U2 prespliceosome 
complex, together with numerous non-snRNP protein factors, to form an active 
spliceosome. 
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1.2.3 UsnRNAs 
Mammalian U snRNAs are typically encoded by more than one gene and 
represent the most abundant class of RNA molecule in the nucleus, present in 
approximately 105106 copies per cell (Table 1.1). In contrast, yeast U snRNAs 
are in low abundance, less than 200 copies per cell, and each is encoded by a 
single gene. U6 snRNA is the most evolutionarily-conserved of the spliceosomal 
snRNAs, the yeast molecule being over 60% identical to its mammalian 
homologue (Brow and Guthrie, 1988). Other yeast U snRNAs have retained only 
limited regions of primary sequence similarity. For example, yeast Ui snRNA is 
568 nucleotides long compared to 165 nucleotides and contains internal sequences 
that are phylogenetically variable but which appear to be functionally non-essential 
(Siliciano et al., 1987; 1991). Strikingly however, the predicted secondary 
structures of these individual snRNA molecules have been well conserved even 
though their sizes can vary so widely (Guthrie and Patterson, 1988). The highly 
conserved primary sequence of U6 snRNA, coupled to its close proximity to 
putative catalytic centres of the splicing reaction, has led to the proposal that U6 
snRNA comprises part of the catalytic core of the spliceosome (reviewed in 
Madhani and Guthrie, 1994). 
U snRNA Maturation. The Ui, U2, U4 and US snRNAs are synthesised in the 
nucleus by RNA polymerase II (Dahlberg and Lund, 1988) and acquire a 
m7GpppG cap co-transcriptionally (Reddy and Busch, 1988). Soon after synthesis 
the precursor U snRNAs are exported to the cytoplasm by an as yet 
uncharacterised mechanism, one which appears to involve multiple cis-signal 
elements. For example, export of precursor Ui snRNA is dependent upon two 
signal domains in the 5' and 3' regions of the snRNA (Terns et al., 1993). The 
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m7GpppG cap structure enhances the export of Ul snRNA but is neither sufficient 
nor essential for this process (Mattaj, 1986; Terns et al., 1993). Once in the 
cytoplasm, the precursor U snRNA is modified; the snRNP-particle proteins bind, 
the cap structure is hypermethylated and the 3' end is partially shortened. The 
assembled snRNP-particle is then imported back into the nucleus via a receptor 
mediated pathway where final 3' end modifications take place (Yang et al., 1992). 
Import of snRNPs is dependent on several structural features, including core 
protein-association and the 5' tri-methylated cap structure (Hamm et al., 1987, 
1990a; Fischer and Lührmann, 1990; Fischer etal., 1991; 1993). 
U6 snRNA is transcribed in the nucleus by RNA polymerase III where it rapidly 
undergoes several modifications without ever entering the cytoplasm (Vankan et 
al., 1990). The precursor cap structure is readily modified to form a 7-monomethyl 
phosphate cap (Singh et al., 1990) and the 3' end is elongated by the addition of non-
templated uridylates to which the nuclear protein La binds (Venrooij van et al., 
1993). U6 snRNA may lack signals necessary for its export from the nucleus 
(Terns et al., 1993). Alternatively, this snRNA molecule may be actively retained 
within the nucleus (Boelens et al., 1995). 
SnRNA-Sm Site. Each snRNA, with the exception of U6, contains a short 
consensus sequence called the Sin site. This single-stranded region of RNA flanked 
by hairpin loops is rich in uridylic acid residues (Figure 1.4; Branlant et al., 
1982). The Sm site is the target sequence for core protein assembly onto nascent 
snRNA molecules, an essential step in biogenesis of the snRNP particles. 
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YEAST CONSENSUS: 	A(U3..6)GPu 
MAMMALIAN CONSENSUS: PuA(U3..4)GPu 
Figure 1.4. Sm Consensus sequence for yeast and mammalian snRNAs. A=Adenosine; 
G=Guanosine; U=Uridylic acid; Pu=Purine (A or 0). Spacing parameters are indicated 
by numbers. 
Point mutation and deletions of the Sm site in yeast spliceosomal snRNAs can have 
a marked effect both on snRNP assembly and snRNA stability, and may block 
splicing both in vivo and in vitro (McPheeters et al., 1989; Jones and Guthrie, 
1990; Siliciano et al., 1991). However, despite being highly conserved the Sm 
consensus sequence is tolerant to change. Saturation mutagenesis of the yeast U5 
snRNA Sm site demonstrated that only three of the ten consensus nucleotides 
(UAUUUUUUGG; critical residues underlined) were sensitive to single point 
mutations, the changes conferring a lethal or conditional lethal phenotype (Jones 
and Guthrie, 1990). Nucleotides bordering these three critical residues were 
relatively insensitive to single nucleotide changes, however, multiple mutations at 
these sites did cause decreased steady state levels of U5 snRNA in vivo and severe 
growth defects (Jones and Guthrie, 1990). Complete deletion or substitution of the 
yeast US snRNA Sm site with the sequence UCGGGGGGUU was lethal, 
demonstrating the functional importance of this site. Similar mutation analysis of 
the yeast U4 snRNA Sm site (AAUUUUUGG; mutated residues underlined) 
confirmed the functional significance of the central uridylic acid residues (Hu et 
al., 1995). Rather surprisingly however, deleting the corresponding Sm site of the 
HeLa cell U4 snRNA did not have a great effect on in vitro splicing or 
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1.2.4 Core Sin Proteins 
Ui, U2, U4/U6 and U5 snRNPs are each associated with a single set of 
core proteins, B/B', Dl, D2, D3, E, F, and G (LUhrmann et al., 1990). In 
addition, a 69 kDa protein has been identified that associates with each of these 
spliceosomal snRNPs. However, this protein appears to only interact transiently 
and is not considered a genuine core polypeptide (Hacki et al., 1994). The 
assembly of the core proteins on the snRNA Sm site is an important step in the 
biogenesis of a snRNP particle: cytoplasmic cap tri-methylation and nuclear 
localisation of snRNPs are two core protein-dependent functions (see below; Mataj 
and De Robertis, 1985; Hamm et al., 1990b; Fischer et al., 1993; Plessel et al., 
1994). The core proteins are sometimes referred to as Sm proteins because of their 
reaction with anti-Sm antibodies from patients with the autoimmune disorder 
systemic lupus erythematosus (Lerner and Steitz, 1979). These antibodies have 
been useful in establishing a role for snRNP particles in splicing. 
cDNAs encoding all of the mammalian snRNP core proteins have now been 
isolated from HeLa cells and sequenced (Hermann et al., 1995 and references 
therein). Computer based-sequence comparisons have revealed that all of these 
proteins share two regions of homology, termed the Sm motif (Hermann et al., 
1995; Séraphin, 1995) or snRNP core protein motif (Cooper et al., 1995). The 
identification of this motif and the implications for snRNP core protein function 
will be discussed in greater detail within the context of this thesis. 
With yeast, the ability to combine modern molecular biology and genetics with 
biochemistry has led to the relatively rapid identification and characterisation of 
new factors involved in the nuclear pre-mRNA splicing reaction (reviewed in Ruby 
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and Abelson, 1991; Rymond and Rosbash, 1992; Beggs, 1995). However, 
conventional genetic screens for splicing mutants have been far from saturating. 
Most notable is the failure of these screens to isolate mutants affecting the 
homologues of the mammalian snRNP core proteins. All the evidence available 
suggests that yeast homologues of the Sm-binding core proteins do exist. Firstly, 
the yeast Ul, U2, U4, and U5 snRNAs, although not closely conserved in primary 
sequence, do contain Sm sites (Riedel et al., 1987). These sites are biologically 
functional (Riedel et al., 1987) and required for snRNP stability (Jones and 
Guthrie, 1990). Secondly, the yeast snRNAs can be immunoprecipitated (albeit 
weakly) by human anti-Sm antisera (Siliciano et al., 1987; Tollervey and Mattaj, 
1987), indicating that epitopes of the core proteins have been conserved to some 
degree. Thirdly, large scale immunoaffinity purification of spliceosomal snRNPs 
from yeast has detected a number of candidates for snRNP core proteins (Fabrizio 
et al., 1994). Two yeast genes, SMD1 and SMD3, that encode polypeptides 
homologous to the human Dl and D3 proteins have now been identified 
fortuitously as neighbours of PRP38 and PEP3 respectively (Rymond, 1993; 
Lehmeier et al., 1994; Roy elal., 1995). Both these polypeptides contain the Sm 
motif characteristic of mammalian core proteins and are essential for the stability 
of spliceosomal snRNAs. The removal of either of these proteins causes a dramatic 
reduction in the levels of Ui, U2, U4 and U5 snRNAs but leaves the level of U6 
snRNA relatively unaffected (Rymond et al., 1993; Roy et al., 1995). U6 snRNA 
does not associate with the core polypeptides and is not dependent on the formation 
• of the Sm core structure for stability. Recently, the Sm motif has been used to 
recover new 'Sm-like' proteins from sequence databases, including putative yeast 
homologues of the mammalian core proteins F and G (Hermann et al., 1995; 
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Core Protein Complex Assembly. Extensive studies in mammalian cells have 
shown that core proteins associate with one another, in an ordered step-wise 
manner, to form a cytoplasmic RNA-free protein complex prior to assembling onto 
the snRNA Sm site (Figure 1.5; Fisher et al., 1985; Lehmeier et al., 1994; 
Hermann et al., 1995; R. Lührmann personal communication). The first step 
involves formation of a 6S RNA-free particle containing Dl, D2, E, F, and G core 
polypeptides. This complex interacts with the snRNA Sm site in the absence of the 
remaining core proteins. Formation of the Sm core structure is completed by the 
addition of a second pre-formed protein complex containing B/B' and D3 
polypeptides (Hermann et al., 1995). 
To date, a direct interaction between a core protein and an snRNA molecule has 
been demonstrated only for the snRNP-G polypeptide and the Sm site of Ui 
snRNA (Heinrichs et al., 1992). Significantly, none of the eight core proteins 
contains any of the known RNA binding motifs (reviewed in Birney et al., 1993; 
Burd and Dreyfuss, 1994 and references therein). The ability of snRNP core 
proteins to form stable complexes in the absence of an RNA molecule implies that 
protein-protein interactions are dominant over protein-RNA interactions within the 
snRNP particle. The Sm motif is essential for complex formation in vitro between 
B and D3 proteins, suggesting this region may be important for mediating these 
protein-protein interactions (Hermann et al., 1995). It is possible that an RNA 
recognition domain is generated by the assembly of the individual core proteins. It 
has previously been determined that the ribosomal proteins S6 and S18 are 
mutually dependent for their binding to 16S RNA (Mizushima and Nomura, 1970). 
In addition, two signal recognition particle (Sip) polypeptides, Srp9 and Srpl4, 
must first form an RNA-free heterodimer to permit efficient binding to SRP RNA 
(Strub and Walter, 1990). 
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(B:. 
Sm core structure 
Figure 1.5. Schematic representation of core protein associations leading to the formation 
of a cytoplasmic Sm core structure. In mammalian cells, snRNP assembly begins with the 
interaction of E, F, G, Dl, and D2 core proteins to form a 6S snRNA-free protein 
complex that associates with the Sm site of nascent snRNA molecules (Fisher et al., 
1985; R. Lührmann, personal communication). Formation of the Sm core is completed by 
the addition of a preformed [B/B', D3] protein complex (Hermann et al., 1995; R. 
Lührmann, personal communication). This diagram indicates that both B and B' are 
components of the Sm core structure. However, it is not known if both or only one of 
these closely related polypeptides assemble into the core-protein complex. 
1.2.5 SnRNP Particle Biogenesis 
The biogenesis of a snRNP particle is outlined in Figure 1.6. With the 
exception of U6 snRNA, newly transcribed U snRNAs with their co-
transcriptionally added 7-methyl guanosine cap are exported to the cytoplasm 
where they assemble with the core proteins to form an Sm core structure (Figure 
1.5; Mattaj, 1988). 
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Figure 1.6. Schematic representation of snRNP particle biogenesis. Nascent snRNA 
transcripts are transported from the nucleus into the cytoplasm via an as yet 
uncharacterised receptor-mediated process. Once in the cytoplasm core proteins interact 
with the Sm site of the snRNA molecule to form a stable Sm core particle. This triggers 
cap modification and nuclear relocalisation of the RNP particle. SnRNP-specific proteins 
can associate with the Sm core structure prior to, during or after nuclear relocalisation. 
The formation of the Sm core structure is a pre-requisite for cap hypermethylation 
to form a tri-methylguanosine cap. Plessel et al. (1994) have proposed that 
formation of the Sm core structure creates a binding site for the cap-methylating 
enzyme, snRNA-(guanosine-N2)-methyltransferase. Re-entry of the Sm core 
complex back into the nucleus is facilitated by a bipartite nuclear localisation signal 
consisting of the tri-methylguanosine cap and an undefined region of the Sm core 
domain. 
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SnRNP-specific proteins can associate with the Sm core prior to, during or after 
nuclear relocalisation. The core proteins (individually or as a core complex) may 
provide a flexible platform with which these proteins can associate, adding stability 
to the snRNP particle (Nelissen et al., 1994). Focusing on the Ui snRNP, 
Nelissen et al. (1994) detected direct protein-protein interactions between the Ui 
specific proteins (70K, A and C; Table 1. 1), and the core proteins B, B' and D2. 
These interactions occur in addition to established protein-RNA interactions 
between Ui snRNA and snRNP-specific proteins (Section 1.2.6; Scherly et al., 
1989; Query ëtal., 1989). 
1. 2.6 Particle Specific Proteins 
Ui snRNP. In addition to the common core proteins each snRNP contains a 
number of particle-specific proteins (Table 1.1; Luhrmann et al., 1990b; Will et 
al., 1993). The Ui snRNP contains three such proteins; Ui-A, U1-70K and Ui-C. 
These particle-specific proteins are not required for the nuclear localisation of the 
snRNP particles and are transported into the nucleus independently of the Ui 
snRNP through nuclear localisation signal sequences encoded within the protein 
(Kambach and Mattaj, 1992; Romac etal., 1994). Ui-A and U1-70K, members of 
a large family of RNA binding proteins that contain a conserved RNA recognition 
domain (reviewed in Birney et al., 1993; Burd and Dreyfuss, 1994), bind directly 
to stem-loop structures of Ui snRNA. In contrast, Ui-C does not contain any 
recognised RNA binding motif and is dependent upon protein-protein interactions 
between U1-70K, and similarly between the core polypeptides (BIB' and D2) for 
its assembly into Ui snRNP particles (Hamm et al., 1990b; Nelissen et al., 1994). 
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Interestingly, Ul-70K has an extensive serine/arginine (SR) domain and exists in 
multiple states of phosphorylation both in vitro and in vivo (Woppmann et al., 
1990; 1993). A number of studies have demonstrated that reversible 
phosphorylation of splicing factors is critical for splicing (Mermoud et al., 1992; 
1994; Tazi et al., 1992). In the absence of phosphatase activity, by the use of ATP 
analogues and phosphatase inhibitors, in vitro splicing is blocked at both steps of 
the reaction. Splicing complementation studies using in vitro thiophosphorylated 
Ui snRNPs demonstrated that the phosphorylation state of U1-70K is essential for 
the splicing reaction but not spliceosome formation (Tazi et al., 1993). Ui snRNP 
particles containing normally phosphorylated U1-70K restored active splicing. 
Yeast hornologues of the human Ui-A and U1-70K proteins, Mudip and Snplp 
respectively, have been identified (Liao et al., 1993; Kao and Siliciano, 1992). 
The overall sequence homology between the yeast and the human U1-snRNP 
specific proteins is poor, being at its greatest in the conserved RNA recognition 
motifs (RRM) identified in these proteins (Mattaj, 1993). 
To date, there is little evidence indicating functional roles for these Ui-specific 
proteins, although they may be involved in mediating protein-RNA and/or protein-
protein interactions related to the role of Ui snRNP in the splicing reaction 
(Heinrichs et al, 1990; Wu and Maniatis, 1993; Kohtz et al., 1994; Romac and 
Keene, 1995). 
U2 snRNP. Two distinct forms of U2 snRNP particles have been detected, 
depending on the physiological conditions used for their isolation. The 12S U2 
particle contains two specific proteins, U2A' and U2B". The 17S particle 
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contains, in addition to these two proteins, a further nine polypeptides ranging in 
apparent molecular weight from 35-160 kDa (Table  1.1). 
The precise function(s) of U2A' and U2B" are not known. Like Ui-A and Ui-
70K, U211" contains a recognised RRM. In the absence of U2A' this protein binds 
non-specifically to RNAs. The association of U2B" with U2A' results in a 
specific, high affinity interaction between U2B" and U2 snRNA. U2A' lacks an 
RNA binding domain but can interact specifically, albeit weakly, with U2 snRNA. 
This interaction is dependent upon the presence of U213" and is believed to 
stabilise the U2B"-U2A'-U2 snRNA complex (Boelens et al., 1990). The ability 
of U213" to bind specifically to U2 snRNA only in the presence of U2A' illustrates 
the importance of protein-protein interactions within a large snRNP particle. This 
is reminiscent of the two signal recognition peptides Srp9 and Srpl4 which 
associate specifically with SRP RNA only following the formation of a 
heterodimer, Srpl4p enhancing the weak, inherent ability of Srp9p to bind RNA 
(Strub and Walter, 1990). 
The 17S U2 particle-specific proteins represent one of the most well studied class 
of mammalian snRNP-specific proteins and are essential for the formation of 
spliceosome complexes (reviewed in Hodges and Beggs, 1994; Kramer, 1995). 
These proteins associate with the 5' end of U2 snRNA, a region distinct from that 
upon which the core proteins and U2A' and U213" bind. At least six of the 17S 
particle-specific proteins have been isolated from HeLa nuclear extracts as two 
tightly associated protein complexes, SF3a and SF3b. SF3a, composed of three 
associated subunits of 60, 66 and 120 kDa, (SF3a 6O, SF3a66 and SF3ai 2O), 
interacts with the 12S U2 snRNP particle in an SF3b-dependent manner to 
generate an active 17S U2 snRNP particle. Both of these splicing factors are 
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required for the assembly of the mature U2 snRNP particle and targeting of this 
snRNP to the pre-mRNA (Brosi et al., 1993a; 1993b). All three of the SF3a 
polypeptides can be cross-linked to the 3' splice site region but the functional 
significance of these interactions remains to be defined (Staknis and Reed, 1994). 
However, protein-RNA interactions between these proteins and the substrate pre-
mRNA may be important for targeting U2 snRNP onto the pre-mRNA during 
spliceosome formation, or may stabilise interactions formed following the 
assembly of U2 snRNP into the pre-spliceosome complex. 
Three essential splicing factors required for the assembly of the yeast pre-
spliceosome complex, Prp9, Prpl 1 and Prp2l polypeptides (.Pre-m—RNA 
Processing), have been identified and appear to represent a complex analogous to 
the mammalian SF3a splicing factor (Brosi et al., 1993b; Bennett and Reed, 1993; 
Legrain and Chapon, 1993). On the basis of immunological cross-reactivity and 
structural similarity these proteins represent homologues of the mammalian 
SF3a60 , SF3a66 and SF3a 12° proteins respectively (Brosi et al., 1993b; Bennett 
and Reed, 1993; Behrens et al., 1993; Chiara et al., 1994; Kramer et al., 1994; 
Kramer et al., 1995). SF3a6° and Prp9 proteins have been evolutionarily well 
conserved, each containing a zinc finger-like motif which is functionally 
exchangeable in vivo (Kramer et al., 1994). Mutation analysis of the PRP9 gene 
has demonstrated that this motif is critical for the function of Prp9p and the 
assembly of pre-spliceosome complexes. 
In yeast, extensive genetic suppression analyses (Ruby et al., 1993; Wells and 
Ares, 1994) have demonstrated a complex interrelationship between PRP9, PRPJJ, 
PRP21 and SNR20 (U2 snRNA), implying that a number of physical and/or 
functional interactions occur between these splicing factors within the U2 snRNP- 
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particle and the spliceosome. Physical protein-protein interactions between Prp9p 
and Prp2lp, and similarly between Prpl 1 and Prp21 proteins, have been 
confirmed using the yeast two-hybrid system (Legrain and Chapon, 1993; Beggs, 
1995). No physical interaction has as yet been demonstrated between Prp9p and 
Prpllp. Consistent with these data physical interactions between individual 
components of the mammalian SF3a complex have been demonstrated (Bennett and 
Reed, 1993; Chiara et al., 1994). 
U5 snRNP. The 20S U5 snRNP particle contains a number of specific proteins 
ranging from 15-205 kDa (Table 1. 1), that are retained following the formation of 
the U4/U6.U5 tri-snRNP complex. One of these, the 200 kDa protein, has been 
evolutionarily well conserved implicating a functionally important and conserved 
role in the splicing reaction (Hodges et al., 1995). Its yeast homologue is Prp8p, 
an essential 280 kDa protein that is present in the spliceosome throughout the 
splicing reaction (Lossky et al., 1987; Whittaker et al., 1990). This protein is 
required for the formation of the U4/U6.U5 tri-snRNP complex and its assembly 
into spliceosomes. Genetic and biochemical data imply that Prp8p is also important 
in stabilising RNA structures (Jamieson et al., 1991; Brown and Beggs, 1992). 
During its association with the spliceosome Prp8p makes direct contact with the 
substrate pre-mRNA (Whittaker et al., 1990; Teigelkamp et al., 1995a). These 
interactions have been specifically mapped to nucleotides in the 5' exon adjacent to 
the 5' splice site, initiated prior to and probably maintained after the first trans-
esterification reaction. Interactions between nucleotides near the 3' splice site and 
branch point have also been observed at the time of the second trans-esterification 
reaction, locating Prp8p close to the proposed catalytic centres of the spliceosome 
(Teigelkamp et al., 1995b; Umen and Guthrie, 1995). Biochemical data implying 
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similar interactions between the mammalian homologue and substrate pre-mRNA 
have been observed (MacMillan et al., 1994). 
Genetic and biochemical data have identified interactions between U5 snRNA and 
exon-nucleotides during both chemical steps of splicing with similar kinetics to 
those of Prp8p (Newman and Norman 1991; 1992; Madhani and Guthrie, 1994). 
Interactions between Prp8p and the substrate pre-mRNA may effectively stabilise 
these interactions, possibly maintaining exon 1 and exon 2 in positions critical for 
catalysis (Teigelkamp et al., 1995b; Umen and Guthrie, 1995). 
U41U6. U5 tri-snRNP. The purification of the U4/U6.U5 tri-5nRNP particle 
from HeLa nuclear extracts identified a number of proteins only present in this 
complex and not in the individual U4/U6 and U5 snRNP particles. The function(s) 
of these proteins remains unclear at present. In contrast, largely through genetic 
approaches, a number of proteins have been identified as integral structural 
components of yeast U4/U6 and U4/U6.U5 tri-snRNP particles and their functions 
partially characterised. Prp24 protein has three RNA recognition motifs and is 
associated with U6 snRNA, being required for the U4-U6 interaction (Shannon and 
Guthrie, 1991; Ghetti et al., 1995). Prp3 and Prp4 proteins are components of the 
U4/U6 snRNP (Abovich et al., 1990; Banroques and Abelson, 1989; Bordonné et 
al., 1990; Xu et al., 1990), and Prp6p is a U4/U6.U5 tri-snRNP-associated 
protein required for the stability and accumulation of the tri-snRNP complex 
(Galisson and Legrain, 1993). Prp4p is thought to associate with the 5' stem-loop 
of U4 snRNA, although no direct RNA-protein interaction has been demonstrated 
(Bordonné et al., 1990; Xu et al., 1990). Prp4p is not required for maintaining the 
stability of U4 snRNA since heat-inactivation of a temperature-sensitive pip4-1 
strain significantly reduced the level of U6 but not U4 snRNA (Galisson and 
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Legrain, 1993). Glycerol gradient analysis of pqi4-1 snRNP fractions showed the 
presence of a free U4 snRNP particle in the absence of functional Prp4 protein and 
U6 snRNA. All of these proteins are required for RNA splicing and their in vivo 
inactivation influences the cellular levels of U6 snRNA (Blanton et al., 1992 and 
references therein; Hu et al., 1994). 
1.3 Non-snRNP Splicing Factors 
In addition to proteins that are tightly associated with snRNPs, other 
extrinsic trans-acting factors, or non-snRNP proteins, are required for splicing. 
Many of these factors are not stably associated with the spliceosome and often only 
interact transiently at a specific step in the splicing reaction. 
In mammalian cells, several non-snRNP proteins have been identified as important 
candidates for mediating the association of U2 snRNP into the commitment 
complex to form the pre-spliceosome. A family of related proteins rich in serine 
and arginine residues together with the splicing factor U2AF (U2 Auxiliary Eactor) 
play a critical role in recognising the 5' splice site and promoting the association of 
U2 snRNP. TJ2AF, composed of two subunits of 35 and 65 kDa, recognises and 
binds to the polypyrimidine-rich tract so prominent in mammalian introns 
downstream of the branch point sequence. U2AF65 binds specifically and with 
high affinity to the polypyrimidine tract in the absence of U2AF35 and 
independently of other spliceosomal components through three carboxy-terminal 
RNA binding domains (Zamore et al., 1992). This protein is also characterised by 
an amino-terminal region rich in serine and arginine residues, residues which are 
not required for the interaction of U2AF65 with the substrate RNA but which are 
essential for splicing. U2AF35 lacks an RNA binding domain but contains a 
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carboxy-terminal SR domain. This protein is believed to mediate protein-protein 
interactions that effectively bridge the 5' and 3' splice sites by interacting with 
members of the SR protein family (Figure 1.7). 
All SR proteins contain a domain rich in serine and arginine dipeptides at the 
carboxy-termini and a characteristic RRM near the amino-termini. They are 
capable of strongly influencing the choice of 5' splice site and are required both 
for constitutive and alternative splicing (reviewed in Valcárcel et al., 1995). 
Within a distinct subgroup of SR proteins which share a phosphoepitope recognised 
by the monoclonal antibody mAbl04, two members, ASF/SF2 (Alternative 
Splicing factor/splicing factor 2; Kramer et al., 1991) and SC35 (pliceosomal 
Component; Fu and Maniatis, 1992) have been extensively studied. Using a 
variety of techniques, Wu and Maniatis (1993) demonstrated that these proteins 
interact specifically with the Ui snRNP-specific protein U1-70K as well as with 
U2AF35, but not with U2AF65. On the basis of these interactions a model was 
proposed whereby the SR proteins bridge components bound to both the 5' splice 
site (Ui snRNP) and the 3' splice site (U2AF; Figure 1.7). 
Intrinsic differences between the structures of yeast and mammalian introns, most 
notably the lack of a prominent polypyrimidine tract in many yeast introns, 
suggests this organism may not rely on such a system for bridging the 5' and 3' 
splice sites. Significantly however, binding of Ul snRNP in yeast is affected by 
branch point mutations (Séraphin and Rosbash, 1989) suggesting a possible 
interaction between a component of the commitment complex and the branch point 
that stabilises the association of Ul snRNP and promotes the addition of U2 
snRNP. The yeast Mud2 protein is a potential candidate for performing this 
function. The MUD2 gene was isolated in a synthetic lethal screen for mutant 
27 
CHAPTER O. 	 NUCLEAR P-MRNA SPLICING 
genes that were non-functional in combination with mutant versions of Ui snRNA 
but functional in a wild type background (Abovich et al., 1994). Mudip, yeast 
homologue of the Ui snRNP specific protein Ui-A, was also identified during this 
screen (Liao et al., 1993). MUD2 encodes a 58 kDa protein that is structurally and 
biochemically related to the mammalian U2AF65 subunit. This protein contains a 
single carboxy-terminal located RRM but lacks the characteristic SR domain 
present in U2AF65. However, the amino-terminal region of Mud2p is rich in 
arginine residues and contains four RS or SR dipeptides. The protein interacts 
directly with the substrate pre-mRNA in a branchpoint-dependent manner, this 
binding being conditional on the integrity of the RRM. Strikingly, Mud2p also 
interacts directly with Prpllp (Abovich et al., 1994), homologue of the 
mammalian U2 snRNP-specific protein SF3a 66 (Bennett and Reed, 1993). This 
supports a possible role for Mud2p in mediating protein-protein interactions that 
stabilise the binding of Ui snRNP and promoting the binding of U2 snRNP at the 
branch point (Figure 1.7). 
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3' Splice Site 
Figure 1.7. Model for 5' and 3' splice site association. SR proteins form a bridge 
between Ui snRNP bound to the 5' splice site and U2AF bound to the polypyrimidine 
tract near the 3' splice site. U2 snRNP bound to the branch point sequence is shown. 
Yeast homologues of the mammalian U2AF65 subunit (Mud2p) and SF3a 66 polypeptides 
are shown. The arrow indicates an interaction between these proteins. Known protein-
protein interactions between SR proteins (SC35 and ASF/SF2), U1-70K and the U2AF35 
subunit are also indicated by arrows. Exon sequences (thick black line) and intron 
sequence (thin line) are indicated. 
Yeast genetics provides a powerful tool for identifying and analysing many non-
snRNP factors necessary for pre-mRNA splicing. Essential genes can be defined 
by conditional lethal mutations, most commonly temperature-sensitive mutations. 
For example, the PRP2 gene was cloned by complementation of the temperature-
sensitive growth defect of a prp2-1 mutant strain (Lee et al., 1984). Prp2 is an 
essential non-snRNP protein that interacts transiently with the fully assembled 
spliceosome and is required for the first catalytic step of splicing (King and Beggs 
1990; Kim et al., 1992; Teigelkamp et al., 1994). The PRP18 and PRP19 genes 
were also cloned by complementation of temperature-sensitive mutations. Prpl8p 
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function is dispensable for spliceosome assembly but required for the second step 
of splicing (Horowitz and Abelson, 1993). Prp19 protein, believed to play an early 
role in the splicing process, remains associated with the spliceosome throughout 
the splicing reaction but is not tightly bound to any snRNA (Cheng et al., 1993; 
Tarn et al., 1993). 
Suppression analysis of loss-of-function phenotypes was used to identify PRP16 
(Couto et al., 1987). Couto screened for second-site suppressors of an A to C 
intron branch point mutation (UACUAAC to UACUAC) which causes 
accumulation of unspliced pre-mRNA. The mutated intron sequence was contained 
within a reporter gene to facilitate rapid selection of putative suppressors. 
Expression of the reporter gene required accurate removal of the intron. One 
dominant trans-acting extragenic suppressor was isolated, identifying the PRP16 
gene. The mutant allele prpl6-1 acts by increasing the usage of the defective 
mutant branch point. Suppression was shown to be allele specific. Cloning of the 
PRP16 gene and subsequent genetic analysis revealed that PRP16 is a single copy 
gene, essential for cell viability, which encodes a protein that acts at the second 
catalytic step in the splicing reaction (Schwer and Guthrie, 1991). 
By screening for mutations in genes which are lethal in combination with 
conditional U5 snRNA splicing mutants, the SLU1, SLU2, SLU4 and SLU7 genes 
have been identified (Frank et al., 1992). These mutants exhibit allele-specific 
synergistic lethality with different U5 mutant alleles suggesting that they interact 
with the U5 snRNA. Sluip and Slu2p are candidates for factors that affect the first 
step of splicing while Slu4p and Slu7p are specifically involved in the second step 
of splicing. Furthermore mutant alleles of SLU4 and SLU7 are lethal in 
combination with mutations in two other genes involved in the second step of 
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splicing, PRP16 and PRP18. Newman and Norman (1992) proposed that US 
snRNP plays a role in 5' and 3' splice site selection through base-pairing 
interactions between U5 snRNA and exon sequences in the pre-mRNA substrate. 
These genes may be required to enhance or stabilise this snRNA-pre-mRNA 
interaction. 
To date over thirty yeast genes involved in splicing have been cloned as a result of 
extensive, but by no means saturating screens. Many genes remain to be identified, 
giving an indication as to the complexity of this process. 
1.4 Dynamic Rearrangements During Splicing 
Both during and after assembly of the spliceosome, and as the splicing 
reaction proceeds, many RNA-RNA and RNA-protein interactions are formed, 
broken and rearranged reflecting the dynamic nature of the spliceosome. The next 
section focuses on RNA-RNA interactions essential for accurate and efficient 
splicing. 
The first established RNA-RNA interaction in the spliceosome involves base-
pairing between the 5' end of Ui snRNA and a short conserved nucleotide 
sequence at the 5' splice site (Zhuang and Weiner, 1986; Séraphin et al., 1988). 
Base-pairing interactions between nucleotides at the 5' end of U2 snRNA are 
subsequently established following the addition of U2 snRNP and formation of the 
pre-spliceosome complex. Dramatic rearrangements occur upon addition of the 
pre-formed U4/U6.U5 tri-snRNP complex. U6 snRNA is involved in a myriad of 
snRNA-snRNA and snRNA-pre-mRNA interactions, constantly changing 
conformation as the reaction proceeds. Within the tri-5nRNP particle U6 snRNA is 
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extensively base-paired to U4 (Madhani and Guthrie, 1994). This intermolecular 
snRNA interaction is destabilised in vitro following formation of the spliceosome 
but preceding the first chemical step of the splicing reaction. Residues in U6 freed 
by disruption of the U4/U6 base-paired structure enter into new interactions with 
U2 snRNA, base-pairing with nucleotides that lie immediately upstream of the 
branch point recognition nucleotides to form a structure termed the U2-U6 helix I 
(Madhani and Guthrie, 1992). Residues proposed to be involved in the U2-U6 
helix I are essential for both steps of the splicing reaction (McPheeters and 
Abelson, 1992; Fabrizio and Abelson, 1990). U6 has also been demonstrated to 
directly interact with intron nucleotides at the 5' splice site, contributing to 
accurate recognition of this sequence in yeast (Kandels-Lewis and Séraphin, 1993; 
Lesser and Guthrie, 1993). This interaction involves Watson-Crick base pairing 
between an evolutionarily well conserved hexanucleotide sequence in U6 snRNA, 
critical for both catalytic steps of the splicing reaction (ACAGAG; Fabrizio and 
Abelson, 1990; Madhani and Guthrie, 1992), and intron nucleotides immediately 
downstream of the 5' splice site guanosine (Lesser and Guthrie, 1993; Kandels-
Lewis and Séraphin, 1993). The site of interaction between U6 snRNA and the 
pre-mRNA substrate overlaps that established with Ui snRNA indicating that the 
two may be mutually exclusive. Similar interactions have been observed in 
mammalian cells (Wassarman and Steitz, 1992; Sawa and Shimura, 1992; 
Sontheimer and Steitz, 1993). 
Based on the current model of U2-U6-pre-mRNA interactions the branch point 
nucleophile is effectively positioned close to the target phosphate at the 5' splice 
site, ready for the first catalytic step of the splicing reaction (Madhani and Guthrie, 
1994 and references therein). Significantly the U2-U6 helix I structure juxtaposes 
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the putative catalytically active residues in U6 snRNA in close proximity to the 5' 
splice site - branch point target region. 
U5 snRNA has a highly conserved single-stranded loop sequence that includes an 
invariant nine-nucleotide motif rich in uridylic acid residues (GCCUUUUAC). 
Detailed mutational and subsequent suppression analyses, coupled to recent 
biochemical cross-linking data (Newman and Norman, 1991; 1992; Sontheimer 
and Steitz, 1993; Teigelkamp et al., 1995b), have shown that U5 snRNP probably 
plays an undefined role in recognising both the 5' and 3' cleavage sites, and is a 
potential candidate for holding and orientating free exon 1-splicing intermediate 
ready for the second step of the splicing reaction. Definition of the cleavage sites is 
likely to occur through non-canonical base-pairing between urydilic acid residues 
within the U5 snRNA loop sequence and exon nucleotide sequences adjacent to the 
intron 5' and 3' splice sites. The conserved presence of urydilic acid residues 
within this loop could be explained by their ability to base-pair promiscuously. 
The lack of sequence-specific US snRNA interaction implies that U5 snRNA is 
positioned onto the exon sequences by other elements, for example Ui or U6 
snRNPs whose RNA components recognise the 5' splice site specifically, and that 
once positioned the interactions are stabilised by U5 snRNP proteins. In support of 
this model Prp8p, a U5 snRNP specific protein, cross-links in a non-sequence 
specific manner to large regions of exon sequences at the 5' splice site and at the 
branch point and 3' splice site during the first and second trans-esterification 
reactions respectively (Teigelkamp et al., 1995b). 
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1.5 Protein Motifs in Splicing Factors 
The splicing reaction is highly dependent upon the involvement of multiple 
protein and RNA factors. A variety of protein-protein and protein-RNA 
interactions are essential both for the assembly of the spliceosome and the chemical 
steps of the splicing reaction. A number of splicing proteins contain essential, 
characteristic motifs, some of these being suggestive of the proteins' function. For 
example, five yeast splicing factors, Prp2p, Prp5p, Prpl6p, Prp22p and Prp28p 
have amino acid motifs associated with proteins which have RNA-dependent 
ATPase activity and/or ATP-dependent RNA helicase activity, suggesting that 
conformational changes in RNA are crucial events during the splicing process. 
Many splicing proteins contain an RNA binding motif, a sequence element 
important for specific, high affinity binding of the protein to target RNA. 
Examples include the Ui snRNP specific proteins Ui-A and U1-70K, yeast 
Prp24p and the SR proteins family. A zinc finger-like motif, loosely related to the 
transcription factor TFIIIA (reviewed Harrison, 1991), is common to several 
splicing factors including the yeast proteins Prp6p, Prp9p, Prpl ip and the 
mammalian Ui snRNP-specific protein Ul-C. Prp6 and Prp9 proteins also contain 
a single leucine-repeat sequence element similar to the leucine zipper motif that 
mediates homo- and heterodimerisation in many transcription factors. Prp4p and 
Prpl7p have a repeated amino acid motif with similarity to the 13-transducin and 
subunits of the G-protein family. 
RNA Binding Motif. The RNA recognition motif or RNA binding motif (RRM 
or RBD) is a notable feature, present in one or more copies, in many proteins 
involved in splicing including Ul-A, Ul-70K, U2AF65, ASF/SF2, U2B" and the 
yeast splicing protein Prp24. The RRM motif is typically 70-90 amino acids long 
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and contains two short, well conserved elements, RNP1 and RNP2, embedded 
within a more weakly conserved sequence (reviewed in Birney et al., 1993; Figure 
1.8). Proteins that contain this motif are capable of binding a variety of RNA 
conformations including single-strand and stem-loop structures. The crystal 
structure of the RNA-binding domain of the Ui snRNP-specific protein Ui-A has 
been solved (Oubridge et al., 1994). This protein contains two copies of the RRM 
and binds specifically with high affinity to stem-loop II of Ui snRNA through its 
first RRM (Scherly et al., 1989; Lutz-Freyermuth et al., 1990) and to pre-mRNA 
through its second (Lutz and Alwine, 1994). The secondary structure of the RRM 
domain consists of a four-stranded antiparallel 13-sheet and two a-helices arranged 
in the order 131—al-132-133—a2-134 where the conserved RNP1 and RNP2 sequences 
lie side by side on the middle two 13-strands (Figure 1.8). Conserved charged and 
aromatic residues that protrude from the 13-sheet are believed to interact with the 
target RNA. 
RNP2 	 RNP1 
UxUxx[x]Z[x]xoLxocFxxx[x]GxUx[x]Zxxxxxx[x 21 .]UxVxF[x]xXOOOCZxXA 
 
Figure 1.8. (A) Degenerate RRM consensus 
motif. x, any residue; U, uncharged residues L, 
I, V. A, G, F, W, Y, C, M; Z, all uncharged 
residues plus S and T; + indicates that this 
region may be expanded further. Single letter 
amino acid code is used. (B) Schematic ribbon 
representation of the antiparallel 3-sheet that 
forms the RRM. n-strands are shown as arrows 
and cc-helices as curled ribbons with loops 
indicated by thin lines. Reproduced from Lilley 
(1995). 
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The RRM is important for efficient interaction between the protein and its target 
RNA but multiple sequence elements have the potential to influence RNA-binding 
specificity (Scherly et al., 1990; Bentley and Keene, 1991; Boelens et al., 1991; 
Nelissen et al., 1994). Boelens et al., (1991) demonstrated through RNP-domain 
exchange experiments that RNP1 and not RNP2 of the first RRM in Ui-A is essential 
for this protein binding specifically to stem-loop II of Ui snRNA. Ui-A and the U2 
particle-specific protein U2B" both contain two RRMs (RRM1 and RRM2), the 
sequences within these motifs being very highly conserved between the two proteins 
(Sillekens et al., 1987). However, Ui-A and U2B" proteins associate specifically with 
different snRNAs in vivo. Through extensive RNA-binding studies of various Ui-A 
mutants, progressively introducing changes to convert elements of the Ui-A RRMi 
into the corresponding elements of U2B", a short sequence was identified as 
influencing the specificity of RNA recognition (Scherly et al., 1990; Bentley and 
Keene, 1991). A five to eight amino acid peptide sequence from an evolutionarily 
non-conserved loop between the strands 132 and 133 of U2B" RRM1 conferred 
recognition of U2 snRNA when inserted into the Ui-A protein. The reciprocal 
change, introducing the Ui-A pentamer sequence into U2B" was found to enhance 
the Ui snRNA binding capacity of this protein. However, the mutated protein still 
retained an ability to interact with U2 snRNA implying that other U2B" sequence 
elements are also important for determining the RNA-binding specificity of this 
protein (Bentley and Keene, 1991). Most recently Nelissen et al., (1994) 
demonstrated that the snRNP-specific protein U1-70K, which contains a single, 
essential RRM, can still bind specifically to the Ui snRNP particle in the absence 
of this motif. Extensive deletion analysis of Ul-70K identified the amino-terminal 
one hundred amino acids as critical in mediating protein-protein interactions that 
probably normally contribute to the stability of the Ui snRNP particle, but which 
in the absence of the RRM still permits a specific interaction between this protein 
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and its corresponding snRNP. Significantly, this truncated protein only associates 
with Ui core-snRNP particles, not naked Ui snRNA. This indicates that core 
proteins are necessary and sufficient for an interaction between snRNP-specific 
proteins and their snRNP particle (Hamm et al., 1990b; Nelissen et al., (1994). 
DEAD/H Box Mot?f. Spliceosome assembly and disassembly involves multiple 
RNA-RNA interactions that must be continuously formed, rearranged and 
disrupted to allow each step of splicing to proceed. These RNA conformational 
rearrangements are most likely mediated by protein factors. In yeast, five trans-
acting splicing factors that are homologous to a family of ATP-dependent RNA 
helicases have been identified as potential candidates for performing this function 
(reviewed in Wassarman and Steitz, 1991). The involvement of these proteins at 
every step in the splicing reaction may account for the involvement for ATP. PrpS 
and Prp28 proteins are members of the DEAD-box protein family characterised by 
the eukaryotic transcription factor eIF-4A and p68 (Fuller-Pace and Lane, 1992). 
Three other putative Prp helicase proteins Prp2, 16 and 22 are members of the 
DEAH-box family of proteins (Chen and Lin, 1990). All five of these splicing 
factors are highly conserved within the DEAD/H core region, composed of eight 
short peptide domains including characterised ATP-binding motifs, but the 
flanking amino- and carboxy-terminal regions share very little homology. These 
non-conserved regions may account for the specific functions of the individual 
proteins. 
The three DEAH-box splicing factors appear to play sequential roles in splicing, 
Prp2p being required for the first cleavage-ligation, Prpl6p for the second and 
Prp22p for the release of spliced products. To date, both Prp2 and Prp16 proteins 
have been demonstrated to have RNA-dependent ATPase activity (Kim et al., 
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1992; Schwer and Guthrie, 1991). However, no RNA-unwinding activity has as 
yet been detected for either of these proteins. It is possible that the failure to detect 
an RNA helicase activity for any of the putative yeast helicase proteins may be due 
to the requirement for additional proteins and co-factors. This would be analogous 
to eIF-4A which requires eIF-4B for helicase activity in vitro. Prp2 and Prp16 
proteins can associate with the fully assembled spliceosome in the absence of ATP 
(Teigelkamp et al., 1994; Schwer and Guthrie, 1992a). However, ATP hydrolysis 
is required to allow the first and second steps of the splicing reaction to proceed 
indicating that ATP hydrolysis is necessary for these proteins to function. Indeed, 
Schwer and Guthrie (1992b) demonstrated Prpl6p-ATP hydrolysis-dependent 
conformational rearrangements within the spi iceosome. 
Zinc-Finger like Motif. A number of splicing proteins including Ui-C, SF3a 60 
and the yeast proteins S1u7, Prp6, Prp9 and Prpi 1 contain sequences that relate 
these proteins to the zinc-finger family of DNA binding proteins characterised by 
TFIIIA, a transcription factor that binds both to the 5S rRNA gene and 5S rRNA 
(reviewed in Harrison, 1991). The stable association of Ui-C protein with Ui 
snRNP is dependent upon protein-protein interactions between Ui-C and the 
snRNP-specific polypeptide U1-70K, and interactions between these proteins and 
the snRNP core polypeptides (Hamm et al., 1990b; Nelissen et al., 1994). This 
protein contains a single C 21­12 zinc finger-like motif within the amino-terminal 
sixty amino acids, this region being capable of associating with the Ui snRNP 
particle independently of the carboxy-terminal region. Mutation analysis of each 
cysteine and histidine residue within this structure indicate these residues are 
critical for its interaction with the snRNP (Nelissen etal., 1991). 
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Prp9 protein contains two zinc finger-like domains (CH1 and CH2), together with 
a carboxy-terminal leucine-rich sequence that resembles a leucine zipper. CH2 is 
essential for Prp9p function, residues within this motif being particularly sensitive 
to mutations (Legrain and Choulika, 1990). Prp9p interacts directly with Prp2l 
and is capable of homodimerisation (Legrain and Chapon, 1993; Legrain et al., 
1993). Legrain et al. (1993) demonstrated by point mutation and deletion analysis 
that both CH1 and CH2 are necessary for efficient homodimerisation, but that 
neither zinc finger-like motif is required for Prp9p to interact with Prp2lp. An 
amino-terminal domain distinct from either of these motifs is essential for 
mediating this interaction (Legrain et al., 1993). The mammalian homologue of 
Prp9p, SF3a6° which is one subunit of a tightly associated trimer within the U2 
snRNP 17S particle, contains a single zinc finger-like motif closely resembling 
CH2 of Prp9p. These two domains are evolutionarily conserved and functionally 
exchangeable in vivo (Kramer et al., 1994). 
It is currently believed that the novel zinc finger-like motif identified in a number 
of splicing factors is involved in mediating protein-protein interactions. However, 
the nature of the interacting factors remains uncharacterised (Legrain et al., 1993). 
13-transducin. Two yeast proteins, Prp4 and Prp17 which are required for the 
first and second step of pre-niRNA splicing respectively, contain a consensus 
sequence conserved among 13-subunits of 0-proteins. Prp4, a component of the 
U4/U6 snRNP particle, has been subjected to extensive deletion and amino acid 
substitution analyses in an effort to determine the functional significance of the 13-
transducin-like domain. Essentially, Prp4p can be subdivided into three domains 
consisting of an acidic-rich amino-terminal region, a central basic domain and a 
carboxy-terminal containing the 13-transducin-like sequence. The amino-terminal 
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one hundred and eight amino acids are not required for Prp4p function. In 
contrast, the central basic domain of Prp4p is essential and contains a possible site 
of interaction with the 5' stem-loop of U4 snRNA (Hu et al., 1994). 
Overproduction of Prp4p suppresses a conditionally lethal point mutation within 
the 5' stem-loop of U4 snRNA which supports a direct interaction between U4 
snRNA and Prp4p. Over thirty point mutations (in well conserved and non-
conserved residues) have been isolated in the 13-transducin-like region. 
Surprisingly, although this motif is essential for Prp4p function it is tolerant to 
mutations, several well conserved residues being resistant to changes in character 
(Hu et al., 1994). Significantly however, mutations that perturb the secondary 
structure of this domain have the most dramatic effect, suggesting that it is not the 
nature of the amino acid that is important within this domain but the overall 
secondary structure. The biochemical significance of this domain related to the 
protein's role in splicing is as yet ill-defined. 
This thesis describes the characterisation of a novel S. cerevisiae gene SDB23 
which encodes an essential snRNP protein required early in spliceosome assembly. 
Metabolic depletion causes a splicing defect in vivo and in vitro, the accumulation 
of pre-spliceosomes and reduced levels of U6 snRNA, indicating that this protein is 
essential for the stability of free U6. Over expression of U6 snRNA can partially 
compensate for the loss of Sdb23p. 
Sdb23p associates with both free U6 and U4/U6 snRNPs and is structurally related 
to known snRNP core proteins. Structural similarity is greatest within the amino-
terminal one hundred amino acids and by alignment of Sdb23p together with other 




NUCLEAR PRE-MRNA SPLJCJNG 
substitution and deletion analyses of Sdb23p indicates that this protein is tolerant to 
substantial changes without a strong effect on the function of Sdb23p. 
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M4TER!ALS AND METHODS 
2.1 	Materials 
2.1.1 Chemicals 
Chemicals. The following chemicals were purchased from the indicated sources: 
Sodium dodecyl sulphate, Serva; Acrylamide [30% and 40% (w/v) acrylamide/bis-
acrylamide solutions], Scotlab; Urea, Fisons; Phenol, Rathburn Chemicals; Agarose, 
Boehringer Mannheim; Deoxyribonucleotides and ribonucleotides, Pharmacia; 
Antibiotics, Beecham Research. BCIP/NBT colour development substrate for the 
detection of alkaline phosphatase activity was purchased from Promega. All other 
chemicals or solvents not listed were purchased from Sigma. 
Enzymes and Antibodies. Restriction enzymes, Kienow DNA Polymerase I, T7 RNA 
Polymerase and T4 DNA ligase were purchased from Boehringer Mannheim. Alkaline 
phosphatase and 14 Polynucleotide kinase were purchased from New England 
Biolabs, RNasin (RNase inhibitor) from Promega and ThermoprimeLus DNA 
Polymerase from Advanced Biotechnolgies Ltd. 
2.1.2 General Information 
Sterilisation. All media and solutions were sterilised by autoclaving for 20 min at 
120°C and 15 pounds/inch 2 . Small volumes of solutions were sterilised by filtration 
through disposable Acrodisc filter units (0.45 i; Gelman Sciences). Corex tubes, glass 
pipettes and other glassware were dry sterilised by baking in an oven at 250°C for 16 
h. 
Deionisalion of Sohitions. Solutions were deionised by mixing 0.1-0.2 volumes of 
analytical grade mixed-bed resin (20-50 mesh; Bio-Rad Lab.) for 30-60 mm. Resin 
was removed by filtration through Whatman 3MM filter paper. 
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21.3 Bacteria and Yeast Growth Media 
Bacto-tryptone, Bacto-peptone, Yeast Nitrogen Base without (w/o) amino 
acids and Casamino acids were obtained from Difco. Yeast extract was purchased 
from Beta Lab and Oxoid agar technical (Agar No. 3) from Oxoid. 
TABLE 2.1.1 
BACTERIAL MEDIAa 
MEDIUM 	 COMPONENTS 
Luria-Broth (LB) 	1.0% (w/v) Bacto-tryptone 
0.5% (w/v) Yeast extract 
0.5% (w/v) NaCl 
pH adjusted to 7.2 with NaOH 
4x M9 Salts* 	2.8% (w/v) Na2HPO4.H20 
1.2% (w/v) KH2PO4 
2% (w/v) NaCl 
4% (w/v) NH4CI 
a, For the preparation of plates 1.5% (w/v) agar was added; , Immediately before use a 4x 
M9 salts stock solution was diluted to a lx working solution. Four hundred microlitres of 
1M MgSO4.7H20 and 4 ml of a 20% (w/v) carbon source (glucose or glycerol) was added 
to 100 ml of 4x M9 salts and the solution then made up to 400 ml with sterile water. 
Nutrient and amino acid supplements were added if required for growth of the strain. 
9M9 Supplements: 	0.5% (v/v) of a 20% (w/v) Casamino acid stock solution 
0.0 1% (v/v) of a 0.5% (w/v) Vitamin B  stock solution 
L-amino acids to a final concentration of 40 mg/1 
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TABLE 2.1.2 
YEAST MEDIAa,b 
MEDIUM 	 COMPONENTS 
YPDA 	 1% (wlv) Yeast extract 
2% (w'Iv) Bacto-peptone 
2% (w/v) Glucose 
0.003% (w/v) Adenine 
YPGaIA 	 1% (w/v) Yeast extract 
2% (w/v) Bacto-peptone 
2% (w/v) Galactose 
0.003% (w/v) Adenine 
YMG/CAS 0.67% (w/v) Yeast Nitrogen Base w/o amino acids 
2% (w/v) Casamino acids 
2% (w/v) Glucose 
YMGaI/CAS 0.67% (wlv) Yeast Nitrogen Base w/o amino acids 
2% (w/v) Casamino acids 
2% (w/v) Galactose 
YMM 0.67% (w/v) Yeast Nitrogen Base w/o amino acids 
2% (w/v) Glucose 
Sporulation 1% (w'/v) Potassium acetate 
0.1% (w/v) Yeast extract 
0.05% (w/v) Dextrose 
a, For the preparation of plates 2% (w/v) agar was added; b, Selective media were 
supplemented with nutrients as required (Table 2.1.3). 
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21.4 Nutrients and Supplements 




COMPONENT STOCK SOLUTION FINAL CONCENTRATION AMOUNT OF 
(% w/v) (mgfl) STOCK (ml) PER LITRE 
Adenine sulfate 0.2 20 10 
Uracil 0.2 20 10 
L-Tryptophan 1.0 20 2 
L-Histidine 1.0 20 2 
L-Leucine 1.0 30 3 
L-Methionine 1.0 20 2 
L-Threoninc 4.0 200 5 




ANTIBIOTIC 	 ABBREVIATION SOLVENT STOCK SOLUTION FINAL CONCENTRATION 
(Mg/ml) 	 (tg/ml) 
AmpiciHin* 	 Amp 	H20 	100 	 50-100 
Chloramphenicol 	Cm Ethanol 20 25 
Kanamycin sulphate* 	Kan 	H20 	25 	 25-50 
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2.1.6 Commonly Used Buffers 
TABLE 2.1.5 
COMMONLY USED BUFFERS 
BUFFER 	 COMPONENTS 
lOx MOPS 	0.2 M MOPS (Morpholinopropanesulfonic acid) 
0.05 M Sodium acetate 
0.01 MEOTA 
pH adjusted to 7.0 with acetic acid. Stored in a dark bottle. 
lox PBS 	 1.37MNaCI 
27 mMKCI 
43 mM Na2FIP04.71-120 
14 mM KH2PO4 
pH adjusted to 7.2. Sterilised by autoclaving. 
20x SSC 	 3 M NaCl 
0.3 M Sodium citrate 
Unsterilised. 
lOx TAE 	 0.4 M Tris-acetate (pH 7.5) 
20 mM EDTA 
Unsterilised. 
lOx TB 	 0.9 M Tris-borate (pH 8.3) 
Unsterilised. 
lOx TBE 	 0.9 M Tris-borate (pH 8.3) 
20 mM EDTA 
Unsterilised. 
lOx TBS 	 0.5 M Tris-HC1 
1.5MNaCI 
pH adjusted to 7.5. Sterilised by autoclaving. 
lOx TE 	 0.1 M Tris-HCI (pH 7.4, 7.5, or 8.0) 
0.01 MEDTA 
Sterilised by autoclaving. 
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21.7 Escherichia coil Strains 
Strains of bacteria used in this study are listed in Table 2.1.6. Escherichia coil 
strains DH5aF' and NM522 were routinely used for plasmid cloning and propagation 
steps. E. coil CJ236 is a dui, iing double mutant bacterium and was used for site-
directed mutagenesis studies (Section 2.3.17). The F plasmid pCJ105 carried by this 
strain contains information necessary for pili construction, pill being required for both 
phagemid and helper phage attachment to and entry into the bacterial cell. Strain 
CJ236 was grown in the presence of chloramphenicol to maintain selection for this 
plasmid. 
TABLE 2.1.6 
BACTERIA STRAINS - E. COLI 
STRAIN 	 GENOTYPE 
	
SOURCE 
CJ236 	dutl, ungl, thi-1, re/Al; pCJIO5 (CmR  F) 	 Kunkel eta/., 1987. 
Bio-Rad 
DH5aF' 	F, 480d!acZM15, L(lacZYA-argF) U169, deoR 	Gibco BRL 
recA 1, endA 1, hsdRl7 (rjç, MK),  supE44, X7, thi-1, 
gyrA96, re/Al 
F', /acJlL(/acZ)Ml5, proAB/supE, (hi-i, A(/ac- 
NM522 	 Noreen Murray 
proAB), L(hsd,ns-merB)5, (rç, mj( McrBC-) 
CHAPTF-R Two 
	
M4TERL4LS AND MFTHODS 
2 1,8 Yeast Strains 
Strains of Saccharomyces cerevisiae used in this study are listed in Table 2.1.7. 
TABLE 2.1.7 
YEAST STRAINS 
STRAIN GENOTYPE SOURCE 
S150 2B MA Ta, his3-1, leu2-3,112, trpi-289, ura3-52, GAL GLAXO 
MCY1 MA Ta/a, 	ADE/adel-JO], 	his3-11HJS3, 	Ieu2- This work. 
3,1 12/leu2-3, 112, 	trpl-2891TRPJ, 	ura3-521ura3-52, 
GAL 
MCY2 M4Ta, adel-101, HIS3, !eu2-3,112, frpl-289, ura3-52, This work 
Gal 
MCY3 MA Ta/a, 	ADE/adel-101, 	his3-11HIS3, 	leu2- This work. 
3,1 12/!eu2-3, 112, 	trpl-2891TRPI, 	ura3-521ura3-52, 
GAL, LEU2-GA L1-SDB23. 
MCY4 IvL4Ta, ode]-101, his3-1, leu2-3,112, trpl-289, ura3- This work. 
52, LEU2-GALJ-SDB23, GAL 
MCY5 IvJA Ta/CL, 	ADE/adel-101, 	his3-11HJS3, 	leu2- This work. 
3,1 ]2/Ieu2-3, 112, 	trpl-2891TRPJ, 	ura3-521ura3-52, 
sdb23::LEU2, GAL 
L119 7-D MA Ta, dbJ2-1, add, trpl12, ura3-52 Parkes and 
Johnston, 1992. 
DJY36 MA Ta, prp2-1, ade2, ura3-52 Beggs lab. 
SPJ3.37 MA Ta, prp3-I, his, leu2, ura3-52 Beggs lab. 
SPJ4.4 MA Ta, prp4-1, his?, lys2, ura3-52 Beggs lab. 
SPJ6.88 MA Ta, prp6- 1, his3, lys2, ura3-52 Beggs lab. 






Oligonucleotides used in this study are listed in Table 2.1.8. T7 primer was 
obtained from Stratagene, whilst Taq6A oligonucleotide was a gift from David Brow 
(University of Wisconsin). All other oligonucleotides were obtained as single-
stranded, non-phosphorylated DNA-fragments from Oswell DNA Service (Chemistry 
Dept., University of Edinburgh). For long-term storage oligonucleotides were 
maintained at -70°C; small aliquots of the oligonucleotide were maintained at -20°C 
for up to one year. 
TABLE 218a 
snRNA SPECIFIC OLICONUCLEOTIDES 
OLIGO 	DESCRIPTION 	SEQUENCE (5 1 -3 1) 	 pm0141 
G8102 	Ui snRNA 	CACGCCTTCCGCGCCGT 	 121 
G8103 	U2 snRNA 	CTACACTFGATCTAAGCCAAAAGGC 	85.2 
483A U4 snRNA CCGTGCATAAGGAT 30 
U4B U4 snRNA AGGTATTCCAAAAATI'CCC 96.6 
(G6568) 
485A US snRNA AATATGGCAAGCCC 47 
Taq6A U6 snRNA TC('/T)rFCTCTGTATrG 206 
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TABLE 218b 
SDB23 SPECIFIC OLIGONUCLEOTIDES 
OLIG0 SEQUENCE (5'-3') STRAND pmol4d 
217S GAATTCTCGAGGTAGCATIGAGG C 126 
787R GAATT'CGGATCCACAATGCTACCTVrA C 115 
788R CTGCAGTCGACGGTAATCAACATFCAC T 137 
H3478 GCAGTCGACATGGACGGCGGTTGC T 12.5 
M0055 GCAGTCGACTTGCTGCTI'GACCU T 21.5 
M1927 TAAAGTAAGTTGCATCCAGTFA T 22.8 
M1928 TAAAGTAAGG GTCATCCAGTFA T 24.7 
M1929 TAAAGTAAGGTACATCCAGTFA T 22.2 
M1930 TAAAGTAAGCTTCATCCAGTTA T 24.1 
M1931 TGATAAAAGTAGCTCTAATATA T 23.9 
M1932 TGATAAAAGTATCTCTAATATA T 22.0 
M4158 CCGCGGATCCAATGCTACC'IT C 23.2 
N0326 GAGCAGTAAAGC C 21.1 
N0831* ATGCTAAAGCTFGGCAATAG C 19.1 
C, coding strand; T, template strand;* , Located within the SWI41SDB23 intergenic 
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TABLE 2.1.8C 
LINKERS AND UNIVERSAL PRIMERS 
OLIGo DESCRIPTION SEQUENCE (5 1-3 1) pm0140 
M13Rcv M13 Reverse AGCGGATAACAA1TTCACACAGGA Unknown 
Primer 
T7 17 Promoter in AATACGACTCACTATAG Unknown 
polylinker 
974X XhoI-PstI-EcoRI AAUCTGCAGC 91.0 
Linker 
975X XhoI-PstI-EcoRJ TCGAGCTGCAG 91.0 
Linker 
M5392 Stop Codon TCGATTAACTAACTAG 17.1 
Linker 
M5393 Stop Codon TCGACTAGTFAGTTAA 11.8 
Linker 
N4084 FLAG Linker TCGACCCGGGGGATCCAGACTACAAGG 9.2 
ACGACGATGACAAGCT 









PLASMID 	 FEATURES 	 REFERENCE 
pBluescript KS 	Phagemid cloning vector: Multiple cloning site; 	Stratagene 
lacZa; AmpR;  fl. ori, T3 and T7 promoters. 
pUC19 E. co/i cloning vector: Multiple cloning site; IacZa; Vieria and 
AmpR . Messing, 1982. 
pF139 Yeast -E.coli shuttle vector: 	Multiple cloning site Bonneaud etal., 
/acZa, AmpR;  CEN4, ARSI; TRP]. 1991. 
pBM125 Yeast-E.co/i shuttle vector: GAL]-GALIO promoter Johnston and 
sequence; AmpR; TetR; CEN4, ARS); URA3. Davies, 1984. 
YEp24 Yeast -E.co/i shuttle vector: 	AmpR; TetR; 	2 pin; Botstein etal., 
URA3. 1979. 
YCp50 Yeast -E.coli shuttle vector: 	AmpR; TetR; CEN4, Rose etal., 1987. 
ARSJ; URA3. 
pATH3 E. co/i expression vector: Multiple cloning site; trp Koerner et al., 
operon promoter and incomplete trpE gene; AmpR. 1990. 
pUR288 E. co/i expression vector: Multiple cloning site; !ac RUther and 
promoter; A mpR. Muller-Hill, 
1983. 
pJD3 Modified pUCI9: contains the yeast LEU2 gene This lab. 
isolated on a BglII fragment from YEp13 cloned into 
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TABLE 219b 
MODIFIED VECTORS 
NAME 	 DESCRIPTION 	 REFERENCE 
YEp24-SDB23 	Original SDB23 clone isolated in a screen for high 	Parkes and 
or 	 copy-number suppressors of dbJ2-1 using a YEp24- Johnston, 1992. 
YEp24-USS1 	based yeast genomic library. Contains the entire 
SDB23 gene with its own promoter, SWI4 promoter 
sequence and truncated SW14 gene on a BamHI 
fragment (Figure 3.IB). 
pBS-SDB23 	Modified pBluescript KS: contains BamHI fragment 	Parkes and 
isolated from YEp24-SDB23 cloned in the BamHI Johnston, 1992. 
restriction site of pBluescript KS. Fragment cloned 
such that the SDB23 gene and T7 promoter are 
transcribed in the same direction. 
pBSksHIIT3 	Modified pBluescript KS: contains 1.7 Kb HindIlI 	This work. 
fragment isolated from YEp24-SDB23, bearing 
SDB23 with its own promoter, cloned in the Hindill 
restriction site of pBluescript KS. The fragment is 
cloned such that the SDB23 gene and T3 promoter 
are transcribed in the same direction. 
pSDB23-1 	Modified pFL39: contains 1.7 Kb Hindlil fragment 	This work. 
or 	 isolated from YEp24-SDB23, bearing SDB23 with 
pUSS!4 	its own promoter, cloned in the HindIII restriction 
site of pFL39. 
pGALI-SDB23 	Modified pBM 125: contains SDB23 gene under the 	This work. 
or 	 control of the GAL) promoter. A 648 nucleotide 
pGALI-USS1 	fragment encoding the SDB23 gene and 3' 
processing sequences was generated by PCR, using 
pBS-SDB23 as template and primers 787R and 788R 
(Table 2.1.8), incorporating Ba,nHl and Sail 
restriction sites 5' and 3' of the gene respectively. 
The PCR product was cut with BamHI and Sail, gel 
purified and cloned between the BamHT and Sail 
restriction sites of pBM125 (Figure 3.5). 
pHIK2 	 Modified pJD3: contains 5' non-transcribed 	This work. 
8DB231SiV14 sequence. This sequence was generated 
by PCR using pBS-SDB23 as template and primers 
T7 and 217S, incorporating a XhoI restriction site 
into primer 217S (Table 2.1.8). The PCR product 
was cut with !lindlll and Xhol, gel purified and 
cloned between the HindIII and XhoI restriction sites 
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TABLE 2.1.9 1)  
MODIFIED VECTORS 
N1E 	 DESCRIPTION 	 REFERENCE 
pHI(3 	 Modified pGAL1-SDB23. The EcoRI site of pGAL1- 	This work. 
SDB23 was converted to XhoI by linker insertion 
using primers 974X and 975X (Table 2.1.8; Figure 
3.5). 
pHK4 	 Modified pHK2: contains the LEU2-GALJ-SDB23 	This work. 
gene fusion. The GAL 1-SDB23 fusion was isolated 
on a XhoI/SalI restriction fragment from pHK3 and 
cloned into the Sail restriction site of pHK2 (Figure 
3.5). 
pU6 	 Modified YEp24: contains the U6 snRNA gene with Hu etal., 1994. 
its own promoter cloned between the SmaI and 
Ba,nHI restriction sites of YEp24. The U6 snRNA 
gene was generated by PCR using yeast genomic 
DNA as template and two U6-specific primers. 
pMC11 	Modified pFL39: contains truncated SDB23IUSSJ 	This work. 
(USSJJ*) gene with its own promoter. A 1.49 Kb 
fragment containing the USS]zl*  gene was generated 
by PCR using pBS-SDB23 as template and primers 
T7 and H3478, incorporating a Sail restriction site 
into primer H3478 (Table 2.1.8). The PCR product 
was cut with Hindill and Sail, gel purified and 
cloned between the HindIlI and Sail restriction sites 
of pFL39, upstream of a stop-codon linker (primers 
M5392 and M5393; Table 2.1.8) that had been 
inserted into the Sail restriction site of this vector 
(Figure 6.1). 
pMC12 	Modified pFL39: contains truncated SDB231USSJ 	This work. 
(USSI/J) gene with its own promoter. A 1.36 Kb 
fragment containing the USSJzI gene was generated 
by PCR using pBS-SDB23 as template and primers 
T7 and M0055, incorporating a Sail restriction site 
into primer M0055 (Table 2.1,8). The PCR product 
was cut with Hindlil and Sail, gel purified and 
cloned between the Hindl!1 and Sail restriction sites 
of pFL39, upstream of a stop-codon linker (primers 
M5392 and M5393; Table 2.1.8) that had been 
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TABLE 219b 
MODIFIED VECTORS 
NAME 	 DESCRIPTION 	 REFERENCE 
pATH-S 	 Modified pATH3: contains SDB23 gene under the 	This work. 
control of the E. co/i trp promoter. A 648 nucleotide 
fragment encoding the 5DB23 gene and 3' 
processing sequences was generated by PCR using 
pBS-SDB23 as template and primers 787R and 788R 
(Table 2.1.8), incorporating BamHl and Sail 
restriction sites 5' and 3' of the gene respectively. 
The PCR product was cut with Ba,nHl and Sail, gel 
purified and cloned between the BamFll and Sail 
restriction sites of pATH3. 
pUR288-S 	Modified p1JR288: contains SDB23 gene under the 	This work. 
control of the Inc promoter. A 648 nucleotide 
fragment encoding the SDB23 gene and 3' 
processing sequences was generated by PCR using 
pBS-SDB23 as template and primers 787R and 788R 
(Table 2.1.8), incorporating BamHl and Sail 
restriction sites 5' and 3' of the gene respectively. 
The PCR product was cut with BamI-ll and Sail, gel 
purified and cloned between the BamHl and Sail 
restriction sites of pUR288. 
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Table 2.1.9c. Plasmid DNA nomenclature and the mutant Ussl polypeptides that they 
encode. Single point mutations were introduced into the USSJ-encoded polypeptide by the 
method of Kunkel et al. (1987; Section 2.3.17), using pBSksHIII3 (Table 2.1.9b) as 
template and mutagenic primers (Table 2.1.8). Additional mutations were introduced by a 
second round of mutagenesis using either pMC 18 or pMC 19 as template and mutagenic 
primers (Table 2.1.8). Clones were identified by sequencing the USSI-coding region and its 
promoter sequence (performed by M. Cooper and C. Russell; Section 2.3.16). , Plasmid 
pMC41 contains USSI that bears multiple mutations; nucleotide changes that encode N37Y 
and G73D amino acid substitutions in the conserved snRNP core protein motif, and 
nucleotide-deletions that result in a frame-shift. The mutant Ussip encoded by pMC41 is 
prematurely truncated, being 168 amino acids long, with the asparagine-rich carboxy-
terminal region replaced by a non-biased amino acid sequence. With the exception of 
pMC42, the mutated USSJ gene with its promoter sequence was isolated on a Hindlil 
fragment and cloned into the unique HindlII restriction site of pFL39 (Bonneaud et al., 
1990; Table 2.1.9a). pMC42 was constructed by isolating the mutated USSJ-coding region 
on an EcoRJ/Sall fragment, which was then cloned between the EcoRl and Sall restriction 
sites of pFL39. -- 
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TABLE 219C 
MUTATED pSDB23-1/pUSS1-1 CLONES* 
NAME 	 MUTANT Ussi POLYPEPTIDE 	REFERENCE 
pMC15 Ussl(N37Q) This work. 
pMC16 Ussi (N37T) This work. 
pMC17 Ussi (N37Y) This work. 
pMC42 Ussi (N37K) This work. 
pMC18 Ussi (G73A) This work. 
pMC19 Ussi (G73D) This work. 
pMC36 Ussi (N37Q, 073 A) This work. 
pMC37 Ussi (N37T, G73A) This work. 
pMC38 Ussi (N37Y, 073 A) This work. 
pMC39 Ussi (N37Q, G73D) This work. 
pMC40 Ussi (N37T, G73D) This work. 
pMC41* Truncated Ussi (N37Y, G73D)p with This work. 
non-biased carboxy-terminal region. 
W. 
Table 2.1.9d. Plasmid DNA nomenclature and the mutant UsslA polypeptides that they 
encode. USSJ sequence encoding the carboxy-terminal domain of mutant Ussi 
polypeptides was truncated using PCR. Plasmid DNAs described in Table 2.1.9c were used 
as templates with primers N0381 and M0055 (Table 2.1.8) to generate a PCR product 
bearing the 3' deleted, mutated USSI gene with its own promoter, incorporating HindIlI 
and Sail restriction sites 5' and 3' of the gene respectively. The PCR products were cut with 
Hindill and Sail, gel purified and cloned between the HindlIl and Sail restriction sites of 
modified pFL39. Modified pFL39 contains a stop-codon linker (primers M5392 and 
M5393; Table 2.1.8) cloned into the unique Sail restriction site (Bonneaud etal., 1991; this 
work). Note: Plasmid pMC66 contains 3' deleted, mutated USSI constructed by PCR using 
pMC42 (Table 2.1.9) as template and primers M13 Rev and M0055 (Table 2.1.8). The PCR 
product was cut with CiaI and Sail, gel purified and cloned between the AccI and Sail 
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TABLE 219d 
MUTATED pMC12 CLONES* 
NAME MUTANT Ussi POLYPEPTIDE REFERENCE 
pMC25 UsslA (N37Q) This work. 
pMC26 Uss1 	(N37T) This work. 
pMC27 Uss1i (N37Y) This work. 
pMC66 UsslA (N37K) This work. 
pMC28 Uss1 A (G73 A) This work. 
pMC29 UssIi (G73D) This work. 
pMC44 Uss1 	(N37Q, 073 A) This work. 
pMC45 Uss1i (N37T, G73A) This work. 
pMC46 Uss1 	(N37Y, G73A) This work. 
pMC47 Uss1 	(N37Q, G73D) This work. 
pMC48 Uss1 	(N37T, G73D) This work. 








ANTIBODY 	 DESCRIPTION 	 REFERENCE 
a-TMG 	Rabbit polyclonal serum against tri-methylguanosine 	Lührmann 
cap. 	 etal., 1982 
• 25 j.tg per immunoprecipitation. 
a-Prp8 	Anti-8.6 serum against a 35 amino acid peptide of 
the amino-terminal region of Prp8 polypeptide. 	This lab. 
• 15 l.tl of crude serum per immunoprecipitation. 
a-Sdb23 	Rabbit polyclonal anti-Sdb23p antibodies raised 
against a 3-galactosidase-Sdb23 fusion protein, 	This work. 
containing the entire 187 amino acid Sdb23 
polypeptide. 
• Western Blots - 1:5000 dilution of crude serum. 
• 50 Ill of crude serum per immunoprecipitation. 
a-Mouse IgG 	Anti-mouse IgG (H+L) alkaline phosphatase- 	Promega 
conjugated antibody developed in goat and affinity 
purified. 
• Western Blots - 1:7500 dilution. 
a-Rabbit IgG 	Anti-rabbit IgG (Fc) alkaline phosphatase 	 Promega 
conjugated antibody developed in goat and affinity 
purified. 
• Western Blots - 1:7500 dilution. 
a-FLAG M2 	Anti-Flag M2 mouse monoclonal antibody that 	ff1 Flag - 
recognises the FLAG®  peptide whether located at Biosystem Kodak 
the amino-terminus, internal site or carboxy- 
terminus of a FLAG-fusion polypeptide. 
• Western Blots - 1:1000 dilution. 
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2.2 	Microbiological Methods 
2.2.1 Growth of Strains 
Growth of Bacteria. E. co/i strains were routinely grown at 37°C in rich LB or 
minimal M9 media (Table 2.1.1). Nutrient supplements were added to M9 medium 
according to the strain's requirements. To maintain selection for plasmid DNA, 
transformed bacteria were grown in medium containing antibiotics (Table 2.1.4). 
Growth of Yeast. Yeast strains were routinely grown at 30°C on complete media, 
YPDA or YPGaIA (Table 2.1.2). To maintain selection for plasmid DNA, 
transformed yeast were grown in selective medium (Table 2.1.2) supplemented with 
nutrients (Table 2.1 .3) according to the strain's requirements. 
2.2.2 Strain Preservation 
Bacterial Strain Preservation. E. co/i strains were stored for short periods of time at 
4°C on LB-agar medium in petri dishes. Strains were stored indefinitely at -70°C in 
bacterial storage buffer [65% (v/v) glycerol, 0.1 M MgSO4.7H20, 0.025 M Tris-HC1 
pH 8.0]. A stationary culture of the strain to be frozen was grown in LB-medium. Six 
hundred microlitres of the culture were transferred to a 2 ml vial (35 x 12 mm) 
containing an equal volume of sterile bacterial storage buffer, the contents gently 
mixed and the vial then placed in dry ice to rapidly freeze the sample. 
Yeast Strain Preservation. Yeast strains were stored for short periods of time at 4°C 
on YPDA, '{PGaIA or selective media in petri dishes. Strains were stored indefinitely 
at -70°C in 5% (v/v) glycerol. The strain to be frozen was first grown in the 
appropriate liquid medium to mid-logarithmic phase. Six hundred microlitres of the 
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yeast culture were transferred to a 2 ml vial (35 x 12 mm) containing an equal volume 
of sterile 30% (v/v) glycerol, the contents gently mixed and the vial then placed in dry 
ice to rapidly freeze the sample. 
2.2.3 Sporulation of Yeast 
Growth of diploid. Ten millilitres of YPDA medium was inoculated with the diploid 
yeast strain to be sporulated and the culture grown at 30°C to an optical density at 
600 nm of 2.5-3.0. One millilitre of cells were transferred to a sterile Eppendorf,  
washed once with sterile water and resuspended in 1 ml of liquid sporulation medium 
(Table 2.1.2) supplemented with nutrients (Table 2.1.3) required for the growth of the 
diploid strain. The cells were grown in sporulation medium for three days at 30°C to 
induce tetrad formation. 
Tetrad Dissection. Following growth in sporulation medium the culture was 
transferred to an Eppendorf, the cells pelleted by centrifugation, washed twice with 
sterile water then resuspended in 5 ml sterile water. Thirty microlitres of cells were 
diluted in 270 .tI of sterile distilled water and incubated with 20 i.tl of - 
Glucuronidase/Arylsulfatase (Boehringer Mannheim) for 30-60 min at room 
temperature. Cell wall digestion was analysed microscopically during this incubation 
period. It was frequently found that the best results were obtained when the spores 
were incubated in the presence of 3-Glucuronidase/Arylsulfatase at 4°C overnight. 
Tetrads were dissected using a Singer MSM system micro-manipulator. 
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22.4 Transformation of E. coli 
E. co/i strains were transformed using the method of Hanahan (1983). 
Preparation of Competent E. coil cells. E. co/i cells were grown overnight at 37°C to 
saturation in 10 ml of LB-medium (Table 2.1.1). The following day 1 ml of the 
overnight culture was used to inoculate 100 ml of fresh, pre-warmed liquid LB-
medium and the culture incubated at 37°C until the optical density at 550 nm reached 
0.48. The culture was transferred to sterile GSA bottles, cooled on ice for 15 min and 
the cells then sedimented by centrifugation for 5 min at 4000 rpm (4°C; Sorvall GSA 
rotor). The supernate was discarded, the pellet gently resuspended in 40 ml of ice-
cold TfbI (Table 2.2. 1) and incubated on ice for 10 mm. The cells were sedimented by 
centrifugation for 5 min at 4000 rpm (4°C; Sorvall GSA rotor), the supernate 
discarded and the cell pellet gently resuspended in 4 ml of ice-cold TfbII (Table 
2.2.1). After a further 30 min incubation on ice the cells were competent for uptake of 
plasmid DNA and were dispensed into sterile, chilled Eppendorfs, snap frozen in a dry 
ice-ethanol bath and stored at -70°C until required. 
Transformation of Competent E. coil cells. Competent E. coil cells were thawed in 
ice. Up to 100 ng of transforming DNA was added to 200 p1 of competent cells. The 
cells were incubated on ice for 30-60 min then heat shocked at 42°C for 90 s; 1 ml of 
LB-medium was immediately added and the cells incubated at 37°C for 60 min on a 
rotating wheel. The cells were concentrated or diluted as appropriate then plated onto 
selective LB-agar medium. The plates were incubated overnight at 37°C. To assay for 
lac-complementation, plates were supplemented with 40 p1 X-gal (20 mg/ml) and 4 p1 
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BUFFER 	COMPONENTS 
TfbI 	30 mM Potassium acetate 
100 mM Rubidium chloride 
10 mM Calcium chloride 
50 mM Manganese chloride 
15% (v/v) Glycerol 
pH adjusted to 5.8 with 0.2 M acetic acid. Sterilised by filtration. 
TThH 	10 mm MOPs 
75 mM Calcium chloride 
10 mM Rubidium chloride 
15% (v/v) Glycerol 
pH adjusted to 6.5 with potassium hydroxide pellets. Sterilised by 
filtration. 
2.2.5 Yeast Transformations 
Yeast transformations were carried out using the method of Geitz et al. (1992). 
Yeast cells to be transformed were inoculated into 10 ml of liquid medium (Table 
2.1.2) and grown overnight to 1-2 x 10 7 cells/mi. The following morning the cells 
were diluted in fresh, pre-warmed medium to 2 x 106 cells/ml and regrown to 1 x 107 
cells/mi. At the correct optical density cells were harvested by centrifugation at 3000 
rpm for 5 mm (Mistral 1000 centrifuge). The supernate was discarded and the cell 
pellet resuspended in 1 ml sterile water. The cells were washed twice in 1 ml of lx 
TE/LiAc (made fresh from lOx filter sterilised stocks; Table 2.2.2) and finally 
resuspended at 2 x 10 9  cells/ml in lx TE/LiAc. Fifty microlitres of the yeast cell 
suspension was mixed with I tg of transforming DNA and 50 tg of single-stranded 
salmon sperm carrier DNA that had been boiled at 100°C for 5 mm. Three hundred 
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gently and incubated at 30°C for 30 min on a rotating wheel. Cells were heat-shocked 
at 42°C for 15 min then immediately sedimented by a brief centrifugation. The cell 
pellet was resuspended in 500 R'  of lx TE, diluted appropriately and plated onto 
selective medium. Plates were incubated at the appropriate temperature, typically 
30°C, for 2-3 days until the appearance of colonies. 
TABLE 2.2.2 
YEAST TRANSFORMATION SOLUTIONS 
BUFFER 	COMPONENTS 
lOx TE 	0.1 M Tris-HCI pH 7.5 
0.01 MEDTA 
lOx LiAc 	1 M Lithium acetate adjusted to pH 7.5 with diluted acetic acid. 
40% PEG 	40% (w/v) PEG 
Ix TE 
Ix Lithium acetate. 
Prepared fresh from filter sterilised 50% (w/v) PEG 3500 stock, and 
sterile lOx TE and lOx Lithium acetate solutions. 
2.2.6 Growth Curves 
Growth of MCY4 cells in galactose-containing medium or after a shift to 
glucose medium was assayed as follows: cells were grown to mid-logarithmic phase in 
galactose medium, pelleted, washed then resuspended in sterile water. A suitable 
volume of this cell suspension was used to inoculate either fresh pre-warmed YPGaIA 
or YPDA (Table 2.1.2) to an initial 0D600 of 0.05. Cultures were diluted with the 
same medium to keep all 0D600 readings below 0.6, maintaining the cells in 
logarithmic growth. 
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2.3 	Nucleic Acid Methods 
2.3.1 Spectrophotometric Determination of DNA and RNA concentrations 
Nucleic acid concentrations were determined by measuring the absorption of• 
diluted solutions at 260 nm using an Ultrospec III spectrophotometer (Pharmacia 
LKB Biochem.). For double-stranded DNA an 0D260 value of 1 represents a DNA 
concentration of 50 p.g/ml, and 40 jig/ml for single-stranded DNA and RNA. 
DNA purity was determined by measuring the absorption at wavelengths of 260 and 
280 nm. Protein-free preparations of DNA and RNA should give a 260/280 ratio 
close to 1.8 and 2.0 respectively. 
2.3.2 Restriction Digests Of DNA 
Restriction endonuclease digestion of DNA was typically performed in 
volumes of 20-100 p1. These contained the requisite quantity of DNA and the 
appropriate Boehringer Mannheim restriction buffer at lx concentration. The 
restriction enzyme was usually added in a two to fivefold excess. All restriction 
digests were made up to their final volume with sterile distilled water. The restriction 
digest was incubated at the recommended temperature, typically 37°C for 2-4 h. 
Genomic DNA to be used in Southern blot analyses was generally digested overnight 
to ensure complete digestion. The products of the digestion reaction were either 
analysed directly by agarose gel electrophoresis, or extracted with phenol: chloroform, 
then precipitated with ethanol and dissolved in a suitable volume of lx TB buffer for 
further manipulations. 
2.3.3 Precipitation of Nucleic Acids 
Nucleic acids (DNA and RNA) were precipitated with ethanol in the presence 
of salts. The salt concentration of the nucleic acid-containing solution was adjusted by 
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adding 0.1 volume of 3 M sodium acetate (pH 5.2), or alternatively, by adding 0.5 
volume of 7.5 M ammonium acetate. Three volumes of ice-cold ethanol were added 
and the mixture inverted several times. Nucleic acid was precipitated at -20°C for 15 
min or at -70°C for 5 min followed by centrifugation at 4°C for 10 mm. The nucleic 
acid pellet was briefly washed with 70% (v/v) ethanol, dried under vacuum and 
resuspended in the appropriate volume of lx TE buffer. 
When relatively large amounts of DNA were purified from bacterial cells or yeast, 
sodium acetate was the salt used. Precipitation of nucleic acid with ammonium acetate 
was used when the efficient removal of impurities was necessary; ammonium acetate 
removes detergents, heavy metals and many other compounds that may inhibit 
restriction endonucleases, as well as other enzymes. In addition, ammonium salts are 
more effetive at removing free nucleotides present in the DNA solution. 
2.3.4 Agarose Gel Electrophoresis 
Agarose gel electrophoretic analysis of DNA was always performed using 
TAE buffer (Table 2.1.5). Gels were prepared by melting agarose, typically 0.7-1.2% 
(w/v) in lx TAE buffer. Ethidium bromide (10 mg/ml) was added to a final 
concentration of 0.5 tg/ml for visualisation of DNA. Samples to be analysed by gel 
electrophoresis were loaded directly using Ficoll loading buffer. 
• lOx Ficoll Loading Buffer: 20 mM IEDTA 
20% (w/v) Ficoll 
0.15% (w/v) Bromophenol blue 
0.15% (w/v) Xylene cyanol 
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23.5 Isolation of DNA from Agarose Gel Slices 
To isolate and purify DNA from agarose gels the QIAEX Gel extraction kit 
(QIAGEN) was employed. QIAEX utilises a silica gel suspension which binds to 
DNA in high-salt solutions but not in low-salt solutions to purify DNA. 
DNA fragments were separated on a TAE/agarose gel (Section 2.3.4), the desired 
DNA band located under UV-transillumination and cut out using a clean razor blade 
in as small a volume of agarose as possible. The gel slice was transferred to an 
Eppendorf, the weight of the slice determined and three volumes of QX1 solution 
added (approximately 100 mg = 300 tl QX1). Ten microlitres of QIAEX matrix was 
then added and the Eppendorf incubated at 50°C for 10 min until the gel slice had 
dissolved; the Eppendorf was inverted every 2-3 min during this incubation period to 
gently mix the contents of the tube. The QIAEX matrix was sedimented by 
centrifugation for 30 s, the supernate removed and the pellet washed three times in 
500 lal of QX2 solution (centrifuging and resuspending the pellet between each wash). 
The pellet was then washed three times with QX3 solution. After the final wash, all 
traces of QX3 were removed and the pellet allowed to air dry for 15-20 mm. The 
dried pellet was resuspended in 25 p1 lx TE buffer and incubated at room temperature 
for 5 mm. DNA was recovered from the suspension by pelleting the QIAEX matrix 
and transferring the DNA-containing supernate to a fresh Eppendorf. To improve the 
recovery yield this elution step was repeated. The DNA was used directly for further 
manipulations or stored at 4°C. 
2.3.6 Ligation of DNA 
Ligations of DNA were typically performed in a final volume of 10 tl. These 
contained 0.5-1.0 tg total DNA, lx ligation buffer and T4 DNA ligase. For the 
ligation of cohesive DNA termini 0.2 units of ligase was used; one unit of the enzyme 
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was used for the ligation of blunt-ended molecules. Vector and insert DNA were 
typically present in a 1:1 or 1:2 ratio. The reactions were incubated for at least 12 hat 
16°C or 23°C for sticky and blunt-end ligations respectively. Between 5-10 Al of the 
reaction mixture was used to transform competent E. co/i cells (Section 2.2.4). 
2.3.7 'Filling in' of Recessed 3' Termini 
Klenow DNA Polymerase I was used to fill-in recessed 3' termini (generated 
by various restriction enzymes) to give blunt-ended DNA molecules. Reactions were 
performed in a final volume of 20 p1 containing 1 tg DNA, lx buffer (Boehringer 
Mannheim restriction buffers were found to work well), all four dNTPs each at a 
concentration of 20 mM and 2 units of Klenow DNA Polymerase I. Reactions were 
incubated at 16°C for 45 min then the unincorporated nucleotides removed by 
increasing the reaction volume to 200 p.1 with lx TE and extracting with phenol. The 
DNA was ethanol precipitated (Section 2.3.3). 
2.3.8 Amplification of DNA using the Polymerase Chain Reaction 
General PCR Reaction. Specific regions of DNA were amplified using the 
Polymerase chain reaction (PCR). Typically, small quantities (10-20 ng) of non-
linearised plasmid DNA were used as templates and specific oligonucleotide primers 
were obtained commercially (Table 2.1.8). A standard reaction, using plasmid DNA 
as template, was as follows: 
lOx ThermoprimePs Polymerase Buffer - M902 	10 p.1 
2 mM dNTP stock (dATP, dCTP, dGTP, dTTP) 10 p.1 
25mMMgC12 	 12 p 
Oligonucleotide primer 1 (100 pmoles/p.l) 	1 p.1 
Oligonucleotide primer 2 (100 pmoles/pl) 1 p.1 
Template DNA (10 ng/p.l) 	 1 p.1 
Sterile distilled water 	 76 p.1 
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All PCR reactions were carried out in a Hybaid" Thermal Reactor, programmed 
according to the length of the desired product and the approximate melting 
temperature of the primer/template duplex. A typical programme most frequently used 
was: 
STEP 1:95°C for 3 mm, hold at 45°C. 
Add I p.1 of diluted ThermoprimeIs Polymerase (1:25 dilution) and mineral oil 
to cover surface (Sigma). 
STEP 2:30 cycles of 92°C for 1 mm, 45°C for 1 min and 72°C for 3 mm. 
PCR on Bacteria Colonies. Bacterial-colony PCR was routinely used to screen for the 
correct orientation of linkers during the construction of recombinant plasmid DNA. 
Typically, a large scale PCR reaction 'mix' was prepared as above, scaling the volume 
up or down depending on the number of colonies to be screened. ThermopfimePLus  
Polymerase was added directly to this 'mix'. Template DNA was prepared by 
resuspending a single bacterial colony into 500 p.1 of sterile water, lysing the cells by 
boiling at 100°C for 5 mm, and then pelleting cell debris by centrifugation for 2 mm. 
Five microlitres of the cell lysate was mixed with 15 p.1 of the PCR reaction 'mix' and 
the PCR program initiated as above, with the exception that no further 
Thermoprimes Polymerase was added between steps one and two. 
2.3.9 Labelling DNA Fragments by Random-Priming 
DNA fragments of cloned genes were radiolabelled by the random priming 
method of Feinberg and Vogelstein (1983; 1984). 
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Incorporation of Radioactive Label. The DNA solution was made up to 35 jil with 
distilled water, boiled for 5 min then stored on ice. The random-priming reaction was 
prepared as follows and incubated overnight at room-temperature: 
Oligo-labelling buffer (OLB*) 10 i.tl 
BSA (20 mg/ml; Boehringer Mannheim) 2 ptl 
[(X-32p] dCTP (10 mCi/mi) 3 jil 
Denatured DNA in water 35 	.tl 
Klenow DNA Polymerase I 2 units 
* OLB consists of a 1:2.5:1.5 mixture of solutions A:B:C prepared as follows: 
• Solution A* 	18 tl 3-mercaptoethanoi and 5 .tl of each 0.1 M dNTP solution 
in I ml solution 0. 
• Solution B 	2 M HEPES buffer 
pH adjusted to 6.6 with 5 M NaOH. 
• Solution C 	Random hexadeoxyribonucleotides (Pharmacia) at 90 OD 
units/ml in sterile water. 
• Solution O 	1.25 M Tris-HCI pH 8.0 
0.125 MMgCl2. 
, Stored at -20°C; +, Stored at 4°C. 
'Pur/icallon' of Random-Primed DNA Probes. Random-primed DNA was separated 
from unincorporated nucleotides using a NAP-5 column (Pharmacia) according to the 
manufacturer's instructions. 
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23.10 End-labelling of Oligon ucleotides 
Oligonucleotides were labelled in a 20 tl reaction at 37°C for 45 min using 
New England Biolab T4 polynucleotide kinase as follows: 
Oligonucleotide 
lOx T4 Polynucleotide kinase buffer 
[y-32P] ATP (10 mCi/mi, Amersham) 
No 
2mMATP 




Sterile distilled water to 20 jil 
T4 Polynucleotide kinase 	 2 units 
'Pur/lcation' of End-labelled Oligonucleotide Probes. 	Radiolabelled- 
oligonucleotides were separated from unincorporated nucleotides using a NAP-5 
column (Pharmaci a) according to the manufacturer's instructions. 
2.3. 11 Plasmid DNA Preparations 
Small Scale Preparation. The following protocol is based on the alkaline lysis method 
of Birnboim and Doly (1979). 
Five millilitres of LB-medium (containing selective antibiotic) was inoculated with a 
single colony of the plasmid-bearing E. co/i strain and incubated overnight with 
continuous shaking at 37'C. Four millilitres of the culture was centrifuged for 2 min at 
12,000 g, the supernate discarded and the cell pellet resuspended in 100 41 of solution 
A. Two hundred microlitres of solution B was added to the cell suspension, the 
mixture gently vortexed and incubated on ice for 3 mm. Finally, 150 tl of solution C 
was added, the lysed cells mixed gently by inversion and incubated on ice for 5 mm. 
Chromosomal DNA and cell debris were sedimented by centrifugation for 15 min at 
4°C and the pellet removed from the Eppendorf using a sterile toothpick. Residual 
protein debris was removed from the lysate by sequential phenol: chloroform and 
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chloroform extractions and the DNA then recovered by ethanol precipitation. The 
DNA pellet was washed once with 70% (v/v) ethanol, dried in a dessicator and 
resuspended in 25 tl of lx TEIRNase A. 
• Solution A 50 mM Glucose 
25 mM Tris-RCI pH 8.0 
10 rnMEDTA 
• Solution B 200 mM NaOH 
1% (wlv) SDS 
Freshly prepared 
• Solution C 3 M Sodium Acetate pH 5.2 
Ix TEIRNase A (prepared from lOx TE stock solution; Table 2.1.5) containing 
RNase A at a final concentration of 20 tg/ml. 
Large Scale Preparation. 
Five hundred millilitres of LB-medium (containing selective antibiotic, Table 2.1.4) 
was inoculated using 1 ml of a saturated plasmid-bearing E. coli strain and incubated 
at 37°C with shaking overnight. The culture was centrifuged for 10 min at 4000 rpm 
in a Sorvall 50B centrifuge (Sorvall GS-3 rotor). The supernate was discarded and the 
cell pellet resuspended in 20 ml of solution A. To this cell suspension 40 ml of 
solution B was added, the suspension thoroughly mixed by swirling then incubated on 
ice for 10 min. Thirty millilitres of ice-cold solution C was added, the lysed cells 
mixed by swirling and left on ice for a further 5 min The mixture was centrifuged for 
10 min at 5000 rpm (Sorvall GS-3 rotor) to pellet chromosomal DNA and cell debris. 
The DNA-containing supernate was transferred to a fresh GS-3 bottle with a pipette, 
then 0.6 volumes of iso-propanol added, mixed well and left at room temperature for 
10 mm. DNA was pelleted by spinning for 15 min at 7000 rpm (Sorvall GS-3 rotor). 
The pellet was dissolved in 5 ml of lx TE, then 2.4 ml of 8 M ammonium acetate was 
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added, the DNA-containing solution mixed by inversion and incubated on ice for 20 
mm. The solution was centrifuged for 15 min at 7000 rpm, the supernate transferred 
to a sterile, baked 30 ml glass Corex tube and the DNA recovered from solution by 
ethanol precipitation. The pellet was immediately resuspended in 750 j.tl of lx 
TEIRNase A, transferred to an Eppendorf and incubated at 37°C for 30 mm. Protein 
debris was removed by sequential phenol, phenol: chloroform and chloroform 
extractions. The DNA was finally ethanol precipitated in the presence of 0.1 volume 
of 3M sodium acetate (pH 5.2). Typically the dried DNA pellet was resuspended in 
500 l lx TE buffer. 
• Solution A 25 mM Tris-HCI pH 8.0 
50 mM EDTA 
• Solution B 200 mM NaOH 
1% (wlv) SDS 
Freshly prepared. 
• Solution C 5M Potassium acetate 
Ix TEIRNase A (prepared from lOx TE stock solution; Table 2.1.5) containing 
RNase A at a final concentration of 20 tg/ml. 
2.3.12 Yeast Genomic DNA Preparation 
Genomic DNA was routinely prepared from a 50 ml mid-logarithmic culture 
grown in rich medium (Table 2.1.2). The culture was harvested by centrifugation for 5 
min at 3000 rpm (Mistral 1000 centrifuge). The supernate was discarded, the cells 
washed in sterile water and then resuspended in 3 ml of Buffer A containing 1500 
units of lyticase enzyme (Sigma). The cells were incubated at 37°C with continuous 
slow shaking until conversion to spheroplasts was complete, as determined 
microscopically. Spheroplasts were sedimented at 2000 rpm for 5 mm, the supernate 
carefully discarded and the pellet gently resuspended in 3 ml of Buffer B then 
transferred to a 15 ml Corex tube. Three hundred microlitres of 10% (w/v) SDS and 
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50 tl of 10 mg/ml RNase A were added to the spheroplasts, the suspension gently 
mixed and incubated at 65°C for 30 mm. One millilitre of 5 M potassium acetate was 
then added, the suspension mixed by inversion and placed on ice for 60 mm. The 
suspension was then centrifuged at 15,000 rpm for 30 mm (Sorvail SS34 rotor) and 
the lysate transferred to a fresh Corex tube. Protein debris was removed by sequential 
phenol, phenol: chloroform and chloroform extractions. The DNA was finally ethanol 
precipitated in the presence of 0.1 volume of 3M sodium acetate (pH 5.2). Typically 
the final DNA pellet was resuspended in 500 p1 lx TE buffer. 
• Buffer A 	 0.9 M Sorbitol 
0.1 MEDTA 
50 mM DTT 
• Buffer B 	 50 mM Tris-HC1 pH 7.5 
50 rnMEDTA 
2.3.13 Southern Blotting Procedures 
DNA was digested with the desired restriction enzymes, electrophoresed 
through an agarose gel and photographed as described (Sections 2.3.2 and 2.3.4). The 
gel was first immersed in denaturing buffer with gentle agitation for 30 mm, then 
transferred to neutralisation buffer for a further 30 mm. 
Denaturing Buffer: 	0.5 MNaOHII.5 MNaCI. 
• Neutralisation Buffer: 	1.5 M NaCl, 0.5 M Tris-HCI pH 7.5, 1 mM EDTA. 
Transfer of DNA from Agarose Gels to Nylon Membranes. HybondTM-N nylon 
membrane (Amersham) and four sheets of Whatman 3MM paper were cut to the same 
size as the gel. One sheet of blotting paper was saturated with 20x SSC (Table 2.1.5) 
and placed over a clean glass plate arranged so that it hung over the edge of the plate 
with the ends of the paper in a plastic tray containing 20x SSC. The pre-treated gel 
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was placed on top of the saturated Whatman 3MM paper and Saran wrap carefully 
placed on top of regions of the paper left uncovered by the gel to prevent unnecessary 
evaporation. The nylon membrane was placed on top of the gel, taking care to ensure 
no air bubbles formed between the gel and the membrane. The four sheets of pre-cut 
Whatman 3MM paper were saturated in 20x SSC and placed on top of the membrane, 
again taking care to prevent the formation of bubbles between the layers. On top of 
this, 2-4 cm of dry paper towels were arranged, and the whole structure weighted to 
provide even pressure. Transfer was allowed to take place overnight. Once the 
transfer was complete, the membrane was briefly rinsed in 20x SSC, blotted dry, and 
UV-irradiated in a Stratagene UV StratalinkerTM using the °autocrosslink" setting 
(1200 p.joules, 254 nm) to immobilise the DNA to the filter. 
Hybridisation of Randomly-labelled Probes to Nylon Membranes. Hybridisations 
were performed in Hybaid 'Hybridiser ovens' using an adaptation of the method of 
Church and Gilbert (1984). 
The nylon membrane was pre-hybridised in 20 ml of SES1 Buffer for at least 3 h at 
60°C to prevent non-specific hybridisation of the probe to the membrane. Fresh SES1 
buffer was added to the membrane immediately before the addition of the 
radiolabelled probe. The labelled probe (Section 2.3.9) was denatured by heating to 
100°C for 5 min then added to the SES1 buffer and the incubation continued 
overnight at 60°C; the hybridisation temperature was increased or decreased 
depending on the desired stringency conditions. The following morning the probe was 
decanted off and stored at —20°C for possible re-use. The membrane was then washed 
with SES2 for 20 min at 60°C; this temperature was varied to suit the stringency 
required. This was repeated four times. The membrane was then blotted dry, placed 
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• SIES1 Buffer: 	 7% (w/v) SDS 
1 mM EDTA pH 8.0 
0.5 M Sodium phosphate buffer pH 7.2 
• SES2 Buffer: 	 5% (w/v) SDS 
I mM EDTA pH 8.0 
40 mM Sodium phosphate buffer pH 7.2 
Membrane Stripping for Reprobing. For successful removal of probes, membranes 
were never allowed to dry during or after hybridisation and washing. A boiling 
solution of 0.1% (w/v) SDS was poured onto the Hybond TM-N nylon membrane to be 
stripped and allowed to cool to room temperature. The membrane was blotted dry 
and stored between Saran wrap for future use. 
2.3.14 Total Yeast RNA Preparations 
Total RNA was extracted by the method of Hopper et al. (1978) from yeast 
cells grown in rich or selective media (Table 2.1.2). Cultures were grown at 30°C and 
maintained at an optical density at 600 nm less than 0.8 until harvest by periodic 
dilution in fresh growth medium. The degradation of RNA was avoided by treating all 
solutions with diethyl pyrocarbonate (DEPC), baking glassware for 2 hr at 200°C and 
working as fast as possible, keeping the RNA preparations on ice. 
Isolation of RNA. Yeast cells from a 100 ml liquid culture in late logarithmic phase 
were harvested by centrifugation for 5 min at 3000 rpm (Mistral 1000 centrifuge). 
The supernate was discarded and the cell pellet washed twice with DEPC-treated 
water and TNE respectively. The cell pellet was finally resuspended in 1 ml 1'NE and 
1 ml phenol. Using a baked spatula 15 mg of RNase-free glass beads were added and 
the suspension then diluted by the addition of 2 ml of TNE, 2 ml phenol and 0.4 ml 
20% (w/v) SDS. The mixture was vortexed at high speed for three 1 min bursts with a 
30 s interval on ice between each vortex. The suspension was then centrifuged for 5 
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min at 3600 rpm (Mistral 1000 centrifuge), the aqueous phase transferred to a baked 
15 ml Corex tube and the RNA recovered from solution by the addition of 0.1 volume 
of 3M sodium acetate (pH 5.2) and ethanol precipitation (Section 2.3.3). 
• TNE: 	50 mMTris-HCI pH 7.5 
5 mM EDTA 
100 mMNaCI 
• Glass beads 	Glass beads (BDH mesh 100) were boiled for 20 min in 1 M 
HC1, then baked for 2 h at 200°C. 
Purification of RNA. The RNA pellet was immediately resuspended in 500 p.1 DEPC-
treated water and transferred to an Eppendorf containing an equal volume of 
phenol: chloroform. The mixture was vortexed, centrifuged for 5 min and the aqueous 
phase removed to a fresh Eppendorf. This was repeated several times, back extracting 
when necessary to minimise loss of the aqueous phase, until no material was visible at 
the interface. The RNA-containing aqueous phase was finally extracted once with 
chloroform and the RNA ethanol precipitated. The RNA pellet was briefly washed 
with 70% (v/v) ethanol (made with DEPC-treated water), dried under vacuum and 
resuspended in the appropriate volume of DEPC-treated water. All RNA was stored 
at -20°C. 
2.3.15 Northern Blot Analysis 
For Northern blot analysis of mRNA or snRNAs, total RNA was extracted as 
described (Section 2.3.14), followed by denaturing agarose or polyacrylamide gel 
electrophoresis respectively, and transferred onto Hybond 
TM -N nylon membrane. 
Denaturing Agarose Gel Electrophoresis. Agarose gel electrophoresis of total RNA 
was performed using lx MOPS running buffer (Table 2.1.5). Gels were prepared by 
dissolving agarose, typically 1-1.5% (w/v) in 70 ml of sterile water. The mixture was 
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allowed to cool slightly, then 10 ml of lOx MOPS and 17 ml of 37% (vlv) 
formaldehyde solution added, and the volume made up to 100 ml with sterile water. 
Total RNA (30-40 tg) was dissolved in sterile DEPC-treated water such that the final 
volume was 20 pl. An equal volume of denaturing buffer [200 j.tl deionised 
formamide, 120 j.il formaldehyde, 100 tl lOx MOPS] was added, the mixture 
incubated at 65°C for 5 mm, then loaded directly onto the gel using RNase-free lOx 
Ficoll loading buffer (Section 2.3.4). 
Transfer of RNA from Agarose Gels to Nylon Membranes. RNA was transferred 
TT 	 TM directly from the agarose gel onto riybond -N nylon membrane essentially as 
described in section 2.3.13, but without pre-treating the gel. 
Hybridisation of Randomly-labelled Probes to Nylon Membranes. Hybridisations 
were performed as described in section 2.3.13. 
Polyacrylamide Gel Electrophoresis of RNA. For Northern analyses of snRNAs, total 
RNA was mixed in a 1:1 ratio with stop-solution, heated to 85°C for 2 min then 
fractionated on a 6% (w/v) denaturing polyacrylamide gel. For the detection of the 
U4/U6 snRNA complex, RNA samples were mixed with an equal volume of non-
denaturing gel-loading buffer and resolved on a 9% (w/v) non-denaturing 
polyacrylamide gel according to Li and Brow (1993). The RNA was then transferred 
electrophoretically to HybondTM-N nylon membrane at 60 V for 30 mm. All 
hybridisations were performed as described for mRNA Northerns in SES1 buffer 
(Section 2.3.13), except that the hybridisation temperature was adjusted to 5°C below 
the melting temperature of the oligonucleotide/snRNA hybrid. Filters were washed 
three times for 30 min's at the appropriate temperature in SES3 buffer [0.5 M Sodium 
phosphate buffer pH7.2, 1mM EDTA pH 8.0, 5% (w/v) SDS]. 
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• Stop-solution: 	 0.05 M EDTA 
95% (v/v) Deionised formamide 
0.25% (w/v) Bromophenol blue 
0.25% (w/v) Xylene cyanol 
lOx Native gel-loading buffer 0.05 M EDTA 
0.5x TB (Table 2.1.5) 
50% (v/v) Sterile glycerol 
0.25% (w/v) Bromophenol blue 
0.25% (w/v) Xylene cyanol 
Polyacrylamide gels were prepared as follows using the 'Base-Runner System', 
assembled as instructed by the manufactures (fBI, Kodak). All plates were thoroughly 
cleaned with 0.01% (w/v) SDS and then ethanol prior to assembly. 
6% (w/v) Denaturing polyacrylamide gel: 
40% Acrylamide [38% (w/v) acrylamide:2% (w/v) bis-acrylamide] 	7.5 ml 
7MUrea 	 21g 
lOx TBE (Table 2.1.5) 	 5 ml 
The urea was thoroughly dissolved, the volume made up to 50 ml with sterile distilled water, 
then 300 ld of 10% (w/v) APS and 30 l of TEMED were added and the gel poured 
immediately. 
Denaturing polyacrylamide gels were run in lx TBE (Table 2.1.5). 
9% (wlv) Non-denaturing polyacrylamide gel: 
30% Acrylamide [30% (wlv) acrylamide:0.8% (w/v) bis-acrylamide] 	15 ml 
lOx TB (Table 2.1.5) 	 2.5 ml 
0.5MEDTA 	 0.l ml 
The volume was made up to 50 ml with sterile distilled water, then 300 .tl of 10% (w/v) APS 
and 30 j.tl of TEMIED were added and the gel poured immediately. 
Non-denaturing polyacrylamide gels were run in 45 mM Tris-borate pH 8.3, 1 
mM EDTA at 4°C. 
CHAPTER Two 	 MA TERL4LS AND METHODS 
2.3.16 DNA Sequencing 
All sequencing reactions were carried out using the Sequenase Version 2.0 
sequencing kit (USB) according to the manufacturer's instructions. Templates for the 
reactions were either double-stranded DNA plasmid clones or, single-stranded 
preparations of pBluescript KS+'_  (Stratagene). 
Preparation of Single-Stranded Plasmid DNA Templates. DH5aF' cells carrying the 
DNA of interest to be sequenced on a plasmid were grown at 37°C overnight to 
stationary phase in selective LB-medium. A phage-infected culture was prepared by 
adding 50 tl of the overnight culture to 2 ml of LB-medium in a sterile 20 ml bijoux 
tube, growing the cells for 30 min at 37°C and then adding one tenth of a suspension 
of M13K07 helper phage (lxlOi I  pfu/ml). The infected culture was then incubated 
for 5-6 h at 37°C with constant vigorous agitation. One and a half millilitres of the 
infected culture were transferred to an Eppendorf and centrifuged for 5 min at 4°C. 
One millilitre of the supernate was then transferred to a fresh Eppendorf and 200 .tl of 
20% PEG 8000 in 2.5 M NaCl [prepared fresh from sterile 40% (w/v) PEG 8000 and 
5 M NaCl solutions] was added, the solutions mixed by vortexing and incubated at 
room temperature for 15 mm. Bacteriophage particles were sedimented by 
centrifugation for 10 min at 4°C and the supernate discarded. The Eppendorf was 
briefly re-centrifuged, any residual supernate carefully removed and the pellet 
resuspended in 100 j.il of lx TE (pH 8.0). Single-stranded DNA was recovered from 
the phage-suspension by successive extractions with phenol, phenol: chloroform and 
chloroform, and finally ethanol precipitated. The DNA pellet was washed in 70% 
(v/v) ethanol, dried and dissolved in 20 p1 of sterile water. 
Preparation of Double-Stranded Plasmid DNA Templates. Plasmid DNA (2-3 tg; 
Section 2.3. 11) to be sequenced was dissolved in distilled water such that the total 
volume was 20 t1  An equal volume of 2x denaturing buffer [0.4 M NaOH, 0.4 mM 
CHAPTER Two 	 MA TERIALS AND METHODS 
EDTA} was added and the mixture incubated at 37°C for 30 mm. The denaturation 
reaction was neutralised by the addition of 0.1 volume of 3 M sodium acetate (1H 
5.2), followed by the immediate addition of 100 .tl of ethanol. The contents of the 
Eppendorf were gently mixed by inversion and the Eppendorf then placed at -70°C for 
15 mm. The denatured DNA-template was recovered by centrifugation for 10 min at 
4°C, the pellet washed with 70% (v/v) ethanol and dried. 
Primer Annealing Reactions. 
Single-Stranded DNA Template Reactions. The following reaction was prepared in 
an Eppendorf tube: 
Single-stranded template DNA (1 tg4tl) 	 2 .tl 
Primer (0.80 l.LM) 	 2 .tl 
5x Sequenase buffer (Sequenase Version 2.0 sequencing kit) 	2 lii 
Sterile distilled water 	 4 tl 
The contents of the Eppendorf were mixed well, incubated at 65°C for 2 mm, then 
allowed to cool to room temperature over 30-40 mm. 
Double-Stranded DNA Template Reactions. The dried DNA pellet was gently 
resuspended in 10 .ti of Ix Reaction buffer (lx Sequenase buffer, 0.5-1.0 pmole 
primer/template) and incubated at 37°C for 30 mm. 
Once the primer-annealing reaction was complete the Eppendorf was placed on ice 
until all the components necessary for the labelling reaction were prepared. 
Labelling Reaction. For each template to be sequenced, four Eppendorf tubes were 
labelled 'A', 'C', 'G' and 'T' respectively and 2.5 .tl of each of the four ddNTP 
termination mixes were placed into the appropriately labelled Eppendorfs; these tubes 
were pre-incubated at 37°C until use. A labelling reaction mixture was set up in a 
FW 
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separate Eppendorf as follows, adding the individual components in the following 
order: 
dGTP labelling mix (Sequenase Kit; diluted as required) 2 uI per template 
0.1 M DTT 	 1 p.1 per template 
[35 S]dATP 0.5-1 p.1 per template 
Sequenase Enzyme (diluted) 	 2 p.1 per template 
Final volume per template 	 5.5-6 p.1 
Five to six microlitres of the labelling reaction mix were added to the annealed 
template/primer reactions stored on ice, the solutions gently mixed then incubated at 
room temperature for 2-5 mm. 
Termination Reaction. Termination reactions were initiated by adding 4.5 p.1 of the 
labelling reaction to each of the pre-warmed ddNTP mixes. The solutions were gently 
mixed, the Eppendorfs placed back at 37°C for 5 mm, then 4 p.1 of Sequenase stop-
solution was added to each Eppendorf. Reactions were stored at —20°C until required 
for electrophoresis. 
The sequencing reactions were heated at 85°C for 3 min immediately before loading 
onto a 6% (w/v) denaturing polyacrylamide gel (Section 2.3.15). Gels were run at 33 
mA for 4-10 h then fixed in 10% (v/v) methanolll0% (v/v) acetic acid solution for 20 
min at room temperature and finally dried on a vacuum gel drier (Bio-Rad) at 80°C 
for 2 h. Sequence was visualised by autoradiography. 
2.3.17 Site-directed Mutagenesis 
The segment of DNA to be mutated was cloned into the phagemid vector 
pBluescript KS(Stratagene; Table 2.1.9) which contains the single-stranded 
replication origin of the phage fl. An oligonucleotide complementary to the region to 
be altered except for a limited mismatch was hybridised to a single-stranded copy of 
the DNA and a complementary strand then synthesised by Klenow DNA Polymerase 
RE 
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I, using the oligonucleotide as primer. To select against non-mutagenised double-
stranded DNA, the complementary strand was synthesised in a dut, ung double 
mutant as described by Kunkel et al. (1987). 
Propagation of Uracil-containing Phagemids. Competent CJ236 cells (dur, ung; 
Table 2.1.6) were transformed with phagemid DNA (pBluescript KS' -containing the 
desired insert) as described (Section 2.2.4). An isolated colony of CJ236 containing 
phagemid was used to inoculate 5 ml of LB-Cm/Amp medium and the culture grown 
overnight with shaking at 37'C. The following morning, 50 ml of fresh, pre-warmed 
LB-Amp medium was inoculated using 1 ml of the overnight culture and the culture 
incubated at 37°C until the optical density at 600 nm was 0.3 (between 1-4 h). Helper 
phage M13K07 was then added and the incubation continued for a further hour. At 
this stage 70 p.1 of 50 mg/ml kanamycin was added and the incubation continued for a 
further 4-6 h. 
Harvesting Phagemid. Thirty millilitres of the culture were transferred to a sterile 30 
ml corex tube and the cells pelleted by centrifugation at 12,000 rpm for 15 mm (4°C; 
Sorvall SS-34 rotor). The phagemid-containing supernate was transferred to a fresh 
corex tube, the centrifugation repeated and this supernate transferred to a corex tube 
containing 150 p.g of DNase free RNase A. The contents were mixed by inversion and 
incubated at room temperature for 30 mm. A quarter volume of 20% (w/v) PEG 6000 
in 3.5 M ammonium acetate (prepared fresh from sterile 40% (w/v) PEG 6000 and 7 
M ammonium acetate solutions) was added, the contents of the tube thoroughly 
mixed and incubated on ice for 30 mins. Phagemid were sedimented by centrifugation 
at 12,000 rpm for 15 mm (4°C; Sorvall SS34 rotor), the supernate discarded, the 
pellet drained well and then resuspended in 200 p.1 of high salt buffer [300 mM NaCl, 
100 mIvI Tris-HCI pH 8.0, 1 mM EDTA]. The bacteriophage suspension was 
transferred to an Eppendorf and chilled on ice for 30 mm. To remove insoluble matter 
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the suspension was centrifuged for 2 min and the phagemid-containing supernate then 
transferred to a fresh Eppendorf. The phagemid was either extracted immediately or 
stored in this state for up to 1 week at 4°C. 
Titering Phagemid Stock. Before proceeding any further the relative titer of phagemid 
stock was determined using CJ236 and DH5aF' to ensure that the single-stranded 
DNA template contained high levels of uracil. Phagemids containing uracil in their 
DNA survive far more readily in a bacterium without an active uracil N-glycosylase 
(ung-; 0236) than in one with an active enzyme such as DH5aF. 
Overnight cultures of CJ236 and DH5aF' were grown at 37°C. The following 
morning, 50 ml of fresh LB-medium were inoculated with either 1 ml of the CJ236 
overnight culture or 0.5 ml of DH5aF cells. The cultures were incubated with 
shaking at 37°C until the 0D600 was 0.3-0.35; if one culture reached this optical 
density before the other it was stored on ice. Once the desired optical density had 
been reached 10 p1 of uracil-containing phagemid stock was added, and the cultures 
incubated for a further 2 h at 37°C. An aliquot of the DH5aF-infected culture was 
diluted 10-fold and 100-fold then 50 .tl of each dilution and 50 p.1 of the undiluted 
culture spread onto LB-Amp plates. An aliquot of the CJ236 culture was diluted iO 3 -
fold, 104-fold and 10 5 -fold and 50 p.1 of each of these dilutions plated onto LB-Amp 
plates. The plates were incubated overnight at 37°C. 
Extraction of Phagemid. DNA was recovered from the phagemid stock by successive 
extractions with phenol, phenol: chloroform and chloroform, followed by precipitation 
with ethanol in the presence of 0.1 volume of 7.8 M ammonium acetate. The DNA 






Synthesis of the Mutagenic Strand. Synthesis of the mutagenic strand was achieved by 
priming synthesis from the single-stranded uracil-containing DNA template with the 
oligonucleotide containing the sequence of the desired mutation (Table 2.1.8). 
Phosphorviation of Mutagenic Oligonucleotide. Up to 200 pmoles of 
mutagenic oligonucleotide was phosphorylated as described in section 2.3.10. 
Annealing o[ Mutagenic Oligonucleotide to Template DNA. The following 
reaction was prepared in an Eppendorf 
Mutagenic oligonucleotide 	 10 pmoles (variable volume) 
Uracil-containing template DNA 	0.2 .tg (typically 0.5 RI) 
5x SDM1 buffer 	 2 R' 
Sterile distilled water to 10 R 1 
• 5x SDM1 buffer: 	200 mM Tris-HCI pH7.5 
100 mM MgCl2 
250 mMNaCI 
The mixture was incubated for 5 min at 20°C above the theoretical melting 
temperature (Tm) of a perfect hybrid formed by the mutagenic oligonucleotide, 
calculated using 
Tm = 4(G+C) + 2(A+T) 
The reaction was allowed to cool slowly to room temperature over 40-60 mm, then 
stored on ice. A control reaction containing all of the above ingredients but lacking 
the mutagenic primer was always set up to test for non-specific endogenous priming, 
caused by contaminating nucleic acids in the template preparation. 
Synthesis of 	Complementary Strand. Ten microlitres of ice-cold SDM3 
buffer was added to each of the annealed primer-template reactions, the components 
gently mixed and incubated overnight at 15°C. 
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. SDM3 Reaction Buffer: 
lOx SDM2 
2 mM dNTP mix [dATP, dGTP, dCTP, dTTP] 
10 mM ATP 
T4 DNA ligase 
Kienow DNA Polymerase I 






• lOx SDM2: 200 mM Tris-HCI pH7.5 
100 MM  MgCl2 
100 mMDTT 
Transformation o[ the reaction mix into E. coil DH5aF. Following overnight 
incubation at 15°C, 5 pis of the reaction mixture was used to transform competent 
DH5cF' cells (Section 2.2.4). Plates were incubated at 37°C overnight. 
Selection by DNA Sequencing. Double-stranded DNA sequence analysis was 
used to identify the desired mutant clones (Section 2.3.16). 
2.4 	Protein Methods 
2.4.1 Quantification of Total Cellular Protein 
Protein concentrations were determined by the Bradford method using Bio-
Rad protein detection solution as instructed by the manufactures. Ovalbumin was used 
as standard. 
2.4.2 Extraction of Total Cellular Protein 
Small Scale E. coil Extracts. E. coil cells were grown overnight at 37°C to saturation 
in the appropriate selective medium, typically LB-Amp (Table 2.1.1). The following 
day 100 .tl of the overnight culture was used to inoculate 10 ml of fresh, pre-warmed 
LB-Amp medium and the culture incubated at 37°C until the optical density at 550 nm 
reached 0.4. The culture was chilled on ice for 15 min then 1 ml was transferred to an 
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Eppendorf and the cells sedimented by centrifugation for 5 min at 4°C. The supernate 
was discarded, the cell pellet resuspended in 100 il of lx SDS-sample buffer (Table 
2.4. 1) and the cells lysed by heating to 100°C for 5 mm. The lysate was centrifuged 
for 5 min to pellet cell debris, then 15-20 pis of the lysate loaded onto an SDS-
polyacrylamide gel (Section 2.4.3). The remaining supernate was frozen in dry ice and 
stored at -70°C. 
Large Scale E. coli Extracts. E. co/i cells were grown overnight at 37°C to saturation 
in the appropriate selective medium, typically LB-Amp (Table 2.1.1). The following 
day I ml of the overnight culture was used to inoculate 100 ml of fresh, pre-warmed 
LB-Amp medium and the culture incubated at 37°C until the optical density at 550 nm 
reached 0.4. The culture was transferred to GSA bottles and the cells sedimented by 
centrifugation for 5 min at 4000 rpm (4°C; Sorvall GSA rotor). The supernate was 
discarded and the cell pellet washed once with 20 ml of 10 mM Tris-HCI pH 7.5. The 
cell pellet was then resuspended in 20 ml of lysis buffer (50 mM Tris-HC1 pH 7.5, 5 
mM EDTA, 3 mg/ml lysozyme), incubated on ice for 2 h, then 1.4 ml of SM NaC1 
was added and the suspension mixed by inversion. Cell lysis was completed by the 
addition of 1.5 ml 10% (v/v) NP-40. To shear DNA and reduce viscosity, the cell 
suspension was sonicated, using a MSE sonicator at full power, for three 30 s bursts 
with a 30 s interval between each sonication; all samples were sonicated in ice. A 
portion of the total cell lysate was saved for SDS-polyacrylamide gel analysis. The 
remainder of the lysate was separated into soluble and insoluble fractions. 
(i) Soluble fraction. The cell lysate was centrifuged for 10 min at 9000 rpm (4°C; 
Sorvall SS34 rotor), the supernate transferred to Eppendorfs, frozen in dry ice and 
stored in aliquots at -70°C. 
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(ii) Pellet fraction. The pellet was then washed twice with 20 ml of 10 mM Tns-HC1 
pH 7.5, and finally resuspended in I ml of urea-extraction buffer (6 M urea, 10 mlvi 
Tris-HCI pH 7.5, 0.2 mM EDTA). The suspension was transferred to dialysis tubing 
(Visking size 1-8/32", 12-14 kDa cut off) and dialysed against [10 mM Tris-HC1 pH 
7.5, 0.2 mM EDTA, 0.05% (v/v) NP-40] for 3.5 h at 4°C. The suspension was 
centrifuged for 10 min at 4000 rpm (4°C; Sorvall SS34 rotor) to pellet cell debris, the 
supernate then transferred to Eppendorfs, frozen in dry ice and stored at -70°C. 
Conditions for protein extraction were modified for individual protein-induction 
experiments (Section 2.6.1). 
Yeast Protein Extraction. Yeast cells were grown in rich or selective media (Table 
2. 1.2) such that at the time of harvesting cells the optical density at 600 nm was less 
than 0.6. The culture was harvested by centrifugation for 5 min at 2000 rpm, the 
supernate discarded and the pellet washed successively with distilled water and lx 
PBS (Table 2.1.5). The pellet was finally resuspended in 400 j.tl of lysis buffer [lx 
PBS/0. 1% (v/v) NP-40, 1 mM DTT] and transferred to an Eppendorf. The cell 
suspension was sonicated, using a MSE sonicator at full power, for three 30 s bursts 
with a 30 s interval between each sonication; all samples were sonicated in ice. The 
lysate was briefly centrifuged for 15 s at room temperature, the supernate transferred 
to a fresh Eppendorf and centrifuged for a further 10 min at 4°C. The supernate was 
then transferred to a fresh tube, frozen in dry ice and stored at -70°C. 
For SDS-polyacrylamide gel electrophoresis, protein extracts were mixed with an 
equal volume of 2x SIDS-sample buffer (Table 2.4.1) and the contents of the tube 
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24.3 SDS Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
All SDS-polyacrylamide gels were run using two 'sealed' 16 X 16 cm glass 
plates separated by either 1.5 or 2.0 mm spacers; 14 well combs accommodating 10-
50 j.il of sample, or single well combs for preparative gels were used. The resolving 
polyacrylamide gel solution was prepared (Table 2.4.1), poured between the plates to 
a level of 4 cm from the top, the gel layered with water-saturated butan-2-ol and 
allowed to polymerise for 60 min at room temperature. After polymerisation the 
butan-2-ol was washed off with distilled water and a 4.8% polyacrylamide stacking 
gel (Table 2.4. 1) poured on top of the resolving gel; the comb was inserted between 
the two plates, and the gel allowed to polymerise for at least 30 min at 37'C. Prior to 
electrophoresis the seal was removed from the plates, the comb gently taken out of 
the gel and the wells washed with distilled water. The plates were firmly fixed in the 
'ATTO' electrophoresis apparatus and the chambers filled with lx protein gel running 
buffer (Table 2.4.1). Protein extracts were mixed with an equal volume of 2x SDS-
sample buffer (Table 2.4.1), heated for 5 min at 100°C, then centrifuged for 5 min to 
pellet insoluble matter. Samples were loaded onto the gel, and the gel then run at 15 
mA until the bromophenol blue dye had entered the resolving gel, and then at 30 mA 
for the required time appropriate to the experiment. 
• High Molecular Weight pre-stained protein standards (Range 27,000-180,000 Da) 
were obtained from Sigma. 
• Low Molecular Weight pre-stained protein standards (Range 2850-43,000 Da) were 
obtained from Gibco BRL. 
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TABLE 2.4.1 
SDS-POLYACRYLAMIDE GEL ELECrROPIIORESIS SOLUTIONS 
SOLUTION 	 COMPONENTS 
30 % Acrylamide 	 30% (w/v) acrylamide:0.8% (w/v) bis-aciylamide 
4x Resolving gel buffer (pH 8.8) 	1.5 M Tris-HCI pH 8.8 
0.4%SDS(w/v) 
4x Stacking gel buffer (pH 6.8) 	 0.5 M Tris HCl pH 6.8 
0.4% SDS (w/v) 
SDS-sample buffer* 	 125 mM Tris-HC1 pH 6.8 
20% (v/v) Glycerol 
4% (w/v) SDS 
0.1% (w/v) Bromophenol Blue 
lOx Protein gel running buffer 	 250 mM Tris-Base 
2.5 M Glycine 
1.0% (w/v) SDS 




RESOLVING GEL 	 STACKING GEL 
6.0% 7.5% 8.5% 15%* COMPONENTS 
Water (ml) 	 16.5 
30% Acrylamide (ml) 	 6.0 
Buffer (ml) 	 7.5 
4.8% 
15 	14 	7.5 	5.9 
7.5 8.5 15.0 1.6 
7.5 	7.5 	7.5 	2.5 
Solutions were degassed for 10 mm 
Fresh 10% (w/v) APS (RI) 	55 	55 	55 	120 	30 
TEMED (1.d) 	 27.5 27.5 27.5 120 10 





Depending on the experiment the polyacrylamide gel was then either: 
stained in Coomassie Brilliant Blue R250. 
blotted onto Immobilon-P membrane and processed with antibodies. 
2.4.4 Coomassie Blue Staining of Polyacrylamide Gels 
After electrophoresis the polyacrylamide gel was stained in Coomassie Blue 
for 2-6 h at room temperature with gentle shaking. The stain was removed and stored 
for re-use up to 20-30 times. The gel was destained by incubating in 5% (v/v) 
methanoll7.5% (v/v) acetic acid at 37°C. 
Coomassie Blue: 	0.125% (wlv) Coomassie Brilliant Blue R250 
50% (v/v) Methanol 
10% (v/v) Acetic acid 
2.4.5 Western Blotting 
Electrophoretic Transfer of Proteins onto PVDF Immobilon-P Membrane. Proteins 
were transferred eletrophoretically onto Immobilon-P membrane (Millpore) using the 
Bio-Rad transfer system as instructed by the manufacturer. Extreme care was taken to 
ensure that there were no air bubbles between the gel and membrane. All transfers 
were performed at constant voltage using lx Western transfer buffer; the time of 
transfer and the precise voltage used were dependent on the size of the protein of 
interest (Table 2.4.3). 
Blotting Procedure. Non-specific protein interactions were blocked by incubating the 
membrane in 5% (w/v) dry-milk in I x TBS (Table 2.1.5) for 2 h at room temperature 
or overnight at 4°C. The membrane was incubated with primary antibody diluted in lx 
TBS for 2 h at room temperature. The membrane was then washed in lx TBS for 15 
mm; this was repeated three times. Secondary antibody conjugated to alkaline 
phosphatase was diluted in lx TBS, added to the membrane and incubated for 1 h at 
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room temperature. The membrane was washed thoroughly as before. Development of 
the membrane was achieved by exposing the membrane to alkaline phosphate 
substrates, NBT and BCIP according to the manufacturers instructions. 
TABLE 2.4.3 
WESTERN TRANSFER CONDITIONS 
PROTEIN 	POLYACRLYMIDE RESOLVING GEL TRANSFER CONDITIONS 
(TABLE 2.4.2) 
10-40kDa 	 15% 	 6OV for 6Omin 
40-140 kDa 7.5-8.5% 	 100 V for 60 mm 
140-220kDa 	 6.0% 100 V for 3-6h 
lOx Western Transfer Buffer: 	1.5 M Glycmne, 200 mM Tris-HCI pH 8.3 
2.5 	In vitro Splicing Reactions 
2.5.1 Yeast Splicing Extract 
Cell Harvesting and Lysis. Two litres of rich medium (Table 2.1.2) were inoculated 
with a mid-logarithmic phase culture of the selected yeast strain and the culture grown 
overnight at 30°C. When the optical density at 600 nm was between 0.5 and 0.7 the 
cells were harvested by centrifugation for 5 min at 4000 rpm (Sorvall GS-3 rotor). 
The supernate was discarded, the cell pellet resuspended in 25 mIs of lx PBS (Table 
2.1.5) and transferred to a sterile 50 ml Falcon tube. Cells were pelleted by 
centrifugation for S min at 3000 rpm (Mistral 1000 centrifuge), the supernate 
discarded, and the pellet resuspended in 40 mIs of lyticase buffer (Table 2.5.1). The 
cell suspension was transferred to a 500 ml flask and incubated at 30°C for 30-60 mm 
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with continuous slow shaking until 70-80% of the cells had formed spheroplasts, as 
determined microscopically. 
Cell Homogenisation. Spheroplasts were harvested by centrifugation for 5 min at 
2000 rpm (Mistral 1000 centrifuge) The supernate was discarded and the spheroplasts 
then washed twice with 1.2 M sorbitol and once with ice-cold SB-3 buffer (Table 
2.5.1); after each wash spheroplasts were gently resuspended using a 'sealed' pipette. 
After the final SB-3 wash the pellet was weighed, resuspended in approximately 1 
mg/ml of ice-cold Buffer A, transferred to a chilled Dounce homogeniser and 
incubated on ice for 5 mm. Spheroplasts were lysed by 10-13 slow, rotating strokes of 
the tight fitting pestle; this was performed at 4°C in the cold room but the 
homogeniser was not maintained on ice. 
Post-Homogenisation Treatment of Extract. After homogenisation the lysate was 
transferred to a chilled, sterile 20 ml glass beaker, the volume of lysate measured and 
1/9th volume of cold 2 M KCI added dropwise. The suspension was continuously 
stirred for 30 min at 4°C, then transferred to a chilled 15 ml polycarbonate SS34 tube 
and centrifuged for 15 min at 17,000 rpm at 4°C in a pre-cooled Sorvall RC-5B 
centrifuge (Sorvall SS34 rotor). Trying not to disturb the lipid layer, the supernate 
was transferred to a fresh 15 ml chilled polycarbonate SS34 tube and centrifuged for a 
further 15 min at 17,000 rpm (4°C; Sorvall SS34 rotor). The supernate was then 
transferred to a chilled Ti-SO polycarbonate tube, again taking care to avoid disturbing 
the lipid layer, and centrifuged at 38,000 rpm for 60 min at 4°C in a pre-cooled Ti-SO 
rotor using a chilled Sorvall 50-B or 55-B Ultracentrifuge. 
Dialysis. The final supernate was transferred to dialysis tubing (Visking size 1-8/32", 
12-14 kDa cut oft) and dialysed against two changes of ice cold Buffer D (Table 
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chilled Eppendorfs, centrifuged for 10 min at 4 °C to remove insoluble matter, then 
aliquoted into fresh Eppendorfs and frozen in dry ice. Extracts were stored for long 
periods at -70°C; repeated freeze-thawing was avoided by storing the extract in small 
volumes. 
TABLE 2.5.1 
SPLICING ExTIttc'r BUFFERS AND SOLUTIONS 
BUFFER 	 COMPONENTS 
Lyticase Buffer 	1.2 M Sorbitol 
50 mM Potassium phosphate buffer pH 7.5 
30 mM DTT* 
2500 units Lyticase enzyme*  (Sigma) 
SB-3 Buffer 	50 mM Tris-HCI pH 7.5 
1.2 M Sorbitol 
10 MM  MgCl2 
3 mM DTT* 
Buffer A 	 10 mM HEPES-KOH pH 7.9 
1.5 mMMgCl2 
10 mMKCI 
0.5 mM DT* 
Buffer D 	 20 mM HEPES-KOH pH 7.9 
0.2 mMEDTA 
0.5 mMDTr'* 
50 mM KCI 
20% (v/v) Glycerol 
All solutions were prepared in advanced and sterilised by autoclaving; *, Added to the 
solution immediately before use; , Prepared in advance and chilled overnight at 4°C. 
2.5.2 In vitro Transcription 
T7 RNA Polymerase directed in vitro transcription reactions were performed 
essentially as described by Melton el al. (1984). 
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Preparation of DNA Template. RNase-free plasmid DNA pT7rp28s (Lossky et al., 
1987) was linearised by digestion with EcoRT. An aliquot of the digested DNA was 
analysed by agarose gel electrophoresis (Section 2.3.4) to verify that the DNA 
template had been cleaved to completion. Following digestion the DNA template was 
purified by extraction with phenol: chloroform, ethanol precipitated in the presence of 
ammonium acetate and then resuspended in sterile DEPC-treated water. 
Transcription Reaction. The following transcription reaction was prepared in an 
Eppendorf, the tube incubated at 37°C for 12 min then placed on ice to stop the 
reaction. Transcripts were stored at -20°C for 2-3 days. 
Transcription Reaction: 
400-500 ng linearised template DNA 2 	.tl 




250 .tM UTP 1 	tl 
800 Cilmmol [(x-32p] UTP 1 	tl 
Sterile distilled water 1.2 	.t1 
RNasin 10 Units 
T7 RNA Polymerase 0.5 pi 




Filter sterilised and stored in aliquots at -20°C. 
2.5.3 In vitro Splicing Assay 
The assay for the production of spliced RNA and splicing intermediates was 
performed essentially as described by Lin et al. (1985). 
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Splicing extract preparation. Yeast whole cell extracts were prepared as described in 
section 2.5.1. Extracts from strain MCY4 were depleted of Sdb23p by growth in 
glucose medium for 13 h at 30°C, maintaining the cells in logarithmic growth by 
dilution to keep all 0D600 readings below 0.6. 
In vitro splicing reactions. A splicing reaction 'mix' was prepared in an Eppendorf 
chilled on ice as follows, using solutions listed in Table 2.5.2: 
. Splicing Reaction 'Mix': 
30% (w/v) PEG 10 p.1 
2OmMATP 10 P1 
IgG buffer 8 p.1 
1 M Potassium phosphate pH 7.5 6 p.1 
100 mMM902 2.5 p.1 
Radiolabelled RNA transcript 0.5 p.1 
Sterile distilled water 13 p.1 
Typically, 5 p.1 of splicing extract was mixed with an equal volume of splicing reaction 
'mix', the contents mixed gently and incubated at 25°C for 2-25 mm. Reactions were 
terminated by incubating on ice for 5 mm. The RNA products and/or spliceosome 
complex formation were analysed as follows: 
(i) RNA Analysis. For analysis of the RNA products, 5 p.1 of proteinase K (Table 
2.5.2) was added to the splicing reaction, the contents gently mixed and incubated at 
37°C for 30 mm. At the end of this incubation 150 p.1 of splicing cocktail buffer (Table 
2.5.2) was added and the resulting mixture extracted once with phenol: chloroform to 
remove protein debris. Approximately 120 p.1 of the aqueous phase was removed to a 
fresh Eppendorf, and a further 150 p.1 of splicing cocktail buffer added to the 
remaining solution and the extraction repeated. Four microlitres of E. coil tRNA was 
added to the pooled aqueous phases and the RNA recovered by ethanol precipitation, 




.tl of Stop-solution (Section 2.3.15). The reaction products were fractionated on a 
6% (w/v) denaturing polyacrylamide gel (Section 2.3.15) and visualised by 
autoradiography. 
(ii) Splicing Complexes. For the analysis of splicing complexes, the splicing reaction 
was mixed with an equal volume of Q Buffer (Table 2.5.2) incubated on ice for 10 
min and then loaded directly onto a non-denaturing polyacrylamide gel (Section 2.5.4) 
using non-denaturing gel-loading buffer (Section 2.3.15). 
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TABLE 2.5.2 
IN VITRO SPLICING BUFFERS 
SOLUTION 	 COMPONENTS 
IgG Buffer* 	0.5 M Potassium phosphate buffer pH 7.5 
33 mIvi Citrate pH 3.0 
16.67% (v/v) Glycerol 
pH of Citric acid adjusted to 3.0 using sodium citrate pH 8.6. 
E. coli tRNA* 	E. co/i tRNA Type XX (Sigma) dissolved in sterile DEPC-treated water 
to a final concentration of 20 mg/ml. The stock solution was purified by 
six phenol: chloroform extractions and a single chloroform extraction. 
The aqueous phase was ethanol precipitated in the presence of 1/10th 
volume sodium acetate and the pellet resuspended in sterile DEPC-
treated water to obtain a final stock solution of 20 mg/ml. 
30% PEG* 	30% (w/v) PEG 8000 in sterile DEPC-treated water 
Proteinase K* 	1 mg/ml proteinase K 
50 mM EDTA 
1% (w/v) SDS 
Splicing Cocktailt 	50 mM Sodium acetate pH 5.3 
1 mM EDTA 
0.1% (w/v) SDS 
Q Buffer 	 0.4 M KCI 
2 mM Magnesium acetate 
20 mM EDTA pH 8.0 
16 mM Tris-HCI pH 7.4 
2 mg/ml Yeast total RNA. 
', Stored in aliquots at -20°C; t, Prepared fresh from sterile solutions; T , Total RNA prepared from 
temperature-sensitive splicing mutants under non-permissive growth conditions were found to resolve 
splicing complexes the best. 
2.5.4 Non-Denaturing Gel Electrophoresis of Splicing Complexes 
Splicing complexes were resolved by non-denaturing polyacrylamide gel 
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EDTA was present in both the electrophoresis buffer and the resolving gel (Table 
2.5.4) 
Two 16 X 16 cm glass plates separated by 1.5 mm spacers were taped together and 
prewarmed at 65°C. A blocking-gel was prepared (Table 2.5.4), poured immediately 
and the gel-assembly left to stand at 37°C for 5 mm. A separating-gel (Table 2.5.4) 
was then prepared, poured on top of the blocking-gel up to the top of the plates and a 
10 x 1.0 cm comb was inserted. The gel was allowed to polymerise at 37°C for 30 
min then stored at 4°C until use. Non-denaturing gels were run at 4°C in pre-chilled 
lx native gel running buffer at 80 V for 10-12 h, or overnight at 40 V until the xylene 
blue dye front had reached the blocking gel. 
Blocking Gel: 
30% Acrylamide [30% (w/v) acrylamide:0.8% (w/v) bis-acrylamide] 	1 ml 
0.5MEDTA 	 100 PI 
lOx TB (Table 2.1.5) 	 250 .tl 
Sterile distilled water to 5 ml 
50 tl of 10% (w/v) APS and 20 .tl of TEMED was added and the gel poured immediately. 
. Resolving Gel: 
Agarose 	 0.25 g 
Agarose was dissolved in 40 ml of sterile distilled water then allowed to cool before the addition 
of the remaining gel components. 
30% Acrylamide [30% (w/v) acrylamide:0.8% (w/v) bis-acrylamide] 	5 ml 
0.5MEDTA 	 imi 
lOx TB (Table 2.1.5) 	 2.5 ml 
400 pi of 10% (w/v) APS and 50 i.tl of TEMED was added and the gel poured immediately. 
. lOx Native Gel Running Buffer: 5x TB, 100 m EDTA pH 8.0. 
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25.5 Immunoprecipitations 
Antibodies (Table 2.1.10) were bound to pre-swollen protein A-Sepharose 
beads (PAS; Sigma) in NTN buffer for a further hour at room temperature (150 mM 
NaCl, 50 mM Tris-HCI pH 7.5, 0.1% (v/v) NP-40). For snRNA analysis, PAS-bound 
antibodies were then incubated for a further I h in NTN-B (NTN plus 100 .tg each of 
glycogen, E. co/i tRNA and BSA). The PAS-bound antibodies were then washed four 
times with NTN buffer. Splicing extract was made up to a 100 p1 with sterile DEPC-
treated water, mixed with an equal volume of 2x immunoprecipitation buffer (300 
mM NaCl, 5 mM M902, 10 mM HEPES buffer pH 7.9) and incubated at 4°C with 
PAS-bound antibodies for 2 h with constant rotation. The antibody complexes were 
then washed three times with NTN, and once with NT (N1'N without NP-40); the salt 
concentration of N1'N was varied according to the stringency of the wash required. 
Immunoprecipitation of Proteins. Immunoprecipitated proteins were recovered from 
the PAS-bound antibodies by resuspending the PAS-matrix in 50 .ti of 2x SDS-
sample buffer (Table 2.4.1), heating the sample to 100°C for 5 min then pelleting the 
matrix by centrifugation for 5 mm. The protein-containing supernate was resolved on 
an SDS-polyacrylamide gel (Section 2.4.3). 
Immunoprecipitation of snRNAs. Immunoprecipitated snRNAs were recovered from 
the PAS-bound antibodies by treatment with 50 .tl of 2 mg/ml proteinase K 
(Boehringer Mannheim, prepared according to manufactures instructions) for 30 mins 
at 37'C. One hundred microlitres of sterile, DEPC-treated water was added to the 
Eppendorf and the resulting mixture extracted once with an equal volume of 
phenol: chloroform. Approximately 200 tl of the aqueous phase was transferred to a 
fresh Eppendorf, a further 100 .tl of DEPC-treated water were then added to the 
remaining solution and the extraction repeated. Four microlitres of E. co/i tRNA and 
0.1 volume of 3 M sodium acetate (pH 5.2) were added to the pooled aqueous phases 
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and the RNA recovered by ethanol precipitation. The RNA pellet was dried, 
resuspended in 10 j.tl of Stop-solution (Section 2.3.15) and then fractionated on a 6% 
(w/v) denaturing polyacrylamide gel (Section 2.3.15). 
2.6 	Immunisation Procedures 
2.6.1 Expression of !acZ and trpE Fusion Protein 
Two expression systems were used to produce large amounts of fusion protein 
in bacteria. LacZ-gene fusions were generated using the pUR series of vectors 
(Ruther and MUller-Hill, 1983) and trpE-gene fusions were constructed using pATH 
vectors (Koerner et al., 1990). The gene of interest was subcloned into either a pUR 
or pATH vector to create an in-frame fusion with either the lacZ or trpE open reading 
frame (ORF). 
Induction of lacZ fusion proteins. E. co/i cells carrying the desired /acZ-gene fusion 
were grown overnight to saturation at 37°C in LB-Amp medium. The following 
morning, the culture was diluted by a factor of ten with fresh, pre-warmed LB-
medium and the incubation continued with vigorous shaking at 37°C for 2 h. IPTG 
was added to the culture to a final concentration of 1mM and the culture then 
incubated at 37°C for a further 3 h. 
Induction of trpE fusion proteins. Induction of trpE-fusion protein synthesis was 
performed as described by Koerner et al. (1990). E. co/i cells carrying the desired 
trpE-gene fusion were grown overnight to saturation at 37°C in synthetic M9 medium 
supplemented with 20 j.tg/ml tryptophan. The following morning, the culture was 
diluted by a factor of ten with fresh, pre-warmed synthetic M9 medium lacking 
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Indoleacrylic acid (IAA; 2 mg/ml in 95% ethanol) was added to a final concentration 
of 0.01 mg/ml and the culture incubated at 37°C for a further 4 h. 
Induced cultures were harvested by centrifugation for 5 min at 5000 rpm (Sorvall 
GSA rotor) for large scale protein extracts, or in a bench top centrifuge for 1.5 ml 
volumes Section 2.4.2). 
2.6.2 Partial Purification of /3-galactosidase-Sdb23 Fusion Protein 
Partial Purification of Fusion Protein. Large scale protein extracts prepared from 
E.coli cells overproducing -gaIactosidase-Sdb23 fusion protein were fractionated on 
a preparative 8.5% SDS-polyacryl amid e gel (Sections 2.4. and 2.6.1). Following 
electrophoresis, 0.5 cm strips were cut from either side of the polyacrylamide gel and 
briefly stained with Coomassie Blue to locate the 3-galactosidase-Sdb23 fusion 
protein. These strips were then aligned with the remainder of the polyaciyiamide gel 
and the band of interest excised. This gel slice was placed in dialysis tubing (Visking 
size 1-8/32", 12-14 kDa cut off) and filled with 1 ml of lx protein gel running buffer 
(Table 2.4. 1) per milligram of wet polyacrylamide gel. The dialysis tubing was sealed, 
placed crosswise in a horizontal electrophoresis chamber containing lx protein gel 
running buffer, and the protein electroeluted from the gel slice for three hours at 100 
V. The gel slice was then removed from the dialysis tubing and Coomassie blue 
stained to confirm that the protein had been effectively eluted. The protein-containing 
buffer was then either further treated, or transferred from the dialysis tubing to 
Eppendorfs, frozen in dry ice and stored at -70°C. 
Concentration of Partially Purified /3-galactosidase-Sdb23 Fusion Protein. To 
concentrate partially purified 3-galactosidase-Sdb23 fusion protein, the protein-
containing buffer was dialysed against two changes of [0.2 M sodium bicarbonate, 
0.02 % (w/v) SDS] for 2 h at 4°C. This solution was then transferred to an 
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Eppendorf, lyophilised and the protein resuspended in 0.1 volume of the original gel 
volume using sterile water. 
2.6.3 Immunisation of Rabbits 
All experiments on live animals were performed in compliance with the 
"Cruelty to Animals Act" 1986 under licence 63181. New Zealand White female 
rabbits were used. 
Immunisation. For the initial immunisation, 100 tg of partially purified fusion protein 
(Section 2.6. 1) was diluted into 600 .tl of lx PBS (Table 2.1.5), mixed with an equal 
volume of Freud's Complete adjuvant (Sigma) and an emulsion formed by vigorous, 
prolonged mixing. This was injected into the rabbit subcutaneously. All subsequent 
injections consisted of 50 ,..tg of fusion protein mixed with Freud's Incomplete 
adjuvant. Immunisations were performed at 4-6 weekly intervals, depending on the 
immune response of the rabbit as determined by test bleeds. 
Bleeds. Blood was collected from the rabbit prior to the first immunisation (pre-
immune) and 10-12 days after the second and all subsequent injections. Ten days after 
the final immunisation, when the immune response had reached a peak, the rabbit was 
anaesthetised with Sagatal, 100-150 ml of blood withdrawn directly from the heart 
and the rabbit killed with a further injection of Sagatal. 
2.6.4 Serum Preparation and Storage 
After collection the blood was allowed to clot at room temperature for 30-60 
mm. The clot was then detached from the side of the container using a sterile Pasteur 
pipette, and the container placed at 4°C overnight. Serum was separated from the clot 
by centrifugation for 5 min at 2000 rpm, transferred to a fresh tube and aliquoted into 
Eppendorfs and stored at -70°C. 
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2.7 	Computer Analysis 
Extensive searches of protein databases were performed on the EMBL-
Heidelberg and NCBI network file-servers, using the BLITZ (Sturrock and Collins, 
1993) and BLAST (Altschul et al., 1990) search programs respectively with varied 
search-sensitivity levels. In addition, the GCG8 suite of programs was used to search 
protein databases and perform multiple sequence alignments (Devereux et al., 1984; 
Pearson and Lipman, 1988). 
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INTRODUCFION 
The removal of introns from nuclear pre-mRNA proceeds via a conserved 
mechanism, involving two trans-esterification reactions (Section 1.1.2). These 
reactions take place in a large complex called the spliceosome which is composed of 
the pre-mRNA, five snRNP particles and other protein components, many of which 
are as yet undetermined. In vitro, biochemical characterisation and fractionation of 
higher eukaryotic cell extracts have identified a number of splicing factors, both 
proteins that are integral components of the spliceo some, and those that only interact 
transiently, at specific stages of the splicing reaction. 
Large scale immunoafilnity purification of spliceosomal snRNPs has been used to 
identify a number of potential snRNP core proteins from yeast (Fabrizio et al., 1994). 
However, compared to the success of this method in higher eukaryotic systems, these 
efforts have so far failed to identify conclusively novel yeast core proteins. 
Yeast genetics provides an alternative, powerful tool for the identification and analysis 
of splicing factors (Beggs, 1995). The first yeast splicing factors were identified by 
characterisation of a set of temperature-sensitive prp mutants (originally ma mutants; 
Hartwell et al., 1970), that were identified as being defective in RNA metabolism. A 
vast number of PRP genes have now been recovered in extensive screens of newly 
isolated temperature-sensitive mutants that are defective in pre-mRNA processing. 
Others have been identified as suppressors of mutations either in PRP or snRNA genes 
(reviewed in Ruby and Abelson, 1991; Brown et al 1993; Beggs, 1995). However, 
such conventional genetic screens have been far from saturating. Significantly, these 
screens have failed to isolate mutants affecting homologues of the mammalian snRNP 
core proteins. 
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Nevertheless, all the evidence available suggests that yeast homologues of the Sm-
binding core proteins do exist. For example, the yeast Ui, U2, U4, and U5 
snRNAs, although not closely conserved in primary sequence, do contain Sm sites 
(Riedel et al., 1987). These sites are biologically functional (Riedel et al., 1987) 
and required for snRNP stability (Jones and Guthrie, 1990). Additionally, the yeast 
snRNAs can be immunoprecipitated (albeit weakly) by human anti-Sm antisera 
(Siliciano et al., 1987; Tollervey and Mattaj, 1987), indicating that epitopes of the 
core proteins have been conserved to some degree. 
To date, two yeast genes, SMDJ and SMD3, that encode polypeptides homologous to 
the mammalian Dl and D3 proteins have been identified fortuitously as neighbours of 
PRP38 and PEP3 (Rymond, 1993; Rymond et al., 1993; Lehmeier et al., 1994; Roy 
et al., 1995). The in vivo depletion of either Smdlp or Smd3p causes a dramatic 
reduction in the levels of Ui, U2, U4 and U5 snRNAs, but leaves the level of U6 
snRNA relatively unaffected since this RNA does not associate with core proteins, 
and is not dependent on the formation of the Sm core structure for stability 
(Rymond et al., 1993; Roy et al., 1995). Smdl and Smd3 polypeptides have been 
evolutionarily well conserved. Indeed, the mammalian Dl protein can functionally 
replace its yeast counterpart (Rymond et al., 1993). 
This chapter describes the initial isolation (Parkes and Johnston, 1992) and 
subsequent characterisation (this work) of a yeast gene, SDB23. SDB23 encodes a 
polypeptide with low but significant homology to the mammalian Dl core protein and 





3.1 Isolation of the SDB23 Gene 
SDB23 was one of three genes isolated in a search for high copy-number 
suppressors of a mutation in DBF2, which encodes a cell cycle protein kinase (Parkes 
and Johnston, 1992). The suppressing activity of the complementing plasmid (YEp24-
SDB23) was localised by Tnl000 insertion mutagenesis to a 1.7 Kb Hindffl fragment 
(Parkes and Johnston, 1992). This region was subjected to DNA sequence analysis 
and found to contain a single, short 564 nucleotide uninterrupted open reading frame 
(ORF) beginning with an ATG codon at position 1 (Figure 3. 1A) and terminating with 
TAA at positions 562-564 (Parkes and Johnston, 1992; this work). 
When the nucleotide sequence of the 1.7 Kb Hind In fragment was compared with 
sequences in the GenBank database, nucleotides -290 to -374 were identified as the 
SWJ4 promoter sequence (Foster et al., 1993). Thus, the DNA fragment that 
complements the temperature-sensitive defect of dbf2-1 contains a single ORF 
(Database accession number X82649) whose transcriptional control elements are 
adjacent to (if not overlapping) the SWI4 promoter sequence (Figure 3. 1B). 
Chromosome mapping of the SDB23 locus was performed by hybridising 32P-labelled 
SDB23 DNA to a yeast chromosome OFAGE blot (provided by E. Gordon, 
University of Edinburgh). A single band corresponding to chromosome V was 
detected. Complete sequencing of this chromosome as part of the 'Yeast Genome 
Sequencing Project' independently confirmed this result, and identified the precise 
location of SDB23 on the right arm of chromosome V (Database accession number 
Sc978 1). 
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3.1.1 SDB23 Gene Sequence 
A single sequence resembling the yeast transcriptional control consensus 
TATAA is located at position -78 (TATTA) 5' of the ORF (Figure 3. 1A). Several 
potential transcription start sites are located between this sequence and the initiation 
methionine codon. The overall base composition of this region is extremely rich in 
adenine nucleotides, typical of the 5' non-transcribed sequence of many yeast genes 
(Cigan and Donahue, 1987; Donahue and Cigan, 1990). The presence of adenine 
nucleotides in this region, is believed to minimise the formation of secondary 
structures which might interfere with and/or inhibit translation initiation. 
The nucleotide sequence immediately adjacent to the initiation methionine also 
influences the efficiency of initiation of translation. The initiation codon of many well 
expressed yeast genes typically has adenine nucleotides upstream at positions -1, -3 
and -5 (Cigan and Donahue, 1987; Donahue and Cigan, 1990). In addition, there is a 
clear preference for nucleotides that encode serine as the second amino acid (Figure 
3.2A). The ATG of SDB23 is embodied within a sequence related to the consensus, 
however, this sequence lacks adenine nucleotides at positions -3 and -5, and contains 
nucleotides that encode leucine as the second amino acid. Potential 3' processing 
sequences, closely related to the degenerate, T-rich consensus sequence are located 
immediately downstream of the presumed SDB23 termination codon, TAA (Figure 
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-374 TTCATAGTGATAAGTAATTTTAAATGAGTTTAAAGTACTACTTTTCCTTTACCGCCAGTT 315 
-314 TCCTGTACTATGAAAAAGGCAAATTCCCATTGTAGCCGCCCACACGCATTTTGATCATC 255 
-254 AATTACGAAATTTGCCGCACACGTGTCACGTGATAPLGCACTCTTACTATCATGTTTTACG 195 
-194 GAGTAGCAATGATGTTCAATTATTGCAGCTTTCTTTCGTGAAATCGTAGTATCATACC 135 
-134 TTCCTAATGATGGAAGCGGTAAAGAAGGAAATCGTAAAAGTAAATTAACGAAGTAGI! -' 
-74 AGTAAAACAGAGTTGAAAAACTGATAAATCTTCAACTCGAACTGAAAPLGAAACACAATAG -15 
-14 AATATTTTTTCTCAATGCTACCTTTATATCTTTTAACAAATGCGAAGGGACAACAAATGC 46 
ML PLY L L TN AK G Q Q M Q 
47 AAATAGAATTGAAAAACGGTGAAATTATACAAGGGATATTGACCAPLCGTAGATAACTGGA 106 
I ELK N G Eli Q GILT N V D N W M 
107 TGAACCTTACTTTATCTAATGTAACCGAATATAGTGAPLGAAAGCGCAATTAATTCAGAPG 166 
N L T L S 	VT E Y SEES AIMS ED 
167 ACAATGCTGAGAGCAGTAAAGCCGTAAAATTGAACGAAATTTATATTAGAGGGPCTTTTA 226 
N A ES S K A V K L N ElY I R G T F I 
227 TCAAGTTTATCAAATTGCAAGATAATATAATTGACAAGGTCAAGCAGCAAATTAACTCCA 286 
K F 1K L Q D N lID K 	K 	Q INS N 
287 ACAATAACTCTAATAGTAACGGCCCTGGGCATAAAAGATACTACAACAATAGGGATTCAA 346 
N N S 	S N G PG H KR Y Y N N RD S  
347 ACAACAATAGAGGTAACTACAACAGAAGAAATAATAATAACGGCAACAGCAACCGCCGTC 406 
N N R G 	Y N R RN N N N G N S 	R R P 
407 CATACTCTCAAAACCGTCAATACAACAACAGCAACAGCAGTAACATTAACAACAGTATCA 466 
Y S 	N R Q Y N N S 	S S 	INNS IN 
467 ACAGTATCAATAGCAACAACCAAAATATGAACAATGGTTTAGGTGGGTCCGTCCAACATC 526 
SINS N N Q N MN MG L G G S V Q H H 
527 ATTTTAACAGCTCTTCTCCACAAAAGGTCGAATTTTAAACAAATTTTGTATTATAATAAT 586 
F N SS S P Q K 	E F 
587 TATGTACATATATAAATATATTGGTACATATGTACTGTGTGTGTATGTGAATGTTGATTA 646 
647 CCGTTTTCTTT 
ii] 
BRv H 	 H 	 B 
4—J S74 Promoter 	SDB23 
SWI4 	 1Kb 
Gene I 	 I 
Figure 3.1. Sequence of SDB23 and a physical map of the SDB23 chromosomal locus. (A) 
SDB23 nucleotide and predicted polypeptide sequences (database accession number 
X82649). Potential TATAA element is underlined, the presumed initiation codon in bold. 
Region corresponding to part of the S994 promoter sequence is italicised. Single letter 
amino acid code is used. (B) Restriction map of SDB23 chromosomal locus isolated on a 
BamHI fragment showing the SDB23 gene (hatched box), SWI4 promoter (open box) and 
gene (Wack box). Arrows indicate direction of transcription. Restriction sites; B, BamHI; 









-s 	 6 
AAAAAATGTCT 
.Y.0 ...... C 
•1CTCAATGCTA 
B 	3' CONSENSUS TAA—X (1 . 140) --T rich ---- TAG ---- TAGT ---- ATrich ---- TTT 
SEQUENCE: 	TAG 	 T&TGTTGA 
3' SDB23 	ThA ----- TTTT ------ TAA ---- TATGT--ATrich--TTT 
SEQUENCE: 
Figure 3.2. 5' and 3' processing sequences. (A) Preferred sequence context surrounding 
yeast initiation codons and the SDB23 initiation sequence. Sequence is numbered using 
the adenine nucleotide of the methionine codon as position one. The initiation codon is 
indicated by enlarged text. (B) Degenerate 3' processing sequences indicating potential 
termination codons in yeast (FAA, TAG and TGA). Bold text indicates preferred 
nucleotides. Y, Pyriinidine; U, Purine; A, Adenine; C, Cytosine; G, Guanine; T, Thymine; 
X, any nucleotide. Spacing parameters are shown by numbers. 
3.2 SDB23 Encodes a Polypeptide with Low but Significant Homology to 
SnRNP Core Proteins 
The SDB23 gene encodes a predicted 187 amino acid protein with a calculated 
molecular weight of 21,276 Da. An initial comparison of the SDB23-encoded ORF 
with protein sequences in the GenEmbl database, using TFASTA (Pearson and 
Lipman, 1988) and BLAST search programs (Altschul et al., 1990), revealed that 
Sdb23p is an uncharacterised protein with low but significant sequence similarity to 
two snRNP core proteins, mammalian Dl polypeptide (Rokeach et al., 1988) and its 
yeast homologue, Smdlp (Rymond, 1993). Significantly, the amino-terminal halves of 
these proteins share the greatest degree of sequence similarity, the carboxy-terminal 
portions diverging considerably (Figure 3.3). Notably, the carboxy-terminal domain of 
Sdb23p is extended by forty one and sixty eight amino acids compared to the 
mammalian Dl and yeast Smdl polypeptides respectively. Additionally, Sdb23 protein 
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residues. The Dl proteins have a preference for arginine and glycine residues in this 
region (Figure 3.3). 
YeastSdb23 	M L P L Y L L T N A K G Q Q H Q I E L K N G E I I Q G I L ; N V D N W M N L T L 
Human DI MEL VR FLMKLS H ETVTI EL KNGTQVHGTI TGVDVS MN THL 
YeastSmdl 	KLVNF KKLRNEQVTIELKNGTTVWGT QSVSPQ 	Al 
YeastSdb23 	s  VT E Y SEES A INS E D N A ES S K A V ................ 
Human D1 KAVKMTLKNREPVQ .......................... 
YeastSmdl 	T DV EL T L P Q PR L N K L N S N G IA MA SLY L T G G Q Q PTA SD N IA 
YeastSdb23 	K L N El Y I R G T F I K F I K L Q D N I I D K V K  Q I N S N N N S N S N GP 
Human DI . LET L SIR G N NI R Y F IL PD S L P L D IL L  DV E P K  KS KKR E 
YeastSmdl 	S QY NI_RGNT 	QI I 	S NLDSLLVDQKQLNSLRRSG 
YeastSdb23 	G H KR Y Y N N RD S  N N R G NY N R RN N N N G N S  R R P Y S  N N Q Y N 
Human DI A V A G N G R G R C N C N G R G N G R G R G G P R N 
Yeast Smdl 	Q I A N D P S K RRRDFCAPANK PNRCL 
YeastSdb23 	N S N S S N I N N S I N S I N S N N Q N M N N G L G G S V Q H H F N S S S P Q K 
Human Dl 
Yeast Smdl 
YeastSdb23 	V E F 
Human Dl 
Yeast Smdl 
Figure 3.3. Alignment of Sdb23 protein with the mammalian Dl polypeptide and its yeast 
homologue Smdlp. Alignment is numbered using the methionine codon as position one. 
Boxed text indicates positions where residues represent a single conservative grouping. 
Alignment gaps are indicated by dots. The Swissprot, EMBL or Genbank accession 
number for the protein sequences, or for the nucleotide sequences from which the peptide 
sequence was derived, are as follows: Human Dl, P13641; Yeast Smdl, L04669; Yeast 
Sdb23, X82649. Single letter amino acid code is used. 
Sequence comparisons using the GAP program (GCG8; Devereux et al., 1984) 
revealed that the entire Sdb23 protein is only weakly homologous to the mammalian 
and yeast Dl polypeptides (27% and 25% identical respectively). In comparison, the 
yeast Smdl polypeptide is 49% identical to its mammalian functional homologue. 
However, two sequence elements located within the amino-terminal 90-110 residues 
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of all three polypeptides are closely related (Figure 3.3, residues 17-43 and residues 
82-101). Such significantly long, phylogenetically conserved sequence elements 
shared between the mammalian and yeast Dl polypeptides, imply that these elements 
may be functionally and/or structurally important core-protein domains. The presence 
of these elements in Sdb23p sequence suggests that this polypeptide may represent a 
homologous yeast core protein. 
3.3 SDB23 is an Essential Gene 
To determine whether SDB23 encodes an essential function, a heterozygous 
diploid strain (MCY5; Table 2.1.7) was constructed in which one SDB23 locus had 
LEU2 integrated at the presumed initiation codon, disrupting read-through from the 
promoter sequence. After sporulation of the sdb23::LEU21SDB23 diploid, ten 
independent tetrads were dissected all of which contained only two viable spores; in 
each case the viable cells were auxotrophic for leucine, indicating that disruption of 
the SDB23 gene results in loss of viability. Genomic Southern blot analyses confirmed 
the chromosomal configurations of the sdb23::LEU21SDB23 diploid and of the 
haploid progeny (data not shown). Thus, SDB23 encodes a novel activity essential for 
spore germination and/or vegetative growth. 
3.4 In Vivo Depletion of Sdb23p Arrests Cell Growth 
To address the potential function of Sdb23p a haploid strain, MCY4 (Table 
2.1.7), was constructed in which the sole chromosomal copy of SDB23 is under the 
control of the inducible GAL] promoter (GAL]-SDB23; Figure 3.4 and Figure 3.5). 
Growth of strain MCY4 is galactose-dependent; the cells grow on galactose as the 
sole carbon source but not on glucose (Figure 3.6A). A plasmid bearing the entire 
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SDB23 gene with its own promoter (pSDB23-1; Table 2.1.9) is capable of rescuing 
lethality on glucose medium (Figure 3.6A). 
CHROMOSOME V 
LEU2 I 	I GAL] Promoter 
LEU2 - GALl- SDB23 
Figure 3.4. Schematic representation of the conditionally-expressed GALJ-SDB23 allele 
integrated at the SDB23 chromosomal locus of strain MCY4 (Table 2.1.7). MCY4 was 
derived from the diploid strain MCY3 ('Fable 2.1.7) which has one SDB23 locus replaced 
with LEU2-GALJ-SDB23, using the one-step gene disruption method of Rothstein (1983). 
Sporulation and tetrad dissection of MCY3, followed by a screen for galactose-dependent 
growth identified strain MCY4 as containing the chromosomal LEU2-GALJ-SDB23 allele. 
GAL) promoter, LEU2 gene (open boxes) and the SDB23 gene (black box) are shown. 
Arrow indicates the direction of transcription from the GAL) promoter. 
When the growth rate of MCY4 cells was monitored following a shift to non-
permissive glucose medium, the doubling times in galactose or glucose media were 
almost indistinguishable for the first ten hours (Figure 3.6B). However, growth began 
to slow after approximately 11-12 hours following the shift to glucose medium and 
stopped after 15-17 hours in glucose. It is possible that overproduction of Sdb23p 
was toxic to MCY4 cells since they grew slower than wild-type (MCY2; Table 2.1.7) 
cells in galactose medium (data not shown). Significantly, MCY4 cells maintained in 
glucose for long periods were viable, since they began to grow again when shifted to 
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H 	 x 	 ligation 
I fjfl 	 — 
SWI4ISDB23 	 GALl 
Promoter Promoter 
Figure 3.5. Schematic representation of the construction of the (JALI-SDB23 conditional 
allele. (a) A 648 nt. fragment encoding the SDB23 gene and 3' processing sequences was 
generated by PCR using pBS-SDB23 as template and primers 787R and 788R (Fable 
2.1.8), incorporating BamHI and Sail restrictions sites 5' and 3' of the gene respectively. 
(b) This fragment was cloned between the BamHl and Sail restrictions sites of pBM 125 to 
form pGAL1-SDB23, placing SDB23 under control of the GALl promoter. (c) The EcoRI 
site of pGAL1-SDB23 was converted toXlzoI by linker insertion (primers 974X and 975X, 
Table 2.1.8) generating plasmid pHK3. (d) 5' non-transcribed SDB23 sequence was 
generated by PCR using pBS-SDB23 as template and primers '11 and 217S, incorporating 
a AlzoI restriction site into primer 217S (Table 2.1.8). (e) A 1.09 Kb HindIllJXhoI 
fragment was isolated from the amplified 5' non-transcribed DNA and cloned into the 
HindEll and .AlioI restriction sites of pJD3, a pUC194based vector containing the yeast 
LEU2 gene, to form plasmid pHK2. The GALJ-SDB23 fusion was isolated from pHK3 on 
a XholJSaII fragment and cloned into the unique Sail restriction site of pHK2 to form 
pHK4. Coding (boxes) and non-transcribed (lines) sequences are indicated. Arrows 
indicate the direction of transcription for 5W14 and 5DB23. Broken lines represent the 
multiple cloning site of pBluescript KS; B, BamHI; Bg, Bgffl; H, Hindffl; P, PsfI; R, 
EcoPJ; Rv, EcoRV; X JthoI. Plasmids pGAL1-SDB23 and pHK2 were constructed by H. 
Kulesza. 
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Figure 3.6. Depletion of Sdb23p leads to growth arrest. (A) 10-fold serial dilutions of 
galactose-grown, mid-logarithmic cultures of MCY4 cells transformed with either vector 
(pFL39) or pSDB23-1 were spotted onto selective galactose and glucose solid media and 
incubated at 30°C for three days. (B) A culture of untransformed MCY4 cells was grown to 
mid-logarithmic phase in galactose liquid medium, harvested, washed and resuspended in 
sterile water. Half of this suspension was used to inoculate either fresh pre-warmed 
galactose or glucose liquid media to an initial 0D600 of 0.05. Cultures were diluted to 
keep all 0D600 readings below 0.6, maintaining the cells in logarithmic growth. (C) A 
culture of untransformed MCY4 cells was prepared and grown as described in (B). 
Samples were removed from cultures grown continuously in galactose or at various times 
following a shift to glucose medium, the cells washed, resuspended in sterile water and 






















0 	4 	8 	12 16 20 24 28 32 36 
TIME (HOURS) 
—a-- GALACTOSE -.-- GLUCOSE 
CHAPTER THRFE 	 SDB23 GENE  
3.5 Identification of Sdb23 Protein 
3.5.1 fl-galactosidase-Sdb23 Fusion Protein 
To facilitate the further characterisation of Sdb23 polypeptide, rabbit 
polyclonal antibodies were generated against a 3-galactosidase-Sdb23 fusion protein. 
A 648 nucleotide fragment encoding the entire SDB23 gene and 3' processing 
sequence elements was generated by PCR using pBS-SDB23 as template, 
incorporating BamHI and Sail restriction sites 5' and 3' of the gene respectively 
(Figure 3.5). This fragment was cloned between the BamHL and Sall restriction sites 
of pUR288 to create an in-frame fusion with the lacZ ORF (RUther and Muller-Hill, 
1983). Competent E. coil cells were transformed with the recombinant expression 
plasmid and individual transformants were induced by vigorous shaking with IPTG, a 
non-metabolizable analogue of lactose (Section 2.6.1). Cell extracts were prepared 
from the Sdb23-fusion protein-producing strains and fractionated on an 8.5% SDS-
polyacrylamide gel. Fusion protein was visualised by Coomassie blue staining as a 
distinct thick band, with decreased mobility compared to 3-galactosidase from an 
induced control extract (Figure 3.7A, compare lanes 4 and 2). The Sdb23-fusion 
protein was partially purified by electroelution of this band from a preparative 
polyacrylamide gel (Section 2.6.2), and used to inject rabbits for raising polyclonal 
antibodies. Two rabbits, numbers 756 and 763, were injected with approximately one 
hundred micrograms of 3-galactosidase-Sdb23 fusion protein, initially in complete 
Freud's adjuvant and subsequently in incomplete adjuvant (Section 2.6.3). 
3.5.2 Immunoblot Detection of Sdb23 Protein 
Anti-Sdb23 antibodies, obtained after five injections with fusion protein, specifically 
recognised a unique band in cell extracts prepared from MCY4 cells grown 
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continuously in galactose medium (Figure 3.7B, lane 3). The polypeptide detected 
migrated with an approximate molecular weight of 21-22 kDa, in accordance with the 
predicted molecular weight from the SDB23-coding sequence. This polypeptide was 
not detected by pre-immune serum (Figure 3.7B, lane 1), nor by immune serum when 
probing cell extracts depleted of Sdb23p (lane 4) or extracts derived from wild-type 
(S150 2B; Table 2.1.7) cells (lane 2). Thus these antibodies only detect Sdb23p 
produced at higher than normal levels. 
3.5.3 Anthranilate Synthase-Sdb23 Fusion Protein 
To enable affinity purification of antibodies specific for the Sdb23 portion of the - 
galactosidase-Sdb23 fusion protein from the immune sera, and for use in 
immunoprecipitation-competition experiments, an anthranilate synthase-Sdb23 (trpE-
5db23) fusion protein was constructed. The 648 nucleotide fragment encoding the 
entire SDB23 gene and 3' processing sequence elements (Figure 3.5) was cloned in 
frame between the BamHI and Sail restriction sites of the bpE-expression vector, 
pATH3 (Koerner et al., 1990). E. coil cells expressing the desired recombinant 
plasmid were induced by the addition of indoleactylic acid (IAA), and cell extracts 
were prepared and fractionated on an 8.5% SDS-polyacrylamide gel (Sections 2.4 and 
2.6). Staining with Coomassie blue revealed the trpE-Sdb23 fusion protein as a 
distinct thick band, absent in the uninduced culture (Figure 3.7C, compare lanes 3 and 
4) and migrating slower than the trpE protein alone (lane 2). 
SDS-polyacrylamide gel electrophoresis of total cell extract or soluble and pellet 
fractions, revealed that the trpE-Sdb23 fusion protein was present in equivalent 
amounts in both the soluble and pellet fractions (Figure 3.7D, compare lanes 9 and 
10). The purer pellet fraction of this fusion protein was used in all subsequent studies. 
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Figure 3.7. Detection of Sdb23 protein. (A) SDS-polyacrylamide analysis of 13 -
galactosidase-Sdb23 fusion protein. Total cell extracts were prepared from E. co/i strain 
NM522 transformed with either pUR288 (f3-galactosidase; lanes 1 and 2) or pUR288-S (13 -
galactosidase-Sdb23; lanes 3 and 4), either grown under non-inducing (lanes 1 and 3) or 
inducing conditions (lanes 2 and 4; Section 2.6.1). Extracts were fractionated on an 8.5% 
SDS-polyacrylamide gel and proteins visualised by Coomassie blue staining. (B) 
Immunological detection of the Sdb23 protein in yeast cell extracts with pre-immune (lane 
I) and immune sera raised against 13-galactosidase-Sdb23 fusion protein in rabbit 756 
(lanes 2-4). Crude a-Sdb23 serum recognised a unique polypeptide migrating with the 
predicted molecular weight in an extract derived from MCY4 cells grown continuously in 
galactose medium (MCY4 +, lane 3). This polypeptide was not detected in the same cell 
extract by pre-immune serum (lane 1). Neither was this protein recognised by immune 
serum in an extract from wild-type cells (S150 213; lane 2), or in an extract depleted of 
Sdb23p (MCY4 -; lane 4). Extracts were fractionated on a high-TEMED 15% SDS-
polyacrylamide gel (Section 2.4.3). (C) Total cell extracts were prepared from E. co/i cells 
transformed with either pATH3 (trpE; lanes I and 2) or pATH3-S (trpE-Sdb23; lanes 3 and 
4), either grown under non-inducing (lanes 1 and 3) or inducing (lanes 2 and 4) conditions. 
Extracts were fractionated on an 8.5% SDS-polyacrylamide gel and proteins visualised by 
Coomassie blue staining. (D) Isolation of soluble and pellet fractions from whole cell 
extracts prepared from induced cultures of E. co/i cells carrying either pATH3 (lanes 6 and 
7) or pATH-S (lanes 9 and 10). The positions of marker proteins (M) are indicated; -, 
Uninduced culture; +, Induced culture; T, Total cell extract; 5, Soluble fraction; P, Pellet 
fraction. 
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DISCUSSION 
SDB23 was isolated as a weak suppressor of a temperature-sensitive dbf2 
mutant that has a cell cycle phenotype, being defective in late mitosis and in DNA 
synthesis (Parkes and Johnston, 1992). DBF2 encodes a cell cycle protein kinase that 
functions late in the mitotic cycle and is probably required for the GuS transition. The 
nature of this suppression is not understood nor is it certain that suppression is 
mediated by SDB23. 
Significantly, SDB23 is located immediately upstream of S9I4. Swi4 polypeptide, 
together with Swi6p, forms an essential transcription factor required for the cell cycle-
specific expression of the HO endonuclease (Breeden and Nasmyth, 1987; Breeden 
and Mikesell, 1991), and for high level expression of the periodically expressed GI 
cyclins, CLNJ and CLN2 (Ogas et al., 1991; Stuart and Wittenberg, 1994; Cross et 
al., 1994). The level of SWJ4 mRNA fluctuates during the cell cycle. This cell cycle-
dependent transcription of SWI4 is conferred by multiple, distinct cis-acting 
regulatory elements in the promoter of this gene (Foster et al., 1993). The original 
complementing clone identified by Parkes and Johnston (1992), contains the entire 
transcriptional control elements of SWI4. Although unlikely, it is possible that 
elements within the S9I4 promoter sequence are responsible for the suppression of 
the dbf2-1 mutation, by interacting with and titrating out negatively-regulating 
transcription factors. Whilst rare, examples of this type of suppression have been 
observed. A closely related family of HXT (Hexose Transporter) genes have been 
identified, whose promoter sequences contain elements capable of specifically 
suppressing mutations in SNF3 (sucrose  Non-Fermentable), an important gene 
involved in carbohydrate metabolism (Theodoris etal., 1994). 
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To date, six genes have been isolated as high copy-number suppressors of dbf2 
mutations, including SDB23. These include CDC5 and CDC15, two genes required 
late in mitosis (Kitada et al., 1993), SDB21, SDB22 (Parkes and Johnston, 1992), and 
SDB25 (Donovan et al., 1994). SDB21 and SDB22 have been identified as the 
previously cloned genes SF012 (Malavasic and Elder, 1990) and SIT4 respectively 
(Arndt et al., 1989). The physiological basis for the suppression of dbf2 by these 
genes is currently unclear. However, both of these genes encode polypeptides that 
function in the cell cycle. SF012, a non-essential gene, is believed to act in association 
with DBF2 during mitosis (Parkes and Johnston, 1992; Toyn and Johnston, 1993) and 
also to play a role in meiosis (Malavasic and Elder, 1990). SIT4 encodes a putative 
serine/threonine protein phosphatase (Arndt et al., 1989). This gene may suppress 
DBF2 mutations indirectly, through the ability of its encoded-polypeptide to modulate 
transcription levels of genes known to interact genetically with DBF2 (Parkes and 
Johnston, 1992). Intriguingly, SIT4 is required for the normal accumulation of SWI4, 
CLN1 and CLN2 transcripts during late Gi (Fernandez-Sarabia et al., 1992). Finally, 
SDB25 was recently identified as a gene that encodes p40, a putative cyclin-
dependent kinase inhibitor believed to function late in mitosis (Donovan etal., 1994). 
To date, with the exception of SDB23, each of the characterised high copy-number 
suppressors of temperature-sensitive dbj2 mutants encodes a polypeptide that 
functions at some stage during the cell cycle. Database searches have shown that 
SDB23 encodes a novel protein with no substantial sequence similarity to any known 
cell cycle proteins. Significantly, cells depleted of the 5DB23-encoded polypeptide do 
not have an obvious cell-cycle phenotype (L. Johnston personal communication). 
Instead, on the basis of limited sequence similarity to the mammalian and yeast snRNP 
Dl core proteins, Sdb23p is a potential snRNP core polypeptide. The mammalian Dl 
core protein and its yeast functional homologue Smdlp, share two highly conserved 
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sequence elements in their amino-termini. Significantly, these elements are conserved 
in the amino-terminal domain of Sdb23p. 
If Sdb23p represents a novel yeast core protein, it is unclear how this polypeptide 
could directly mediate suppression of a cell cycle defect. However, DBF3, previously 
isolated as a cell cycle gene (Johnston and Thomas, 1982), was recently cloned, 
sequenced and found to be the same as PRP8 (Shea et al., 1994), a well characterised 
gene that encodes a large U5 snRNP-specific protein essential for splicing. It may be 
possible that genes encoding splicing factors suppress cell cycle defects by enhancing 
the splicing efficiency of transcripts of intron-containing cell cycle genes. 
Initial characterisation of SDB23 shows that this gene encodes a small polypeptide 
essential for growth. Polyclonal anti-Sdb23 antibodies weakly detected a polypeptide 
of 21-22 kDa, in good agreement with the predicted size for the protein encoded by 
the SDB23 ORF. This protein was only detected in strain MCY4 over-expressing 
SDB23 from the GAL] promoter, and was not detected by pre-immune serum, nor by 
immune serum in wild-type cell extracts or extracts depleted of endogenous Sdb23p. 
The long lag after shifting cells expressing the GALJ-SDB23 allele to glucose medium 
before a substantial effect is seen on the growth may indicate slow turn-over of Sdb23 
protein. Typically, shutting off the synthesis of essential, stable proteins or snRNAs 
results in a lag before growth rate slows, since dilution to limiting levels requires 
several generations (e.g. Strauss and Guthrie, 1991). 
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SDB23 ENCODES A NOVEL SNRNP PROTEIN 
CHARACTEPJSATION OF SDB23 
INTRODUcTION 
The importance of the mammalian core proteins (B, B', Dl, D2, D3, E, F and 
G) in snRNP particle biogenesis and nuclear pre-mRNA splicing has been 
demonstrated through extensive in vitro studies (reviewed in LUhrmann et al., 1990; 
Will et al., 1993; Section 1.2.4). However, of the genes encoding core polypeptides, 
yeast SMDJ and SIvID3 have been studied in the greatest detail in vivo (Ryinond, 
1993; Rymond etal., 1993, Roy etal., 1995). 
Conditional expression of SMDJ and SMD3 has demonstrated that both of these 
genes encode essential proteins, necessary for pre-mRNA splicing and snRNP 
biogenesis. Like their mammalian counterparts, Dl and D3, both Smdl and Smd3 
polypeptides are associated with spliceosomal snRNAs (Roy et al., 1995), and are 
required for the hypermethylation and stability of Ui, U2, U4 and U5 snRNAs 
(Rymond et al., 1993, Roy et al., 1995), but not of U6, which does not associate 
directly with the core proteins (Section 1.2.4). Both indirect immunofluorescence 
microscopy and immunoblot analysis of nuclear and cytoplasmic fractions of cell 
extracts have identified a cytoplasmic pool of Smd3p, similar to cytoplasmic pools of 
snRNP core proteins that have been detected in mammalian extracts and Xenopus 
oocytes (Roy et al., 1995 and references therein). This implies that formation of the 
Sm core structure in yeast may proceed by a pathway closely related to that observed 
in higher eukaryotic systems. Smdl and Smd3 represent functionally distinct proteins, 
the overexpression of either gene being unable to compensate for the loss of the other 
(Roy etal., 1995). 
SDB23 was originally identified as a suppressor of a mutation in a cell cycle gene, 
DBF2 (Parkes and Johnston, 1992). This gene encodes a small polypeptide that shares 
low but significant sequence similarity to the mammalian Di core protein and its yeast 
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homologue, Smdlp (Rokeach et al., 1988; Rymond et al., 1993). This chapter 
describes the in vivo and in vitro characterisation of Sdb23p, establishing a role for 
this protein early in the splicing reaction and for maintaining U6 snRNA stability. 
4.1 Sdb23 Protein is Required for Nuclear Pre-mRNA Splicing 
To investigate the effect on pre-mRNA splicing of depleting cells of Sdb23p, 
total RNA was extracted from wild-type (MCY2; Table 2.1.7) and MCY4 cells 
grown continuously in galactose or shifted to glucose medium for various lengths of 
time. Splicing efficiency of these cells was determined by probing Northern blots with 
the yeast intron-containing ribosomal protein gene RP28 (Figure 4. 1A). In the wild-
type control cells splicing of the RP28 transcript was efficient and carbon source-
independent (lanes 1-3 and 7-9). Interestingly, unspliced RP28 pre-niIRNA was 
detected in MCY4 cells grown continuously in galactose medium (lanes 4-6), 
although mature mRNA was the predominant species. This partial splicing defect was 
no longer apparent when MCY4 cells had been in glucose medium for five hours; only 
mature mRNA was detected at this time (lane 10). This indicates that overproduction 
of Sdb23p is in some way detrimental to splicing and could explain the poor growth 
noted for this strain in galactose medium (Section 3.4). However, ten hours following 
the shift to glucose medium, immediately prior to the onset of reduced growth rate 
(Figure 3.6B), the ratio of spliced RP28 mRNA to unspliced RP28 pre-mRNA had 
decreased eighteen-fold (lane 11; data quantified by phosphorimager analysis). By 
twenty hours, when the cells were no longer capable of further growth, the ratio was 
dramatically reduced although mature RP28 mRNA could still be detected (lane 12). 
ACT] transcripts, which also contain an intron, behaved similarly, whereas the level of 
transcript of the intronless URA3 gene was unaffected by repression of SDB23, 
indicating that this effect was specific to intron-containing transcripts (data not 
shown). 
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4.2 	Sdb23p is Required Prior to Step 1 of Splicing in Vitro 
The in vivo depletion of Sdb23p demonstrated a role for this protein in nuclear 
pre-mRNA splicing. To determine whether Sdb23p is also required for splicing in 
vitro, extracts prepared from MCY4 cells either grown continuously in galactose or 
transferred to glucose liquid medium for 13 hours, (i.e. just prior to the point of 
complete growth arrest; Figure 3.6B), were tested for their ability to splice RP28 
transcript. Extracts derived from cells grown in galactose efficiently spliced RP28 
transcript to mature mRNA (Figure 4.1B, lanes 1-3). In contrast, Sdb23p-depleted 
extracts failed to support splicing (lanes 4-6). 
The ability of Sdb23p-depleted extract to form spliceosome complexes was analysed 
by non-denaturing gel electrophoresis (Pikielny et al., 1986). This gel system resolves 
three spliceosome complexes, termed I, II and ifi, from yeast splicing reactions on the 
basis of their electrophoretic mobility. These complexes assemble in the order Ill, I 
and II; splicing reaction intermediates and products are detected in complex II. Figure 
4. 1C shows that complex II rapidly formed in extract derived from galactose-grown 
MCY4 cells. The formation of complex II in these extracts coincided with the 
detection of mature mRNA and splicing intermediates in the corresponding in vitro 
splicing reaction (Figure 4. 113, lanes 2 and 3 compared to Figure 4. 1C, lanes 2 and 3). 
In the Sdb23p-depleted extract, complex assembly stalled following the formation of 
the U1/U2 snRNP-containing pre-spliceosome, complex III (Figure 41C, lanes 4-6). 
The absence of complex I in the Sdb23 p-depleted reaction is consistent with Sdb23p 
being required for the addition of the U4/06.U5 tri-snRNP to the pre-spliceosome. 
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Figure 4.1. Sdb23p is required for nuclear pre-mRNA splicing. (A) Total RNA was 
extracted from wild-type (MCY2) and MCY4 cells grown continuously in galactose or at 
various times following a shift to glucose liquid medium, resolved on a 1.4% (w/v) 
denaturing agarose gel, blotted and probed with radiolabelled RP28 DNA (Section 2.3.15). 
The positions of pre-mRNA and mature mRNA are indicated. (B) In vitro splicing 
inactivation following depletion of Sdb23p. Extracts prepared from MCY4 cells grown in 
continuously in galactose or in glucose medium for 13 h were assayed for their ability to 
splice RP28 transcript (Section 2.5.3). Splicing reactions (10 itl) containing radiolabelled 
RP28 pre-mRNA were incubated at 25°C for 5, 10 and 20 mm, RNA recovered and 
analysed on a 6% (w/v) denaturing polyacrylamide gel. IVS-E2, lariat intron-exon 2; IVS, 
lariat excised intron; pre-mRNA; RP28 substrate RNA; El-E2, spliced exons. (C) For 
analysis of splicing complex formation, 5 p1 aliquots of the splicing reactions shown in 
panel B were fractionated on a non-denaturing gel (Section 2.5.4). Splicing complexes 1, 11, 




TIME 	4z 10 	:u 	5 	10 20 
(HOURS)  
RP-'' 
- - - - - 
I 	2 	3 	4  
GLUCOSE 
MCY2 	MCY4 
5 	10 	20 	5 	10 	20 
- 	Pre-rnRNA 
p. 
- 	S 	0 	10 	11 	12 
r•i 
	
E)RAT 	 MCY4 
EDIA GALACTOSE GLUCOSE 
TME 





- dm  
C 
xrcT 	MCY4 
MEDIA GALACTOSE GLUCOSE 
TIME 





Ciiipr&R Foui 	 CHARACTERJSATION OF SDB23 
4.3 Sdb23p is Essential for the Stability of U6 SnRNA 
Primary database sequence comparisons indicated that Sdb23 polypeptide may 
represent a novel snRNP core protein (Section 3.2). To investigate the possibility that 
the stability of the spliceosomal snRNAs was affected by in vivo depletion of this 
protein, total RNA was extracted at various times from MCY4 cells grown in glucose 
medium. Northern analysis showed that depletion of Sdb23p resulted in a dramatic 
reduction in the level of U6 snRNA (Figure 4.2). After ten hours growth in glucose 
medium, U6 snRNA was reduced to 40-50% of its original level. After twenty hours, 
the level of U6 snRNA was further reduced to 10-20% of the original level. In a 
control experiment, the level of U6 snRNA in a wild-type strain was not affected by 
carbon source (data not shown). Although the levels of U!, U2, U4 and US snRNAs 
fluctuated in both mutant and indeed wild-type cells, this was not significant 
compared to the reproducible effect on U6 of depleting Sdb23p (Figure 4.2). 
Immunoprecipitation of the spliceosomal-associated snIRNAs with antibodies raised 
against either the TMG-cap of the snRNAs, or the US snRNP-specific protein Prp8 
confirmed that Sdb23p is not required for the maintenance of Ui, U2, U4 and U5 
snIRNA stability (Figure 4.3). However, the amount of U4 snRNA associated with U5 
snRNA (and thereby co-precipitated by anti-Prp8 antibodies) was significantly 
reduced in Sdb23p-depleted extracts (compare lanes 4 and 5), suggesting that the 
association of U4 with US is affected by the reduced level of U6 snRNA. 
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Figure 4.2. Effect of in vivo depletion of Sdb23p on snRNA stability. (A) Total RNA was 
extracted from MCY4 cells grown for various lengths of time in glucose liquid medium, 
fractionated on a 6% (wlv) denaturing polyacrylamide gel, blotted and probed with 
oligonucleotides specific for the snRNAs (Table 2.1.8 and Section 2.3.15). The positions of 
Ui, U2, U4, U5S, U5L and U6 snRNAs are indicated. (B) Levels of snRNAs were 
quantified by phosphorimager analysis (data not shown), values normalised against U! 
snRNA and plotted as a percentage of the starting amount as 100%. U51, and U5S data 
were combined and plotted as a single value. Probing with the intron-less URA3 validated 
using U! snRINA as a standard (data not shown). Note: the variability observed in this 
experiment for the level of U2 snRNA is not due to depletion of Sdb23p. In several 
identical experiments the only reproducible, significant effect observed was the reduction 
in the level of U6 snRNA. 
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Figure 4.3. Immunoprecipitation of snRNAs with antibodies against the TMG-cap of the 
snRNAs or the US snRNP-specific protein Prp8 (Table 2.1.10). Extract derived from 
MCY4 cells either grown continuously in galactose (GAL; lanes 3 and 5) or in glucose 
liquid medium (GLU; lanes 2 and 4) for 13 h, was subjected to immunoprecipitation with 
either anti-TMG (lanes 2 and 3) or Prp8 (lanes 4 and 5) antibodies. Incubation of the 
extract with antibodies and subsequent washes were in 150 mM salt. The RNAs were 
recovered and analysed as described for Figure 4.2. Lane I shows total RNA extracted 
from galactose-grown MCY4 cells. The positions of UI, U2, U4, U5S, U51, and U6 
snRNAs are indicated. 
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4.4 Sdb23p is not Required for RNA Polymerase ifi Transcription 
The primary defect of cells metabolically depleted of the SDB23-encoded 
polypeptide is a dramatic reduction in the steady state level of U6 snRNA the levels 
of Ui, U2, U4 and U5 snRNA do not fluctuate significantly. U6 snRNA is unique 
amongst the spliceosomal snRNAs in that it is transcribed by RNA polymerase ifi 
(RNA Pol III). Thus, depletion of Sdb23p could affect the abundance of U6 snRNA 
through decreased U6 snRNA synthesis. Alternatively, depletion of this protein may 
render the RNA more susceptible to decay. To determine whether alterations in the 
intracellular content of Sdb23p specifically affected RNA Pol III transcription without 
affecting the transcription, and hence levels of snRNAs produced by RNA Polymerase 
II, the steady state levels of 5 S rRNA and of tRNAs (also produced by RNA Pol ifi) 
were measured indirectly. Both ethidium bromide staining of RNA fractionated in 
polyacrylamide gels (Figure 4.4A, lane 3), and 3' end-labelling of total RNA isolated 
from Sdb23p-depleted extracts (Figure 4.4B, lane 2), showed that the steady state 
levels of these RNAs were not affected by the reduction in cellular content of Sdb23p. 
This implies that Sdb23p is necessary for the stability of U6 snRNA, and does not 
influence transcription of RNA Pol ifi transcribed genes in general. 
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Figure 4.4. Sdb23p is not required for RNA polymerase III transcription. (A) Total RNA 
was extracted from either wild-type (S 150 213) or MCY4 cells grown for 13 h in glucose 
liquid medium (lanes I and 3 respectively), or from MCY4 cells grown continuously in 
galactose for 13 h (lane 2), fractionated on a 10% (w/v) denaturing polyacrylamide gel and 
stained with ethidium bromide. (B) Total RNA was extracted from MCY4 cells either 
grown continuously in galactose or grown in glucose liquid medium for 13 h (lanes 1 and 2 
respectively), 3' end-radiolabelled as described by England et al. (1980), and fractionated 
on a 6% (w/v) denaturing polyacrylamide gel. The position of marker nucleotides (M), 5S, 
5.8S, 18S and 25S rRNA and of tRNA are indicated. MCY4+, MCY4 cells grown 
continuously in galactose medium; MCY4 -, MCY4 cells grown in glucose liquid medium 
for 13 h, thus depleted of endogenous Sdb23p. 
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4.5 Association of Sdb23p with U6 SnRNA 
Immunoblot analysis of wild-type yeast splicing extracts probed with immune 
serum generated against a 3-galactosidase-Sdb23 fusion protein, specifically 
recognised a polypeptide with an apparent molecular weight of 21-22 kDa (Figure 
3.7B). To determine whether any spliceosomal snRNAs were associated with Sdb23p, 
RNAs co-immunoprecipitated with Sdb23p polyclonal antibodies were analysed by 
Northern blotting. Pre-immune serum did not immunoprecipitate any RNA species 
above background level, whereas at low salt concentrations Ui, U2 (albeit weakly), 
plus U4, U5 and U6 snRNAs were detected in the immune pellet (Figure 4.5A, lanes 
2-5). After extensive washing at moderate to high salt concentrations (500 and 750 
mM NaCl) the precipitate with the immune serum contained U4 and U6 snRNA (lanes 
6 and 7). These results indicated an association between Sdb23p and the U4/U6 
snRNP and perhaps to a lesser extent the U4/U6.U5 tri-snRNP. Competition 
experiments showed that co-immunoprecipitation of spliceosomal snRNAs could be 
specifically blocked by pre-incubating anti-Sdb23 antibodies coupled to protein A 
Sepharose matrix with a crude bacterial cell extract containing trpE-Sdb23 fusion 
protein, but not by a crude extract containing only trpE protein at the same 
concentration (Figure 4.513, lanes 3 and 4). 
To determine whether Sdb23p was associated with free U6, the snRNAs co-
immunoprecipitated by Sdb23 antibodies were fractionated on a non-denaturing 
polyacrylamide gel and probed successively with oligonucleotides complementary to 
U6 or U4 snRNAs (Figure 4.5C). The result clearly demonstrates that Sdb23p 
associates with free U6 snIRNA as well as with the base-paired U4/U6 snRNAs. 
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Figure 4.5. Co-immunoprecipitation of U4, U5 and U6 snRNAs with Sdb23p. (A) Extract 
from wild-type (S150 213) cells was subjected to immunoprecipitation with pre-immune 
serum (lane 3) or anti-Sdb23 antibodies (lanes 4-7; Table 2.1.10). Incubation of the extract 
with antibodies was in 150 mM salt; washes were performed using various concentrations 
of salt (lane 4, 150 mM; 5, 300 mM; 6, 500 mM; 7, 750 mM). The RNAs were recovered 
and analysed as described for Figure 4.2. Lane 2 indicates background precipitation due to 
non-specific binding of the snRNAs to protein A-Sepharose (PAS). Lane 1 in all panels 
shows total RNA extracted from wild-type (S150 213) cells. (B) Extract from wild-type 
(S150 213) cells was subjected to immunoprecipitation with anti-Sdb23 (lane 2) or with 
anti-Sdb23 antibodies pre-incubated with E. coli extract containing trpE protein (lane 3, ± 
pATH3) or trpE-5db23 fusion protein (lane 4, + pATH-S). (C) For analysis of free U6 and 
U4/U6 snRNAs, RNA samples immunoprecipitated from an extract from wild-type (S150 
2B) cells with anti-Sdb23 antibodies were resolved on a 9% (w/v) non-denaturing 
polyacrylamide gel (Li and Brow, 1993; Table 2.1.8 and Section 2.3.15), blotted and 
probed successively with oligonucleotides complementary to U6 snRNA (lanes 1-3) and 
U4 snRNA (lanes 4-6). Incubation of the extract with antibodies was in 150 mM salt; 
washes were performed using various concentrations of salt (lanes 2 and 5, 150 mM; 3 and 
6, 500 mM). Lanes 2 and 5 correspond to samples shown in lanes 4 and 6 respectively in 
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On the basis of limited sequence similarity to human and yeast snRNP Dl core 
proteins, Sdb23 polypeptide was designated a potential snRNP core protein. In vivo 
characterisation of this polypeptide shows that it is required for nuclear pre-mRNA 
splicing. The decreased growth rate of MCY4 cells depleted of Sdb23p corresponded 
with reduced splicing efficiency in these cells, as evidenced by a decrease in the 
mRNA/pre-mRNA ratio for the two transcripts examined. The partial splicing defect 
observed with MCY4 cells grown continuously in galactose could be a consequence 
of Sdb23p overproduction. Excess Sdb23p could potentially interact with and titrate-
out other factors (possibly U6-associated proteins) that are required for nuclear pre-
niRNA splicing. 
In vitro, extracts depleted of Sdb23p failed to support splicing. Spliceosome complex 
assembly in these extracts was blocked at an early stage, after formation of the Ul/U2 
5nIRNP-containing pre-spliceosome complex. These data are consistent with Sdb23p 
being required for the assembly of the U4/U6.U5 tri-snRNP into the spliceosomes, or 
for the stable formation of the U4/U6.U5 tri-snRNP itself. 
Unlike known core proteins, metabolic depletion of Sdb23p resulted in a vast 
reduction in the level of U6 snRNA without causing significant changes to the levels 
of Ui, U2, U4 and US snRNAs. In the absence of Sdb23p the rate of decay of U6 
snRNA appears to be accelerated, the steady state levels of other RNA Pol ifi 
transcripts not being influenced by the loss of this protein. Thus, Sdb23p may 
influence the rate of U6 snRNA decay directly by associating with and stabilising this 
RNA molecule. Alternatively, Sdb23p could affect other factors required for U6 
stability. 
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Significantly, anti-Sdb23p antibodies strongly co-immunoprecipitated U4 and U6 
snRNAs from a wild-type splicing extract which suggests that Sdb23p is associated 
with U6-containing particles. The specificity of this interaction was confirmed by 
competition with trpE-Sdb23 fusion protein. Ui, U2 and U5 snRNAs were only 
weakly co-immunoprecipitated with Sdb23p at low salt concentrations. The inability 
to detect U5 snRNA above 300 mM NaC1 may reflect the sensitivity of the U41U6.U5 
tri-5nRNP complex to high salt concentrations (Abovich et al., 1990; Banroques and 
Abelson, 1989). However, bearing in mind the high degree of sequence similarity 
between Smdlp, Smd3p and Ussip, polyclonal anti-Sdb23p antibodies may recognise 
epitopes shared by all three proteins. Thus, weak immunoprecipitation of Ui, U2 and 
U5 snRNAs could be attributed to the immunoprecipitation of low amounts of Smdlp 
and Smd3p. 
Immunoprecipitation of snRNPs from Sdb23p-depleted extracts, using antibodies 
against the TMG-cap, similarly showed that the total cellular level of U4 snRNA was 
not affected by reduced levels of U6 snRNA. However, the association of U4 snRNP 
with U5 snRNP was affected, as indicated by immunoprecipitations with antibodies 
raised against the U5 snRNP-specific protein, Prp8. Thus, the level of U41U6.U5 tn-
snRNP complex is reduced in an Sdb23p-depleted extract, suggesting that Sdb23p is 
required, either directly or indirectly, for the stable formation of the U41U6.U5 tn-
snRNP. 
Non-denaturing gel electrophoresis demonstrated a clear association between Sdb23p 
and free U6, in addition to its association with U4/U6 snRNP. These data indicate a 
direct or indirect interaction between Sdb23p and U6 snRNA that is maintained 
Mowing the physical association of U4 and U6 snRNAs in the U4f1J6 snRNP 
(reviewed in Madhani and Guthrie, 1994). At present, however, it is not known 
whether Sdb23p is a component of spliceosomes since antibodies to Sdb23 protein do 
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not detectably interact with the pre-mRNA-containing spliceosome complexes. This 
could be a either a consequence of masking of the Sdb23p epitopes or the absence of 
Sdb23 polypeptide in these complexes. 
Point mutations and deletions in the Sm-site of yeast spliceosomal snRNAs can have a 
marked effect on snRNP assembly and snRNA stability, and may block splicing both 
in vivo and in vitro (McPheeters et al., 1989; Jones and Guthrie, 1990; Siliciano et 
al., 1991). In yeast, the spliceosomal snRNAs are extremely sensitive to in vivo 
depletion of Smdlp or Smd3p. The removal of either of these proteins causes a 
dramatic reduction in the levels of Ui, U2, U4 and U5 snRNAs but leaves the level of 
U6 snRNA relatively unaffected (Rymond, 1993; Roy etal., 1995). U6 snRNA differs 
from the other spliceosomal snRNAs in that it lacks a good match to the consensus 
Sm site and, by itself, does not associate with core proteins. Thus, although the 
SDB23-encoded polypeptide resembles the core proteins in terms of sequence 
similarity and in being required for nuclear pre-mRNA splicing and the stability of an 
snRNA molecule, it differs in terms of its functional specificity. We therefore 
proposed the more logical name USSJ (U Six SnRNP) for this gene (Cooper et al., 
1995), as its original name SDB23 was based on its uncharacterised suppressor 
activity (Parkes and Johnston, 1992). Conceivably, U6 snRNA could be complexed 
with as many "core" proteins as the other spliceosomal snRNAs. Indeed, another 
yeast gene, SMX4 or USS2, has now been identified which encodes a core protein-like 
polypeptide that also associates with U6 snRNA particles (Séraphin, 1995). 
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INTRODUCTION 
Characterisation of spliceosomal snRNPs from a wide range of organisms 
indicates that core proteins have been evolutionarily well conserved. For example, 
anti-Sm auto-antibodies precipitate spliceosomal snRNPs from a number of organisms 
including yeast, implying that epitopes of the core proteins have been conserved to 
some extent (Siliciano et al., 1987; Tollervey and Mattaj, 1987). In addition, 
immunoaffinity purification of yeast snRNP particles has identified a number of 
candidate snRNP core proteins (Fabrizio et al. 1994). The identification of two yeast 
genes, SAM] and SMD3, that encode polypeptides homologous to the mammalian Dl 
and D3 core proteins, has revealed just how closely related these proteins are 
(Rymond, 1993; Rymond et al., 1993; Roy et al., 1995). Indeed, the mammalian Dl 
protein can functionally replace the corresponding yeast protein in vivo (Rymond et 
al., 1993). 
On the basis of limited sequence similarity to mammalian and yeast snRNP Dl 
polypeptides, Sdb23IUssl protein was originally identified as a putative yeast core 
protein (Parkes and Johnson, 1992). Like Smdlp and Smd3p (Rymond et al., 1993; 
Roy et al., 1995), Sdb23IUsslp is essential for cell viability and required for nuclear 
pre-mRNA splicing both in vivo and in vitro (Cooper et al., 1995). In addition, 
spliceosome complex assembly is blocked at an early stage in the absence of 
Sdb23IUsslp. However, unlike the canonical core proteins Sdb23/Usslp is necessary 
for maintaining U6 snRNA stability and only associates with free U6 and U6-
containing particles. The stability of other spliceosomal snRNAs is not affected by the 
metabolic depletion of this protein (Cooper etal., 1995). 
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Biochemical characterisation of Sdb23/Usslp has shown that this is a core-like 
protein, differing most strikingly from known mammalian and yeast core proteins in 
its snRNP-specificity. This chapter analyses the primary sequence of Ussip, 
comparing the sequence of this polypeptide to canonical core proteins. 
5.1 	Ussi Protein 
The SDB231USSJ gene encodes a predicted protein of 187 amino acids with a 
calculated molecular weight of 21, 276 Da (Table 5.1 and Table 5.2). This is a small, 
hydrophilic protein which contains no hydrophobic regions long enough to predict a 
membrane-spanning domain. There are six potential N-glycosylation sites (Asn-X-
Ser/Thr, where X represents any amino acid; Figure 5.1). Sdb23fUssl protein is basic 
with an apparent p1 value of 10.3 1, in common with the majority of the snRNP core 
proteins which have apparent p1 values ranging between eight and ten. However, the 
charge distribution in Sdb23/Usslp is uneven. Essentially Sdb23/Ussl protein can be 
divided into two distinct domains (Figure 5.1 and Table 5.3). Domain I, the amino-
terminal ninety amino acids, is essentially neutral with an approximately equal number 
of evenly distributed basic and acidic residues. This region is slightly hydrophilic 
overall. In contrast, domain II, composed of the carboxy-terminal ninety seven amino 
acids, contains a preponderance of basic residues and is predominantly hydrophilic. 
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TABLE 5.1 
AMINO ACED SEQUENCE SUMMARY FOR LJSS1 PROTEIN 
A11INo Ac!!) CODON CODON Ammo ACED CODON CODON 
RESIDUE OCCURRENCE RESIDUE OCCURRENCE 
Ala GCG 1 Leu CTC 0 
Ala GCA 1 Leu TTG 4 
Ala GCT5 1 Leu TFA 4 
Ala GCC* 1 Lys AAG5 5 
Arg AGO 1 Lys AAA 5 
Arg AGA 5 Met ATG 4 
Arg CGG 0 Phe ITF 4 
Arg CGA 0 Phe TFC5 0 
Arg CGT 2 Pro CCG 0 
Arg CGC 1 Pro CCA5 2 
Mn AAT 15 Pro CCT 2 
Mn AAC5 29 Pro CCC 0 
Asp GAT 3 Ser AGT 6 
Asp GAC 2 Ser AGC 7 
Cys TGT5 0 Ser TCG 0 
Cys TGC 0 Ser TCA 2 
Gin CAG 1 Ser TCT5 5 
Gin CAM 11 Ser TCC5 2 
Glu GAG 1 Thr ACG 0 
Glu GAA5 8 Thr ACA 1 
Giy GGG 4 Thr ACTS 2 
Gly GGA5 1 Thr ACC* 2 
Gly GGT 4 Tyr TAT 3 
Gly GGC 2 Tyr TAC5 5 
His CAT 3 Trp TOG 1 
His CAC* 0 Val GTG 0 
He ATA 4 Val GTA 3 
He ATF5 7 Val GTT 5 0 
Be ATC5 4 Val GTC5 3 
Leu CTG 0 Stop TGA 0 
Leu CTA 1 Stop TAG 0 
Leu CTF 2 Stop TAA 1 
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TABLE 5.2 
Ussi PROTEIN DATA 




Small Hydrophilic A + G 15 8.02 
Hydroxylic S + T 27 14.4 
Acidic D+E 14 7.5 
Acidic & Acid Amide D+E+N+Q 70 37.4 
Basic H+K+R 22 11.8 
Acidic &Basic D+E+H+K+R 36 19.3 
Hydrophobic I + L + M + V 36 19.3 
Aromatic F+W+Y 13 7.0 
Predicted Molecular Weight = 21,276 Da; Residues = 187. 
Average Residue Weight = 113.8 Da; Predicted Isoelectric Point = 10.31; Charge = 5. 
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Figure 5.1. Predicted amino acid sequence of Ussip indicating the amino-terminal 
domain I and carboxy-terminal domain II separated by a broken line. Sequence is 
numbered using the methiomne codon as position one. Hydrophilic amino acid residues 
are shaded. -, Acidic residue; +, Basic residue; *, Potential N-glycosylation site. Single 
letter amino acid code is used. 
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TABLE 5.3 
Ussip DOMAIN lAND DOMAIN II DATA 
NATURE OF RESIDUE 	RESIDUES 	 OCCURRENCE IN IJsslp 
DoMAIN! 	DoMAIr4ll 
Small Hydrophilic A + G 8 7 
Hydroxylic S+T 11 16 
Acidic D+E 12 2 
Acidic & Acid Amide D + E + N + Q 27 43 
Basic H+K+R 9 13 
Acidic &Basic D+E+H+K+R 21 15 
Hydrophobic I + L + M + V 28 8 
Aromatic F+W+Y 6 7 
Ussi protein is notably rich in acid-amide residues, asparagine being more prevalent 
than glutamine (Table 5.1). In contrast to the glutamine residues which are randomly 
distributed evenly throughout the protein, the asparagine residues are predominantly 
located within domain H. Indeed, 35% of the residues within this domain are 
asparagine amino acids. Interestingly, these asparagine residues, plus a number of 
serine and arginine amino acids, form three clusters (Figure 5.2A), one of which 
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A 
94 NSNNNSNSN 	 102 
111 NNNRGNYNRR1NNNGNSN 	133 
144 NNSNSSNINNSINSINSNNQNI"flN 167 
B 
Inverted Asparagine-rich repeat: 
144 NNSNSSNIN 	152 
162 NNSNISNISN 153 
Figure 5.2. (A) Amino acid sequence of three asparagine-rich clusters in domain II of 
Ussip. (B) Inverted asparagine-rich repeat of the third cluster. Numbers refer to positions 
of the clusters in Ussip (Figure 5.1). Asparagine residues are highlighted in bold text. 
5.2 Potential RNA binding Site 
Ussi protein associates specifically with free U6 snRNA and U6-containing 
particles (Section 4.5). However, like the canonical core proteins, Ussip does not 
contain a good match to any of the characterised RNA-binding motifs (Birney et al., 
1993; Burd and Dreyfliss, 1994 and references therein). The amino-terminal eighty 
amino acids of Ussip do include a potential RNP2 motif, but have a very poor match 
to the degenerate RNP1 consensus motif (Figure 5.3). RNP2 and RNP1 are two 
conserved domains embodied within the RNA recognition motif (RRM; Section 1.5; 
Birney et al., 1993). This degenerate consensus sequence, containing a number of 
other, mostly uncharged and aromatic amino acids, is an essential motif present in a 
variety of splicing factors that bind to RNA and other RNA-binding proteins. For 
example, the U6 snRNA-associated protein Prp24 has three RNA recognition motifs 
related to the consensus sequence (Shannon and Guthrie, 1991; Birney et al., 1993; 
Section 1.5). 
The potential Ussip RRM described in Figure 5.3 is not closely related to the 
conserved Prp24p-RRM domains, nor to the consensus sequence (Birney et al., 
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1993). Significantly, the potential Ussip RRM does not contain two phenylalanine 
residues that are very highly conserved within the degenerate RRM consensus 
sequence (positions 23 and 46, Figure 5.3A). Aromatic amino acids distributed 
throughout the RRM have been shown to interact with target RNA. 
,fl' 
1 	RNP2 	 . 	 . 	 30 
Consr.su1Scquencc 	 Uxi xxT xxxxxxxfZjxxxxxxxj1,xxx 	xjJx 
PotcntialUsslpRRMSequence 	I. x Lx x Lxx xxx x xjMi.. x x xLx x xLJx x xj, X1L.X 
31 	. NPI 	 . 60 
Consensus RRMSequence 	 x x x x x x x x U - x V - x x x x x x x x 	x xJ 
PotentialUsslpRRMSequenoc 	x V.x x x x x x XLX x.,'Lx x[]x x x x x x x Vix x x, 
ML PLY L L T NA KG Q Q'M Q I E 1 L K 	GI I Q 	II T 
N VD N NM N L T L S NT E1S E E S A I N$IE D N]AE S 
S KAy FL NE I Y I R 	T F I FF1 FL Q D 	IL D K V K 
Q Q 	N S N NN S  S N G PG H FRY Y NN R D S N N N R  
N Y N R R N N N N G N S N R R P Y S Q  R Q Y N N S NS S  
INNS INS INS N N Q N MN N G L G G S V Q H H F N S S 
S P Q K V E F 
Figure 5.3. Potential amino-terminal RNA recognition motif (RRM) in Ussi protein. (A) 
Residues that correspond to conserved positions within the degenerate RPM consensus 
motif are shaded (Section 1.5; Bimey et al., 1993). Positions that deviate from this 
consensus are boxed. x, any residue; U, uncharged L, I, V, A, G, F, W, Y, C, M; Z, all 
uncharged residues plus S and T; -, gaps introduced into the RPM consensus sequence;., 
gap introduced into Ussi sequence to fit consensus. The highly conserved RNP1 and 
RNP2 sequence elements are shown. (B) Amino-terminal location of the potential (RPM) 
in Ussi protein, encompassing residues 2-58. Single letter amino acid code is used. 
5.3 Sequence Analysis of Canonical snRNP Core Proteins and Ussi 
Protein 
Until recently, only limited sequence information gathered by cloning and 
sequencing cDNAs encoding the core polypeptides B, B', N, Dl and E was available; 
The core polypeptides B, B' and N are all closely related (Table 5.4; Schmauss et al., 
154 
CHAPMER FIVE 	 SNRNP CoRE PROTFJN MOTIF 
1989), so statistically-significant sequence alignments were not possible. The B and B' 
proteins are alternative products of the same gene (Van Dam et al., 1989). The N 
protein, specifically expressed in neural tissues, is encoded by a different gene even 
though it is almost identical to the B and B' proteins (Table 5.4). 
cDNAs encoding all of the remaining mammalian core proteins, E, F, and G, have 
now been isolated and sequenced (Hermann et al., 1995 and references therein). In 
addition, the two yeast genes, SAID] and S/vfD3, that encode polypeptides 
homologous to the mammalian core proteins Dl and D3 respectively, have been 
cloned and characterised in detail (Rymond et al., 1993; Roy et al., 1995). The 
identification of these proteins, and the alignment of their sequences, revealed that the 
amino-terminal regions of snRNP core proteins share a significant degree of sequence 
similarity, and identified a motif characteristic of these proteins (Figure 5.4). 
Significantly, Ussip contains this motif. The motif, consisting of two closely-related 
regions, collectively referred to as the snRNP core protein motif (Cooper et al., 1995) 
or the Sm domain (Hermann et al., 1995; Séraphin, 1995), contains two invariant 
residues embedded within a less-well conserved region containing a number of other, 
often hydrophobic residues. 
The ability of mammalian core proteins to form snRNA-free hetero-oligomers (Fisher 
et al., 1985; Lehmeier et al., 1994; Hermann et al., 1995) implies that protein-protein 
interactions between individual core proteins are critical for the formation of the Sm 
core structure (Figure 1.5). However, the nature of these interactions, and those that 
may form between core proteins and the snRNA molecule are, as yet undefined. The 
snRNP core protein motif was recently demonstrated to be necessary for inter-core 
protein interactions in vitro (Hermann et al., 1995), and may play an essential role in 
mediating assembly of the core polypeptides in vivo. 
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Table 5.4. Amino acid similarity (open box) and identity (shaded box) between mammalian snRNP core proteins, their identified yeast 
homologues and Ussip derived by sequence comparisons using the GAP program (GCG8; Devereux et al., 1984). Values are expressed 
as percentages. Percentage identity is the percentage of amino acids that actually match. Percentage similarity is the percentage of 
amino acids that are similar. A similarity is scored when the scoring matrix value for a pair of amino acids is greater than or equal to 
0.5. The GAP program uses a scoring matrix with matches scored as 1.5 and mismatches scored according to the evolutionarily 
distance between the amino acids as measured by Dayhoff and normalised by Gribskov (Gnbskov and Burgess, Nucleic Acids Res., 14, 
6745-6763 (1986)). 
Ussip Human Human Human Human Yeast Human Human Yeast Human Human Yeast Human Yeast 
B B' N Dl Dl D2 D3 D3 E F F G 0 
Yeast G 49 • ,, .. 4. 54 . 54.......... 42 • 44 • M 37 43 59 50 49 73 100 
21 22 22 22 25 2 27 19 18 29 22 22 53 100 
Human  43 59 59 59 39 53 54 38 41 53 50 56 100 
24 26 26 25 20 34 28 22 18 22 24 2 100 
Yeast  48 44 	1 44 44 51 57 42 45 51 64 73 100 
27 20 20 20 29 40 20 21 27 29 55 100 
Human F 44 44 44 42 43 37 50 47 48 50 100 
26 20 20 18 24 23 22 21 22 24 100 
Human  43 61 61 61 49 41 52 48 36 100 
XXX25 34 35 34 31 20 21 22 10 100 
Yeast D3 51 43 43 48 53 50 36 69 100 
27 22 22 28 29 35 16 45 100 
Human D3 48 48 48 48 53 47 41 100 
27 21 21 20 34 30 14 100 
Human D2 46 56 	1 56 56 37 40 100 
21 24 24 24 13 18 100 
Yeast Dl 45 40 39 39 65 100 
25 20 20 20 49 100 
Human DI 46 46 46 48 100 
27 29 29 32 100 
Human  34 98 52.5 100 
19 92 300 00. iiiii  
Human B' 54 99 100 
Human  34 100 
18 100 
UssI 100 
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5.3.1 snRNP Core Protein Motif 
To date all of the snRNP core proteins identified, including Ussip, have 
closely-related amino-terminal sequences that contain the core protein motif (Figure 
5.4A). This motif can be split into two regions (Figure 5.4B). The first contains two 
invariant residues; G1y54 and Asn64 (numbered according to alignment, Figure 5.4A). 
In addition, with the exception of the mammalian D2 core polyp eptide, there appears 
to be a clear preference for a methionine residue at position 63. In D2, methionine is 
replaced by another sulphur-containing amino acid, cysteine. Position 60, just 
upstream of the conserved methionine, is occupied almost exclusively by an acidic 
residue, either aspartate or glutamate. The first conserved region is separated from the 
second by a variable number of non-conserved amino acids, typically fourteen to 
twenty five (Figure 5.4B). The yeast Smdlp is atypical and introduces the only major 
gap in the alignment (Figure 5.4A, residues 96-108). 
The second conserved domain of the snRNP motif does not contain any invariant 
residues. However, three positions central to this degenerate consensus sequence are 
very well conserved: position 114 is predominantly occupied by a hydrophobic 
residue, either isoleucine, leucine, or valine; position 115 is occupied by a basic amino 
acid, either arginine or lysine; and glycine preferentially occupies position 116. The F 
core polypeptide sequence is unique in that cysteine replaces glycine at position 116. 
Three additional positions in this region are exclusively occupied by non-polar, 
hydrophobic residues (Leu 109, and IlefLeuIVal 112, 119). 
In summary, a novel protein motif characteristic of the snRNP core polypeptides and 
present in Ussip, has been derived from the alignment of published snRNP core 
protein sequences (Figure 5 .4B). 
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Figure 5.4. Alignment of amino-terminal domains of multiple snRNP core proteins identifying a novel snRNP protein motif. (A) snRNP proteins were aligned using 
the program PILEUP in the GCG8 suite of sequence analysis programs. The snRNP motif was identified visually. (B). Alignment gaps are indicated by dots. The 
alignment is numbered above using the methionine codon of Human E protein as position 1. Protein names are given alongside the sequence. Boxed text indicates 
positions in which residues belonging to a single conservative grouping are present in at least 50% of the sequences. The degree of conservation is indicated by the 
symbol below: *, indicates positions which are absolutely invariant; *, indicates positions where a single conservative grouping represents 100% of the sequences; t, 
indicates positions where the nature of the residue is conserved in at least 80% of the sequences. Due to the fact that the core polypeptides B, B' and N are almost 
identical, only the sequence of one of these polypeptides was taken into account when calculating these data. Accepted conservative groupings were I=V=L, D=E, 
R=K, T=S, N=Q, F=Y=W. The Swissprot, EMBL or Genbank accession number for the protein sequences, or for the nucleotide sequences from which the peptide 
sequence was derived, areas follows: Human Dl, P13641; Yeast Smdl, L04669; Yeast Smd3, M65144; Yeast Ussi, X82649; Human B, P14678; Human B', X17568; 
Human E, P08578; Human F, X85372; Human G, X85373; Human N, P14648. (B) Consensus snRNP motif derived from the alignment of multiple published snRNP 
core protein sequences. The font size reflects the degree of conservation at any position with absolutely invariant residues highlighted in enlarged, bold text. At 
positions where alternative residues within a conserved grouping do occur, these residues are listed in order of preference below the most commonly used residue. x 
represents any residue and the spacing parameters are shown by numbers; + indicates that this number is variable. 
A 
Human  . MT VG KS S KM L 	H ID Y RN R C IL Q D G RI FIG T F K  PD K H MN L  LCD C70 
Human B . ......................... MTVGKSSKMLQHIDYRMRCILQDGRIFIGTFKAPD K HMNLILCDC 
Human  . 	 . 	 . 	 . 	 . 	 . 	 . 	 . 	 . 	 . 	 . 	 . 	 . 	 . 	 . 	 . 	 . 	 . 	 . 	 . 	 . 	 . 	 . 	 . 	 . 	 M 	T 	V 	G 	K 	S 	S 	K 	M 	L 	H 	I 	D 	Y 	EM 	RC 	I 	LOD GRIP I G T F K  PD K NM N L  LC DC 
Human Di ........................... MKLVKFLMKLSHETVTIELKNGTQVHGTITGVD V SMNTHLKAV 
Yeast Smdl ........................... MKLVNFLKKLRNEQVTIELKNGTTVWGTLQSVS P QMNAILTDV 
Human D2 N S L L N K P K S E M T P E E L Q K R K E E E F N T G P L S V L T Q S V K N N T Q V L I N C K N N K K L L G R V K A P D K H C N N V L E N V 
Human D3 ........................ N 	I 	i 	G V P I K V L HE A K GM I VT C E T NT GE V Y R G K L I E A E 	D N MN C Q M S N I 
YeastSmd3 ....................... MTMNGIPVKLLNEAQGHIVSLELTTGATYRGKLVESE D SHNVQLRDV 
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B 
snRNP core protein motif: 
Lx9lxLxxGxxxxGxLxxxDxxMNxxLx [14-25+]  Lxx lxi RGI 
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5.4 	Core Protein Subfamilies are Evolutionarily Conserved 
The snRNP core protein motif has been used successfully to identify a number 
of putative core protein homologues from a variety of evolutionaiity diverse organisms 
including yeast, Drosophila, rice, mice and the Chinese cabbage, Brassica campestris 
(this work; Herman et al., 1995; Séraphin, 1995). These studies reveal that 
polypeptides for an individual subclass of core protein are phylogenetically conserved 
and can display a very high degree of sequence similarity. For example, the putative 
mouse Dl protein and yeast Smdlp display 99% and 49% identity respectively, with 
the mammalian Dl sequence. 
Significantly, the alignment of sequences isolated from different organisms for an 
individual subfamily of core protein, revealed that deviations from the consensus 
sequence, first detected in mammalian sequences, are evolutionarily conserved. For 
example, the F core polypeptide sequence varies from the consensus motif at position 
116, a cysteine amino acid replacing the otherwise highly conserved glycine residue 
(Figure 5.4A and Figure 5.5): This change is conserved in all putative homologues of 
the mammalian F protein identified to date (Figure 5.5). Position 115, a central 
residue within the consensus sequence IRG, is exclusively occupied by a basic 
residue, primarily arginine. However, in the E-protein family lysine is substituted for 
arginine, a phylogenetically conserved change that does not alter the nature, nor 
physiochemical properties of the residue at that position (Figure 5.4A; Hermann et 
al., 1995). 
Similar evolutionarily conserved changes are observed in the D-core protein subfamily 
(Figure 5.4A and Figure 5.5). In the snRNP core protein motif, position 72 is 
preferentially occupied by an acidic residue, typically glutamate (Figure 5.4A and 
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Figure 5.5). However, with the exception of the mammalian D2 polypeptide, the D-
protein subfamily have an uncharged residue at this position. The D2 protein has a 
residue that conforms to the consensus sequence (Figure 5.4A and Figure 5.5). 
5.5 Ussi Protein Represents a Novel Subfamily of snRNP Core Protein 
Interestingly, consistent with the observation that Uss 1 protein does not 
behave like a canonical core protein, Ussip sequence is not especially similar to any 
one of the mammalian or yeast core proteins (Table 5.4). Ussip appears to represent 
a novel subfamily of core-proteins, potentially a class of core-like proteins that 
interact specifically with U6-containing particles. 
The amino-terminal domain alignment (Figure 5.4A and Figure 5.5) identifies two 
small sub-motifs that are very highly conserved within the DI-core polypeptide 
subfamily (VTIELKNGT, residues 42-56; ILPDSL, residues 123-128). On the basis 
of very similar regions to these in Ussip, this protein would appear to be structurally 
most similar to the Di-proteins. However, the similarity I between Ussip and the 
mammalian Dl polypeptide (25% identical) is much less than that observed between 
mammalian Dl and its yeast homologue, Smdlp (49% identical; Table 5.4). Ussip 
differs most noticeably from the Dl and Smd 1 proteins in two ways. Firstly, the 
carboxy-terminal domain of Ussip is extended by forty one and sixty eight amino 
acids compared to the mammalian and yeast Dl proteins respectively. Secondly, the 
carboxy-terminal sequence is very distinctive in that it is extremely asparagine-rich. 
Notably, Ussi protein appears to contain a number of phylogenetically conserved 
differences, characteristic of a variety of core protein-subfamilies (Figure 5 .4A and 
Figure 5.5). For example, Ussip contains a glutamate residue at position 72, 
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characteristic of all the core proteins except the Dl and D3 polypeptides. However, 
the Ussi sequence has a basic residue at position 120, present in the Dl and D3 
polypeptides but absent in all other core proteins (Figure 5.4A and Figure 5.5). In 
addition, Ussi protein contains a single tryptophan amino acid at position 62, 
immediately upstream of the highly conserved methionine and asparagine residues 
(Figure 5.5, positions 63 and 64 respectively). A preference for an aromatic residue at 
this position, typically tyrosine or phenylalanine, is shared by three classes of core 
polypeptides, E, F and G. The B core-proteins and the mammalian D2 protein have a 
positively charged residue at this position, whereas Dl and D3 polypeptides contain 
either serine, glutamine or an asp aragine residue (Figure 5 .4A). 
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Figure 5.5. Alignment of amino-terminal domains of putative homologues of the 
mammalian D and F protein families. Ussi protein sequence and the snRNP core protein 
consensus motif are indicated. Boxed text indicates positions where a single conservative 
grouping represents at least 66% of the sequences within each individual protein family. 
Phylogenetically conserved positions that differ significantly between the two families of 
core protein are shaded and these differences are highlighted in Ussip. Alignment gaps are 
indicated by dots. Alignment is numbered, consistent with numbering used in Figure 5.4A. 
The lines indicate conserved Dl sequence elements. Single letter amino acid code is used. 
Adapted from Hermann etal. (1995). 




Mouse DI ............................MKLVR 5HE 
Rice DI 	................................ N N E 
YcastSmdl 	........................... IM K L VIN R N E 
Human 	. . . . . . . . . . . . . . . . . . . . . . . M S L P L N P K P F L N G L T G K 
C.cicgansF ..................... MSAVQPVNPKPFLNSLTGK 
DrosophilaF 	..................... MSAGMPINPKPFLNGLTGI( 
Rice 	 ...................... MATVPVNPKPFLNNLTGK 
Cabbage 	...................... MATIPVNPKPFLNNLTGK 
Yeast  
YcastUssl 	. . . . . . . . . . . . . . . . . . . . . . . . . . .  M L P L Y L L T N A K G Q 
Motif 	 L 
41 	 . 	 . 	 . 	 00 
Human Dl 	IT VT IEL K1t.G T QIVf:H G T I T G V D VM N T H L K A V KM L ;t( N R E
UPV
jj ~ 
Mouse DI IT VT I $ L KG T QV HG TI T G V D VS MN T H L K A V Kit L K N RE
RiceDi 	[V T I K L Kti G T VV HG TI T G VD I S MN TM L K TV K L T L KG K N 
YcastSmdl QIV P IEL KUG T TV.W_G T L11JS PG MN Al L T DV EL 	L P Q PR L N 
Human 	P V MV K L K G M E ? K G Y L V S V DIGIT M N M Q L A N T E ? I G A L S 
C clegansF F V C V: ..: K L K W G M E Y K GL VV DISIT M N L G L AE S ? I D G N S Q G 
DrosophilaF 	P V L V t L K I G[]E 	K G F L V S V DIG TM N M Q L A N T E : * EI G S V T G 
Rice 	 P VI V :': L KWG M ST ICGY L V S V D S TM 	L Q LAN T ET I 	GQ FS G 
Cabbage 	T VI VICL KWG ME? K G F LS VD S TMN LQ L GM T ETI DGQ L PG 
Yeast ............ I R G I TLL V Sl Tj D NY F N L Q L N E A_EFV1] V S H G 
Yeast USA 	Q H Q I EL K GE I Q G I L TN V D NWM N L T L SN VT T S ES Al N 
Motif 	 I 	L 	G 	 G L 	D 	MN 	L 
01 	 . 	 120 
Human Dl 	Q ...........................P
LQ
T L S I RN N IR 
Mouse DI Q 	 TLSIRGNNIR 
Rice Dl 	 T HLSVRGNNIR 
YeastSmdl K L N S N G I AMA S L Y L T G G Q Q P TA S D N I ASY 	RN T i: 
HumanF L GE V L 	R:c.N N Vi 
CelegansF N LGEILIRCNNVL 




Cabbage  N LGEILIRCNNVL 
Yeast  P LGEIrnIRCNNVL 
YcastUssi 	S E D N A E S S K A V 	 KLNEIYIRTFI1 
Motif 	 L 	I 	I R G 
121 	 130 
Human DI 	I F:1.L P DS L PL 
Mouse DI IYFILPDSLPL 
Rice Dl 	ftjLPDSLNL 
Yeast Smdl Q II.LL P D S L NL: 
HumanF 	Y I
]GV
E E E E 
C. elegans F Y V 	0 G E N 
Drosophila F 	Y I 	 E 0 0 D K 
Rice 	 YL PEDAE 
CabbageF 	YI} 	P ED 5
YeastF Y 1 	PM 
YcastUssi 	F IX.L Q DM1 
Motif 
CHAPrER FIVE 	 SNRNP CORE PROTEiN MOTIF 
5.5.1 Putative Ussip Homologues 
Five hypothetical proteins from S. cerevisiae (Ybc6p), Arabidopsis thaliana 
(Atip), Caenorrhabditis elegans (Ceip), Nicotiana tabacum (Ntlp) and Homo 
sapiens (Hslp) were identified in a database search for possible snRNP core protein 
homologues, using the amino-terminal ninety amino acids of Ussip as bait. Like 
Ussip, these proteins exhibit only comparatively low similarity to canonical core 
proteins, illustrating that proteins containing the core protein motif can be highly 
divergent. 
Ussip is more closely related to four of these hypothetical proteins, Atip, Ceip, 
Hslp and Ntlp, than to any of the canonical core proteins (Figure 5.6). However, the 
asparagine-rich carboxy-terminal region of Usslp distinguishes this protein from all 
others. Significantly, these five polypeptides share a highly conserved sequence-
element, rich in basic residues, which is approximately thirty amino acids long and 
extends beyond the second conserved domain of the core protein motif (Figure 5.6, 
positions 63-90). Interestingly, position 71 is occupied exclusively by an aromatic 
residue, tyrosine (Figure 5.6). In canonical core proteins, this position is preferentially 
occupied by an uncharged amino acid, such as leucine, isoleucine, methionine or 
serine (Figure 5.4A, position 113). Only the mammalian D2 and D3 polypeptides and 
the yeast Smd3 protein have an aromatic amino acid at this position, immediately 
upstream of the highly conserved IRG sequence (Figure 5.4A, positions 114-116). In 
addition, this group of putative core polypeptides have an invariant tryptophan 
residue at position 36 (Figure 5.4A, position 62). 
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Atip 	. 
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Ussip SNVTEYSE 	SAINSEDNAESS 	AV 	LN 	I -V- IRGTFIKFI 
Motif 	L 
	
L 	I 	I R G 	I 
Ybc6p 	L D N I SC T D E K KY P . . . . . . . . . H L G S V R NI F I R 	ST V R 	V 
Uss2p V  S DAVE TI I Q L N HEELS ES. . ER RC E EM V F I R 	0 TV T L  
Atip 	R V P DCVI D N V 
Ntlp R V P D E V I D N V 
Hslp 	R I P D E I I D M V 
Ceip RIETVVDLV 
Ussip 	 Q N I I D K 
Motif 
Ybc6p 	Y L N K N M V D T N 
Uss2p S T P S E D D 
Figure 5.6. Sequence alignment of putative Ussip homologues recovered from A. thaliana 
(Atip), N. tabacum (Ntlp) and C. elegans (Ceip). Alignment gaps are indicated by dots. 
Alignment is numbered using the methionine codon of Ceip as position one. Boxed text 
indicates positions in which residues belonging to a single conservative grouping are 
present in at least 80% of these sequences. The consensus core protein sequence is 
indicated. The line highlights a highly conserved sequence element shared between Atip, 
Ntlp, Ceip, Hslp and Ussip. The sequence of two putative yeast core proteins, Ybc6 and 
Uss2, are shown. The Swissprot, EMBL or Genbank accession number for the protein 
sequences, or for the nucleotide sequences from which the peptide sequence was derived, 
are as follows: Yeast Ussi, X82649; Atip, Z27273; Ntlp, X83731; Hslp, T69207; Ceip, 
L04669; Yeast Ybc6p, P38203; Yeast Uss2, X06790, Z30582 and Séraphin (1995). Single 
letter amino acid code is used; X, represents any amino acid. 
Although Ussi protein is clearly similar to Atip, Ntlp, Hslp and Ceip, Ussip is not 
as closely related to these proteins as they are to one another. For example, the 
similarity between Ussip and Atip (41% identity) is much less than that observed 
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between Atip and Ceip (65% identity). However, it should be noted that sequence 
comparisons show that the mammalian and yeast Dl proteins are only 49% identical, 
yet these polypeptides are functionally equivalent (Rymond et al., 1993). 
Interestingly, two positions that are preferentially occupied by leucine, isoleucine or 
valine in canonical core proteins are not well conserved in this family of putative core 
polypeptides (Figure 5.6, positions 67 and 70; Figure 5.4A, 109 and 112). At! and 
Cel proteins were recovered independently by Séraphin (Smx6-Arab and Smx6-Caen, 
respectively; Séraphin, 1995) and Atip by Herman et al., (1995) from database 
searches using the Sm domain as bait. 
Ybc6, a putative yeast core protein, also isolated and identified as SmxS-Yeas 
(Séraphin, 1995), is not significantly identical to Ussip (28% identity, 56% 
similarity). Interestingly, Ybc6p is encoded by a single, intron-containing messenger 
RNA, the intron being defined by highly conserved, canonical splice site sequences 
(Section 1.1). Like Uss 1 protein, Ybc6p contains an aromatic residue, phenylalanine 
as opposed to tryptophan and tyrosine, at positions 36 and 71 (Figure 5.6). 
Significantly, this protein contains the hydrophobic residue leucine at position 37 
(Figure 5.6; Figure 5.4A, position 63), which, with the exception of the putative yeast 
F and G core polypeptides (Hermann et al., 1995; Séraphin, 1995), is exclusively 
occupied by a sulphur-containing residue. The potential yeast G core protein, 
demonstrated to be essential for cell viability and associate with the spliceosomal 
snRNAs (Séraphin, 1995), also has leucine at this position. In contrast, this position is 
occupied by phenylalanine in the putative yeast F core polypeptide (Hermann et al., 
1995; Séraphin, 1995). 
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5.5.2 U6-Associating Core-like Proteins 
A second U6-associating core-like protein, Uss2, has been identified (Figure 5.6; 
Séraphin, 1995). On the basis of protein sequence similarity, Ussi and Uss2 are not 
closely related (26% identity, 46% similarity), and there are no obviously conserved 
residues, or sequence elements, unique to these polypeptides that may be responsible 
for their ability to associate with U6 snRNP particles. 
5.6 Functional Significance of the snRNP Core Protein Motif 
The high degree of evolutionary conservation of the snRNP core protein motif 
implies that this region may be important for the function of the core polypeptides. 
Limited deletion and mutation analysis has confirmed that this motif is essential and 
indicates that it may be involved in mediating protein-protein interactions between 
individual core proteins (Rymond, et al 1993; Hermann et al., 1995; Séraphin, 1995; 
this work). 
Compared to the mammalian Dl protein, yeast Smdlp contains an additional twenty 
seven amino acids. Rymond et al. (1993) demonstrated that Smdlp lacking the yeast 
Di-specific sequence (Figure 5.7, residues 62-81; Figure 5.4A, residues 89-108) is 
fully functional. However, extending this deletion by six amino acids (Figure 5.7, 
residues 61-87; Figure 5.4A, residues 88-114) knocks out Smdlp function (Rymond 
et al., 1993). The larger deletion encompasses three highly conserved positions in the 
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Human DI M K L VR F L H K L S H E T T 
90 
Q V H G T I T V T I E L K N G 
Yeast Smdl MKLVJNFLKKLRNE QVT I E LKNGTTVWGT LQ 
Motif L - - - -  - - - - - I - L - - G - - - - G  
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_____ 
S M N TH L K 
__ 
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R E P V 	Q 	...... 
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Motif - - D - - M N - - L -------------------- 
61 	 90 
HumanDi 	......................LETLSIRGN 
Yeast Smdl RGN 
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HumanDi 	N I H Y F I L P D S L 
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Motif 	-I - - - - - - - - - - - 
Figure 5.7. Deletion analysis of the yeast specific Smdl protein sequence. Comparison of 
the amino-terminal domains of the human Dl core protein and its yeast homologue Sind 1, 
indicating the snRNP core protein motif shown in Figure 5.4B. Alignment gaps are 
indicated by dots. Alignment is numbered above using the methionine codon of Dl as 
position one. Boxed text indicates positions which are absolutely conserved between the 
two D polypeptides. Shaded text indicates residues that can be deleted from Smdlp 
without altering the function of this protein. Amino acid residues highlighted in white font 
on a dark background indicate critical positions essential for Smdlp function in vivo. 
Single letter amino acid code is used. Adapted from Rymond et al. (1993). 
Herman et al. (1995) extended these observations and confirmed the importance of 
the snRNP core protein motif by studying the specific interaction between the 
mammalian snRNP D3 core polypeptide and various truncated, mutant B' proteins. 
Through simple co-immunoprecipitation studies Hermann et al. (1995) demonstrated 
that the amino-terminal ninety three amino acids of the mammalian B' sequence, a 
region containing both conserved elements of the snRNP core protein motif, was 
necessary and sufficient for the B'-D3 interaction. Extending the carboxy-terminal 
deletion to remove the second conserved element of the core-protein motif effectively 
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abolished this interaction. The carboxy-terminal region of B', completely lacking the 
amino-terminal motif was unable to interact with D3. 
Large deletions may cause significant changes to the nature and structure of the 
protein. Site-directed mutagenesis of a single residue of the putative yeast F core 
polypeptide, Smx3p, demonstrated the importance of individual residues within the 
core protein motif (Séraphin, 1995). Changing the highly conserved basic residue 
(arginine 115, Figure 5.4A) to cysteine prevented the co-immunoprecipitation of 
spliceosomal snR.NAs typically associated with this protein (Séraphin, 1995). 
In view of the fact that the snRNP core polypeptides E, F, G, Dl and D2 interact with 
one another to form an snRNA-free protein complex capable of associating with the 
Sm site of the snRNA, these proteins are prime candidates for interacting directly with 
the RNA. Thus, altering the conserved arginine residue in the first domain of the core 
protein motif of Smx3p may block as yet uncharacterised protein-snRNA interactions, 
interactions between this positively charged residue plus other flanking hydrophilic 
residues, and the RNA backbone. Alternatively, mutating the arginine residue may 
alter the conformation of Smx3p, such that inter- or intra-core protein interactions are 
effectively disrupted, impeding interactions necessary for the formation of the 
snRNA-free protein complex. 
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DISCUSSION 
The multiple alignment of all the mammalian snRNP core proteins, 
homologous yeast proteins and Ussip has revealed that the amino-terminal regions of 
these proteins are closely related, and identified a novel protein motif conserved 
among all snRNP core proteins. All of these proteins, with the exception of the F 
polypeptide, share a similar pattern of charge distribution. Each has a neutral amino-
terminal domain followed by a basic carboxy-region. The F sequence is quite unique 
among the core proteins in that it is enriched in acidic residues, predominantly 
glutamic acid with a cluster of six glutamic amino acids close to the extreme carboxy-
terminus. 
The carboxy-terminal portions of the snRNP core proteins diverge considerably. The 
asparagine-rich domain of Ussip distinguishes this polypeptide from the canonical 
core proteins, which although not highly related tend to have an abundance of glycine 
and arginine residues. The functional significance of the divergent carboxy-terminal 
domains is not clear. This region may contribute to the specific function(s) of the 
individual protein within the snRNP core complex, influencing protein-protein 
interactions between the individual core protein complexes. Alternatively, this region 
may determine the snRNP-specificity of the individual protein, a possible explanation 
for the ability of Ussip to associate with U6-containing particles. However, this 
seems unlikely since a second U6-snRNP associating core-like protein has been 
identified, Uss2p (Séraphin, 1995), which lacks an asparagine-rich carboxy-terminus. 
In addition, preliminary data indicate that the amino-terminal region of Ussip, domain 
I, is sufficient for its association with U6 snRNA (Chapter 6). 
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The core protein motif has been evolutionarily well conserved, indicating that this 
sequence is functionally important. Mutation and deletion analysis of the motif has 
demonstrated that this region is essential for snRNP core protein function, and is 
apparently involved in mediating inter-core protein interactions (Herman et al., 1995). 
The conserved residues within the motif may be required for the correct folding, 
stability or function of the individual core protein. In addition, or alternatively, they 
may mediate protein-protein interactions between individual core proteins. In 
mammalian cells, snRNP-particle assembly begins with the interaction of core proteins 
to form an snRNA-free protein complex (Fisher etal., 1985; Lehmeier et al., 1994; R. 
LUhrmann, personal communication) which then associates with the Sm site of the 
snRNA molecule. The ability of snRNP core-proteins to form stable complexes in the 
absence of an snRNA molecule implies that protein-protein interactions are dominant 
over RNA-protein interactions in the snRNA-core protein complex. Some sequence-
element is likely to be involved in determining the specificity of these interactions and 
the order in which they occur. Clearly, the newly identified snRNP core protein motif 
is a prime candidate for performing these functions. 
To date, a direct interaction between a core protein and an snRNA within a snRNP 
has been demonstrated only for the snRNP-G polypeptide and the Sm-site of Ui 
snRNA (Heinrichs et al., 1992). Ussip, like canonical core proteins, lacks a 
convincing RNA recognition domain, suggesting that none of these proteins directly 
interacts with the RNA. It is possible that the association of individual core proteins 
to form a hetero-oligomeric complex effectively generates a novel RNA-binding site. 
Extensive database searches have identified a large number of potential core proteins 
from a wide variety of organisms (Hermann et al., 1995; Sdraphin, 1995). These 
proteins, on the basis of sequence similarity to known core proteins and to one 
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another, have been classified into thirteen to fifteen subfamilies. This represents many 
more core-protein subfamilies than have been identified to date in the mammalian 
system. Significantly, changes within individual families of proteins have been 
phylogenetically conserved suggesting that these proteins are functionally 
homologous. Indeed, functional equivalence has been demonstrated between the 
mammalian Dl polypeptide and its yeast counterpart, Smdlp (Rymond et al., 1993). 
Ussi protein is not significantly similar to any characterised mammalian or yeast core 
polypeptide. Indeed, Ussip appears to represent a novel, evolutionarily conserved 
subfamily of core protein, capable of associating with U6-containing particles. 
Extensive sequence comparisons of known and putative core polypeptides has failed 
to elucidate what sequence element(s) determines whether a core protein associates 
with Ui, U2, U4, U5 or U6 snRNPs. It seems unlikely that residues within the snRNP 
core protein motif are responsible for influencing snRNP-specificity. Most likely 
residues flanking this motif, or possibly non-conserved residues within the motif 
domain are responsible for this. As rapid progress continues to be made in sequencing 
the genome of a variety of organisms, the proposed core protein consensus should aid 
in the identification of other members of this apparently expanding family of proteins 
and probably clarify this current dilemma. 
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FUNCTIONAL SIGNIFICANCE OF DOMAIN II AND THE SNRNP 
CORE PROTEIN MOTIF 
MUTATION ANALYSES OF USSIp 
INTRODUCTION 
In vivo and in vitro characterisation of USSJ-encoded polypeptide has 
demonstrated that this is a novel snRNP factor. Although Ussip resembles the snRNP 
core proteins in terms of sequence similarity and in being required for the stability of 
an snRNA molecule, it differs in terms of its functional specificity. Uniquely, Ussi 
polypeptide associates with both free U6 and U4/U6 snRNPs and is essential for 
maintaining U6 snRNA stability. Comparison of the amino acid sequences of 
canonical and putative core polypeptides from different species and Ussip, shows that 
the amino-termini of these proteins constitute a highly conserved domain, the snRNP 
core protein motif. In contrast, the carboxy-termini vary both in size and amino acid 
sequence. This chapter describes deletion and amino acid substitution analyses of 
Ussip, demonstrating that both its unique, asparagine-rich carboxy-terminus and the 
snRNP core protein motif are functionally important. 
6.1 	Domain II of Ussi Protein is not Essential 
6.1.1 Construction of Truncated Ussi Polypeptide 
The carboxy-terminus of Ussi polypeptide is characterised by a predominantly 
basic, asparagine-rich region (domain II, Section 5.1). Like Ussip, the carboxy-
termini of known canonical core proteins are, with the exception of the F polypeptide, 
basic. However, these proteins do not have a biased amino acid composition such as 
Ussip, although for many of the core polypeptides there is a preference for glycine 
and arginine residues in this region. 
To determine whether residues within domain II of Ussip are essential for the 
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Uss lAp* (encoded by pMC11) and Uss1tp (encoded by pMC12), deleting the 
carboxy-terminal forty six and ninety three amino acid residues respectively (Table 
2.1.9 and Figure 6.1). Both of these truncated polypeptides retain the two highly 
conserved sequence elements that constitute the snRNP core protein motif (Figure 
6.1). Like Ussi polypeptide, UsslAp*  is predominately basic, has a predicted 
isoelectric point of 10.2, and is still rich in asparagine relative to the average 
abundance of this amino acid in many yeast proteins (Table 6.1). In contrast, the 
overall nature of UssIA polypeptide differs dramatically from that of the frill length, 
wild-type Ussi protein. This most truncated polypeptide, essentially equivalent to 
domain I of Ussip (Section 5.1), is relatively acidic with a predicted isoelectric point 
of 4.5 and a calculated net charge of-4 at neutral pH (Table 6.1). 
TABLE 6.1 
TRUNCATED Ussi PROTEIN DATA 
Ussip 	UsslAp* 	UsslAp 
Number of residues 	 187 	141 	94 
Predicted Molecular weight (Da) 	 21,276 16,165 10,719 
Predicted Isoelectric Point 	 10.31 	10.2 	4.5 
Charge 	 +5 +5 -4 
NATURE OF RESIDUE 	RESIDUES 	 OCCURRENCE 
Small Hydrophilic A + G 15 12 8 
Hydroxylic S + T 27 17 11 
Acidic D+E 14 13 13 
Acidic & Acid Amide D + E + N + Q 70 49 30 
Basic H+K+R 22 19 9 
Acidic &Basic D+E+H+K+R 36 32 22 
Hydrophobic I + L + M + V 36 31 29 
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Figure 6.1. Schematic representation of Uss 1 A*  and Uss 1 L, polypeptides, generated by 
deletion of the carboxy-terminal 46 and 93 ammo acids of Ussip respectively. (A) Wild-
type full length Ussip. (B) Ussli\p*:  A 1.49 Kb fragment bearing the USSIA*  ORF with 
its own promoter was generated by PCR using pBS-SDB23 as template and primers T7 and 
H3478 (Table 2.1.8), incorporating a Sail restriction site into the 3' end of the gene. The 
PCR product was cut with Hindlil and Sail, gel purified and cloned between the Hindlil 
and Sail restriction sites of modified pFL39 to form pMC 11 (Table 2.1.9). Modified pFL39 
contains a stop-codon linker (primers M5392 and M5393; Table 2.1.8) cloned into the Sail 
restriction site of pFL39 (Bonneaud et al., 1991; this work). (C) Uss1p: A 1.36 Kb 
fragment containing the USSM ORF was constructed by PCR using pBS-SDB23 as 
template and primers T7 and M0055 (Table 2.1.8), incorporating a Sail restriction site into 
the 3' end of the gene. The PCR product was cut with HindIII and Sail, gel purified and 
cloned between the Hindlil and Sail restriction sites of modified pFL39 to form pMC12 
(Table 2.1.9). Sail restriction site is indicated. Asparagine-rich domain II (hatched box) and 
stop-codon linker (boxed nucleotides) are shown. ", Stop-codon. Single letter amino acid 
code is used. 
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6.1.2 Ussl4p Can Rescue lethality of MCY4 on Glucose Medium 
Due to the presence of a chromosomally encoded conditionally expressed 
GAL]-USSJ allele the growth of strain MCY4 is galactose-dependent; these cells 
grow on galactose as the sole carbon source but not on glucose medium (Section 
3.4). A plasmid bearing the entire USSJ gene with its own promoter (PUSS !-!; Table 
2.1.9) is capable of rescuing lethality on glucose medium. To determine the ability of 
truncated Ussi polypeptides to function in vivo, MCY4 cells were transformed with 
either plasmid pMC1 1 or pMC12, encoding UsslL\p*  and Uss1p respectively 
(Figure 6.1). Both plasmids were capable of rescuing growth of this strain on glucose 
medium and no growth defect was detected on agar plates, implying that domain II is 
not essential for Ussip function in vivo (Figure 6.2A). 
However, when the growth in liquid cultures of MCY4 cells transformed with either 
plasmid pUSS1-1 (MCY4-pUSS1-1 cells) or pMC12 (MCY4-pMC12 cells) was 
monitored following a shift to non-permissive glucose medium there was a noticeable, 
albeit very slight difference in the growth rates of these cells. Following fifteen hours 
growth in glucose medium, when endogenous Ussip had been diluted to limiting 
levels, MCY4 cells solely-dependent on plasmid-encoded UsslA polypeptide grew 
slower than cells transformed with plasmid DNA encoding full-length, wild-type Ussi 
protein (Figure 6.2B). 
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Figure 6.2. (A) MCY4 complementation assay. 10-fold serial dilutions of galactose grown, 
mid-logarithmic cultures of MCY4 cells transformed with either vector (pFL39), pUSS 1-1, 
pMC1 1 or pMC12 were spotted onto selective galactose and glucose solid media and 
incubated at 30°C for three to four days. (B) Cultures of MCY4 cells transformed with 
either pUSS1-1 or pMC12 were initially grown in selective galactose liquid medium to 
mid-logarithmic phase, the cells then harvested, washed in sterile water and used to 
inoculate fresh, rich glucose liquid medium to an initial 0D600 of 0.05. Growth was 
monitored by measuring 0D600 at various times, fifteen hours following the shift to 
glucose medium. Cells were diluted to maintain logarithmic growth. 
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6.1.3 Domain II is Necessary for Efficient Pre-mRNA Splicing In Vivo 
To determine whether domain II of Ussip is required for nuclear pre-mRNA 
splicing and for maintaining U6 snRNA stability in vivo, total RNA was extracted 
from MCY4 cells transformed with either vector, pUSS 1-1 or pMC12 grown 
continuously in glucose liquid medium for various lengths of time. The splicing 
efficiency of these cells was determined by probing Northern blots with the yeast 
ribosomal protein gene RP28 (Figure 63A). In MCY4-pUSS1-1 cells, splicing of the 
RP28 transcript was efficient over the entire time period analysed (lanes 7-12). 
Splicing was efficient in MCY4 cells transformed with vector DNA for the first ten 
hours following the shift to glucose liquid medium. However, by fifteen hours, at the 
onset of reduced growth rate (Figure 3.613), the level of spliced RP28 mRNA had 
decreased (lane 4) and by twenty five hours, when the cells were no longer capable of 
further growth, very little mature RP28 mRNA could be detected (lane 6). 
Interestingly, splicing occurred but with reduced efficiency in MCY4 cells dependent 
on Uss1p for growth. Fifteen hours following the shift to glucose medium, 
coinciding with the onset of reduced growth rate for these cells, the level of mature 
RP28 transcript had noticeably decreased. However, beyond this time point the level 
of mature mRNA did not especially decrease any further (compare lanes 13-15 and 
lanes 16-18). 
Deletion of the carboxy-terminal ninety three amino acids ofUssip does not appear to 
have a significant affect on the stability of U6 snRNA. Northern blot analysis of total 
RNA extracted from MCY4-pMC12 cells grown in glucose liquid medium for twenty 
five hours, demonstrated that Uss 1 A protein is capable of maintaining relatively high 
levels of U6 snRNA in vivo (Figure 6.311, compare lanes 13-15 and lanes 16-18). 
However, in subsequent experiments it was noticed that the level of U6 snIRNA was 
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continuously in rich glucose liquid medium for longer periods, approximately thirty 
hours (Figure 6.5, compare lanes 11 and 13). The level of other spliceosomal snRNAs 
was not influenced by the deletion of the carboxy-terminus ofUssip. 
These data show that the conserved amino-terminal domain of Ussi polypeptide is, by 
itself, sufficient for cell growth and capable of supporting pre-mRNA splicing in vivo. 
Thus, the unique carboxy-terminal domain of Ussip does not play an essential role in 
vivo, although it may be important for efficient splicing. 
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Figure 6.3(A). Ussip domain II is required for efficient nuclear pre-mRINA splicing. Total 
RNA was extracted from MCY4 cells transformed with either vector (MCY4; lanes 1-6), 
pUSSI (MCY4 + Ussip; lanes 7-12) or pMCI2 (MCY4 + Uss1ip; lanes 13-18) grown for 
various lengths of time in glucose liquid medium, resolved on a 1.4% (w/v) denaturing 
agarose gel, blotted and probed with radiolabelled RP28 DNA (Section 2.3.15). The 
positions of pre-mRNA and mature mRNA are indicated. In addition, the level of Ui 
snRNA is indicated to show the relative amounts of total RNA. 
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Figure 6.3(B). Usslp domain Ills not essential for U6 snRNA stability. Total RNA was 
extracted from MCY4 cells transformed with either vector (MCY4; lanes 1-6), pUSS I 
(MCY4 + Uss Ip; lanes 7-12) or pMC 12 (MCY4 + Uss lAp; lanes 13-18) grown for various 
lengths of time in glucose liquid medium, fractionated on a 6% (wlv) denaturing 
polyacrylamide gel, blotted and probed with oligonucleotides specific for the snRNAs 
(Table 2.1.8 and Section 2.3.15). The positions of Ui, U2, U4, U5S, U51- and 1J6 snRNAs 
are indicated. 
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6.1.4 Residue(s) in Domain I Confer Uss1p-U6SnRNA Specificity 
To investigate whether deletion of the carboxy-terminal ninety three amino 
acids of Ussip affect the unique U6 snRNA-specificity of this protein, an epitope-
tagged UsslA polypeptide was constructed (Uss1Lp-F). The FLAG-epitope 
octapeptide® (N-DYKDDDDK-C) coding sequence was cloned into the unique Sail 
restriction site of pMC12 (Figure 6. 1), immediately downstream of and in-frame with 
the truncated USS] (USSJzt) ORF to form pMC43 (Figure 6.4). Addition of the 
FLAG-peptide sequence to the carboxy-terminus of Uss1p does not substantially 
alter the character of this polypeptide, neither does it modify the ability of this 
truncated protein to rescue growth of MCY4 on glucose medium (data not shown). 
Like UsslAp, Uss1-F is an acidic protein with a predicted isoelectric point of 4.21. 
However, the very acidic nature of the FLAG-peptide does mean that Uss lA-F 
protein has a very negative calculated net charge of-8 at neutral pH (Table 6.2). 
Monoclonal anti-FLAG M20  antibodies specifically recognised a single protein 
migrating with the predicted molecular weight, 12-14 kDa, in an extract from wild-
type (S150 2B) cells expressing USSJzI-F from a single-copy vector (Figure 6.4D, 
lane 2). This signal was not produced by anti-FLAG M20  antibodies with an extract 
that contains non-epitope tagged UsslA polypeptide (lane 1). Additionally, these 
antibodies immunoprecipitated a single polypeptide of the expected molecular weight 
from an extract containing Uss lAp-F, but not from a control extract containing 
UsslAp (compare lanes 3 and 4). 
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Figure 6.4. Schematic representation of carboxy-terminal epitope-tagged Uss1i 
polypeptide, Usslp-F. (A) Wild-type full length Ussip. (B) Ussli\p encoded by pMCI2 
(Table 2.1.9). (C) Usslip-F encoded by pMC43 (Table 2.1.9). Plasmid pMC43 was 
generated by insertion of the FLAG-peptide coding sequence (primers N4804 and N4805; 
Table 2.1.8) into the unique Sall restriction site of pMC12 (Figure 6.1; Table 2.1.9). The 
Sall restriction site is indicated. Asparagine-rich domain II (hatched box), FLAG-peptide 
(black box), stop-codon linker (boxed nucleotides) and FLAG-linker (shaded nucleotides) 
are shown. ", stop-codon. Single letter amino acid code is used. (D) Immunological 
detection of Ussli-F polypeptide. Splicing extracts from wild type (S 150 213) cells co-
producing either Ussl and plasmid-encoded UssIA polypeptides, or Ussi and plasmid-
encoded Usslzp-F polypeptides were fractionated on a high-TEMED 15% SDS-
polyacrylamide gel (Section 2.4). Anti-FLAG M20  antibodies recognised a unique 
polypeptide migrating with the predicted molecular weight in an extract from wild-type 
cells producing Usslip-F (lane 2). This po1yeptide was not detected in an extract that 
contains Usslz\p (lane 1). Anti-FLAG M2W antibodies immunoprecipitated a single 
polypeptide of the correct molecular weight from an extract from wild-type cells producing 
Uss 1 isp-F (lane 4), but failed to immunoprecipitate any polypeptides from an extract that 
contained Uss lAp (lane 3). -- 
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TABLE 6.2 
EPITOPE-TAGGED UsslAp 
Number of residues 
Predicted Molecular weight (Da) 
Predicted Isoelectric Point 
Charge 





-4 	 -8 
OCCURRENCE 
Small Hydrophilic A + G 8 9 
Hydroxylic S + T 11 14 
Acidic D+E 13 19 
Acidic & Acid Amide D+E+N+Q 30 36 
Basic H+K+R 9 11 
Acidic &Basic D+E+H+K+R 22 30 
Hydrophobic I + L + M + V 29 30 
Aromatic F+W+Y 6 7 
Anti-FLAG M28  antibodies co-immunoprecipitated U4, US and U6 snRNAs from a 
splicing extract derived from MCY4 cells carrying pMC43 and therefore solely 
expressing USSJ4-F after growth in glucose liquid medium for thirty hours (Figure 
6.5, lane 8). In contrast, these antibodies only weakly co-immunoprecipitated snRNAs 
from an extract from wild-type (S150 2B) cells co-expressing USSJ and plasmid-
encoded USSJzI-F (compare lanes 4 and 8). Anti-FLAG M20  antibodies did not 
immunoprecipitate any RNA species above background level from extracts that 
contained only non-epitope-tagged Uss1p (lanes 3 and 7). Following anti-Ussi 
immunoprecipitation from cell extracts dependent on either Uss1p or Uss lAp-F for 
cell growth, low levels of U4, U5 and U6 spliceosomal snRNAs were detected in the 
immune pellet (lanes 5 and 6). These results indicate that deletion of the carboxy- 
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terminal ninety three amino acids of Ussip does not modify the association of this 
polypeptide with spliceosomal snRNAs, nor is it essential for the U6 snRNA-
specificity of Uss 1 p. 
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Figure 6.5. Immunoprecipitation of snRNAs with antibodies against Ussip or the FLAG-
peptide (Table 2.1.10). Extracts from wild-type (S150 2B) or MCY4 cells grown 
continuously in glucose liquid medium for 30 h, that contained either plasmid-encoded 
non-tagged or tagged Usslip, were subjected to immunoprecipitation with either anti-Ussi 
(lanes 1, 2, 5 and 6) or anti-FLAG M20  antibodies (lanes 3, 4, 7 and 8). Incubation of the 
extracts with antibodies and subsequent washes were in 150 mM NaCl. The RINAs were 
recovered, fractionated on a 6% (w/v) denaturing polyacrylamide gel, blotted and probed 
with oligonucleotides specific for the snRNAs (Table 2.1.8 and Section 2.3.15). Total RNA 
was also recovered from 0.1 volume of the extract subjected to immunoprecipitation (lanes 
11-14; lane 11 corresponds to lane 1, lane 12 to lane 2, lane 13 to lane 5, and lane 14 
corresponds to lane 6). Lanes 9 and 10 show total RNA from an extract from wild-type 
(S150 213) cells grown continuously in glucose liquid medium. The positions of Ui, U2, 
U4, U5S, U51, and U6 snRNAs are indicated. -, Extract contains plasmid-encoded Ussltp; 
+, Extract contains plasmid-encoded Uss lAp-F. 
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6.2 Functional Significance of the snRNP Core Protein Motif 
To determine the importance of individual, highly conserved residues within 
the snRNP core protein motif, site-directed mutagenesis was used to modify two 
residues. The invariant asparagine residue within the first element of the core protein 
motif was mutated to four different residues, one representing a conservative 
substitution, the others involving more substantial changes to the nature of the amino 
acid at that position. The other residue mutated was the highly conserved glycine in 
the second element of the motif, which was changed to alanine or aspartate (Table 
6.3, Figure 6.6). 






Figure 6.6A. Schematic representation of the single point mutations introduced into the 
snRNP core protein motif of Ussip. Single letter amino acid code is used. , amino acid 
residue mutated. 
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Figure 6.6B. Sequence verification of specific mutations in the Ussip snRNP core protein 
motif. Single point mutations were introduced into the USSI ORF by site-directed 
mutagenesis, using pBSksHIII3 (Table 2.1.9) as template and mutagenic oligonucleotide 
primers (Table 2.1.8), by the method of Kunkel et al. (1987; Section 2.3.17). Clones that 
only contained the desired mutations were identified by double-stranded sequencing 
(Section 2.3.16). 5'-3' USSI nucleotide sequence and the corresponding amino acid 
residues that this encodes are indicated. This sequence codes for amino acid residues 35-40 
(a-e) and for residues 69-76 (f-g) ofUssl protein. G, Guanine; A, Adenine; T, Thymine; C, 
Cytosine. Single letter amino acid code is used. 
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TABLE 6.3 
SUMMARY OF MUTATIONS IN THE SNRNP CORE PROTEIN MOTIF OF Ussip 































75 Da 	 133 Da 
Hydrophilic G73D 	 Hydrophilic 
Aliphatic 	I 	 Acidic 
The competence of mutated Ussi proteins to function in vivo was assessed by their 
ability to rescue growth of MCY4 on glucose medium. Surprisingly, no single 
mutation had a dramatic effect on Ussip function; each mutated Ussi polypeptide 
restored growth of MCY4 on glucose solid medium with no detectable growth 
phenotype (Figure 6.7A). However, when the growth rate of MCY4 cells transformed 
with plasmid DNA expressing wild-type or mutant USSJ was monitored following a 
shift to glucose liquid medium, subtle differences were detected for MCY4 cells 
dependent on either of two of the mutant polypeptides for growth. Fifteen hours 
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following the shift to glucose medium, when endogenous Ussip had been diluted to 
limiting levels, MCY4 cells transformed with either pMC17 or pMC19, encoding 
Uss 1 (N3 7Y)p or Uss 1 (G73D)p respectively, grew slower than cells transformed with 
pUSS 1-1 bearing the wild-type USSJ gene with its own promoter (Figure 6.7B). This 
result demonstrates that the snRNP core protein motif of Uss ip can tolerate changes, 
however, significantly altering the nature of highly conserved residues within this 
motif can influence the ability ofUssip to function in vivo. 
Introducing single point mutations simultaneously into both of the highly conserved 
elements that comprise the snRNP core protein motif, confirmed the ability of this 
motif to sustain changes. No single combination of amino acid substitutions resulted 
in a detectable growth defect as determined by the plate assay. However, one mutant 
Ussi polypeptide was lethal, being unable to rescue growth of MCY4 on glucose 
solid medium (Figure 6.8A, Ussl(N37Y,G73D)p encoded by plasmid pMC41). The 
amino acid sequence of this polypeptide contains multiple changes compared to the 
sequence of wild-type Usslp. Nucleotide mutations in the USSJ ORF contained in 
plasmid pMC41 code for two amino acid substitutions in the conserved snRNP core 
protein motif (N37Y and G73D), and a frame-shift in the characteristic carboxy-
terminal ninety amino acids ofUssip. The frame-shift mutation results in the nature of 
the carboxy-terminal sequence of this mutant Ussi polypeptide being dramatically 
modified. The asparagine-rich sequence of wild-type Ussip is replaced by a variety of 
amino acids, but enriched for threonine and the hydrophobic residues isoleucine, 
leucine and valine (data not shown). In addition, the frame-shift mutation introduces a 
stop-codon into the mutant USSJ-coding sequence, such that this sequence encodes a 
truncated polypeptide 168 amino acids long. Thus, multiple mutations which 
significantly alter the overall nature and/or structure of Uss ip, disrupt the ability of 
this polypeptide to function in vivo. Details of plasmid construction and a summary of 
results are shown in Figure 6.9A. 
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Deletion of the carboxy-terminal ninety three amino acids of wild-type Ussip 
demonstrated that this region was not absolutely essential for the function of this 
protein in vivo, but did influence its activity (Section 6.1). Significantly, deletion of 
the carboxy-terminal amino acids of several of the mutated Ussi polypeptides resulted 
in a detectable growth defect, as assessed by the plate assay (Figure 6.8B). Notably, 
deleting domain II from Ussl(N37Y)p and Ussl(G73D)p was lethal. MCY4 cells 
dependent on UsslA(N37Y)p grew very poorly at 30°C, but not at all at 36°C, 
whereas cells producing Uss1E(G73D)p failed to grow at any temperature tested. 
Deleting the carboxy-terminal domain of Ussi polypeptides mutated in both 
conserved elements of the snRNP core motif, involving any combination of the 
individual point mutations, destroyed the ability of these polypeptides to restore 
growth of MCY4 on solid glucose medium (data not shown). These data demonstrate 
that the snRNP core protein motif can tolerate substantial changes, but not within the 
context of the truncated Ussi polypeptide. Plasmid nomenclature and the mutant 
UsslA polypeptides that they encode are summarised in Figure 6.9B. 
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Figure 6.7. (A) MCY4 complementation assay. 10-fold serial dilutions of galactose grown, 
mid-logarithmic cultures of MCY4 cells transformed with either vector (PFL39), pUSS 1-1 
or plasmids bearing mutated USSJ with its own promoter, were spotted onto selective 
galactose and glucose solid media and incubated at 30°C for three to four days. (B) 
Cultures of MCY4 cells transformed with either pUSS 1-1 or plasmids bearing mutated 
USSI were grown in selective galactose liquid medium to mid-logarithmic phase. The cells 
were harvested, washed in sterile water and used to inoculate fresh, rich glucose liquid 
medium to an initial 0D600 of 0.05. Growth was monitored by measuring 0D600 at 
various times, fifteen hours following the shift to glucose liquid medium. Cells were 
diluted to maintain logarithmic growth. 
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Figure 6.8. MCY4 complementation assay. (A) 10-fold serial dilutions of galactose grown, 
mid-logarithmic cultures of MCY4 cells transformed with either vector (pFL39), pUSS 1-1 
or plasm ids bearing double point-mutated USSI with its own promoter, were spotted onto 
selective galactose and glucose solid media and incubated at 30°C for three to four days. 
Note: plasmid pMC4I contains USSI that bears multiple mutations; nucleotide changes 
that encode N37Y and G73D amino acid substitutions in the conserved snRNP core protein 
motif, and nucleotide-deletions that result in a frame-shift. The mutant Usslp encoded by 
pMC4I is prematurely truncated (168 amino acids), with the asparagine-rich carboxy-
terminal region replaced by a non-biased amino acid sequence. (B) 10-fold serial dilutions 
of galactose grown, mid-logarithmic cultures of MCY4 cells transformed with either vector 
(pFL39). pMCI2 or plasmids bearing mutated USS/A with its own promoter were spotted 
onto selective galactose and glucose solid media and incubated at various temperatures for 
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Figure 6.9A. Summary of plasmid DNA nomenclature and the mutant Ussi polypeptides 
that they encode. Single point mutations were introduced into the USS/-encoded 
polypeptide by the method of Kunkel et al. (1987; Section 2.3.17), using pBSksHII13 
(Table 2.1 .9) as template and mutagenic oligonucleotide primers (Table 2.1.8). Additional 
mutations were introduced by a second round of mutagenesis using either pMC 18 or 
pMCI9 as templates and mutagenic oligonucleotides primers (Table 2.1.8). Clones that 
only contained the desired point mutations were identified by sequencing the USS/-coding 
region and its promoter sequence. Note: plasmid pMC4I contains USSI that bears multiple 
mutations; nucleotide changes that encode N37Y and G73D amino acid substitutions in the 
conserved snRNP core protein motif, and nucleotide-deletions that result in a frame-shift. 
The mutant Usslp encoded by pMC41 is prematurely truncated (168 amino acids), with the 
asparagine-rich carboxy-terminal region replaced by a non-biased amino acid sequence. 
With the exception of pMC42, the mutated USSI gene with its promoter sequence was 
isolated on a HindilI fragment and cloned into the unique Hindill restriction site of pFL39 
(Bonneaud et al., 1990). pMC42 was constructed by isolating the mutated USS/-coding 
region on an EcoRl/Sail fragment, which was then cloned between the EcoRI and Sail 
restriction sites of pFL39. Arrows indicate direction of USSI (black box), T7 and T3 
promoter transcription. The asparagine-rich carboxy-terminal domain of Ussip (hatched 
box) is indicated. Single letter amino acid code is used. Broken lines represent the multiple 
cloning site of pBluescript KS (Table 2.1.9). H, Hindlll; 5, Sall; RI, EcoRl. Growth 
phenotype, MCY4 cells dependent on these mutant Ussi polypeptides grow slower than 
cells dependent on plasmid-encoded wild type Usslp in glucose liquid medium; Non-
functional, mutant Usslp can not rescue growth of MCY4 on either solid or liquid glucose 
medium. 
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Figure 6.98. Summary of plasmid DNA nomenclature and the mutant UsslA polypeptides 
that they encode. USSJ sequence encoding the carboxy-terminal domain of mutant Uss 1 
polypeptides was truncated using PCR. Plasmid DNAs described in Figure 6.9A were used 
as templates with primers N0381 and MOOS 5 (Table 2. 1.8) to generate a PCR product 
bearing the 3' deleted, mutated USSI gene with its own promoter, incorporating Hindlil 
and Sail restriction sites 5' and 3' of the gene respectively. The PCR products were cut with 
HindIll and Sail, gel purified and cloned between the Hindu! and Sail restriction sites of 
modified pFL39. Modified pFL39 contains a stop-codon linker (primers M5392 and 
M5393; Table 2.1.8) cloned into the unique Sail restriction site (Bonneaud et al., 1991; this 
work). Note: Plasmid pMC66 contains 3' deleted, mutated USSI constructed by PCR using 
pMC42 (Table 2.1.9) as template and primers Ml 3 Rev and M0055 (Table 2.1.8). The PCR 
product was cut with C/al and Sail, gel purified and cloned between the Accl and Sail 
restriction sites of the modified pFL39 vector. Clones were verified by sequencing (Section 
2.3.16). Arrows indicate direction of mutated USSJ gene (ussl*,  black box), T7 and T3 
promoter transcription. The asparagine-rich carboxy-terminal domain of Uss Ip (hatched 
box) is indicated. Single letter amino acid code is used. Broken lines represent the multiple 
cloning site of pBluescript KS. H, HindIII; C, C/al. Growth phenotype, FVICY4 cells solely-
dependent on these mutant Uss 1 polypeptides grow slower than cells dependent on 
plasmid-encoded wild type Ussip; Nonfunctionalt,  mutant Ussip unable to rescue growth 
of MCY4 at 36°C on glucose solid medium; Non-functional, mutant Ussip unable to rescue 
growth of MCY4 on glucose solid medium at any temperature tested. 
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MUTATION ANALYSES OF USSJp 
DISCUSSION 
Deletion of the carboxy-terminal ninety three amino acids ofUssi polypeptide, 
removing the characteristic asparagine-rich sequence of this protein, significantly 
modifies the overall nature of the Uss ip, but does not substantially alter its ability to 
function in vivo. However, the decreased growth rate of MCY4 cells dependent on 
UsslAp for growth corresponded with reduced splicing efficiency in these cells, as 
evidenced by a slight decrease in the level of mature RP28 transcript. 
The primary defect of cells metabolically depleted of Uss 1 p  is a dramatic reduction in 
the level of U6 snIRNA. Deletion of the asparagine-rich sequence of Ussi polypeptide 
does not have such a substantial effect on the abundance of U6 snIRNA, although the 
stability of this molecule is somewhat affected by the removal of this region. This 
indicates that in the absence of the Ussip carboxy-terminal domain, the rate of decay 
of U6 snRNA is slightly enhanced. Deletion of this region may affect the stability of 
U6 snRNA directly, by weakening the ability of this polypeptide to associate with, and 
hence stabilise U6-containing snRNP particles. Alternatively, and/or additionally, 
deletion of such a substantial portion of Ussip may destabilise this polypeptide in 
vivo, indirectly affecting the stability of U6 snRNA. However, this seems unlikely 
since monoclonal anti-FLAG M28  antibodies readily detected Uss1p-F when the 
gene encoding this polypeptide was expressed from its own promoter on a single 
copy-number plasmid. 
Anti-FLAG M20  antibodies co-immunoprecipitate U4, U5 and U6 snRNAs from a 
cell extract derived from MCY4-pMC43 cells dependent upon UsslA-F protein for 
growth. Thus, the conserved amino-terminal domain of Ussip is sufficient for this 
protein to interact specifically with U6-containing snRNP particles, implying that 
residue(s) within this region confer U6-specificity. However, anti-FLAG M2 0 
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antibodies only weakly co-immunoprecipitated spliceosomal snRNAs from an extract 
from wild-type cells co-producing Ussi and plasmid encoded-UsslA-F polypeptides. 
The weak immunoprecipitation of U4, U5 and U6 snRNAs from this extract could be 
attributed to the inability of the truncated Ussi polypeptide to compete with full 
length, wild-type Ussip for stable association with U6 snRNA and assembly into 
snRNP particles. Similarly, only low levels of snRNAs were immunoprecipitated with 
anti-Ussi antibodies from MCY4 cell extracts that contained only UsslA or Uss lA-F 
polypeptides. However, this result may be due to poor recognition of Uss lAp as a 
consequence of deleting Ussi polypeptide epitopes. 
The high degree of evolutionary conservation of the snIRNP core protein motif 
suggested that this region may be functionally important. Limited deletion and amino 
acid substitution analyses have demonstrated that the snRNP core protein motif is 
essential in vitro and in vivo, and may be involved in mediating protein-protein 
interactions between individual core polypeptides (Chapter 5; Rymond, et a! 1993; 
Hermann et al., 1995; Séraphin, 1995). In this work, mutagenesis of two highly 
conserved residues within the snRNP core protein motif of Ussip demonstrated that 
this polypeptide can tolerate substantial changes within this region. However, 
significantly altering the nature of multiple residues in Ussi polypeptide, or 
introducing point mutations into Uss lAp, resulted in detectable growth defects. For 
example, introducing the large aromatic residue tyrosine in place of the absolutely 
conserved asparagine, or substituting an acidic base for a small hydrophilic one, 
modified the ability ofUssi polypeptide to function in vivo. Significantly, deleting the 
carboxy-terminal ninety three residues of these mutant polypeptides was lethal. 
Additionally, drastically altering the nature of the carboxy-terminal sequence of Ussi 
polypeptide mutated in both conserved elements that comprise the snRNP core 
protein motif [LJss1(N37Y,G73D)p], disrupted the ability of Ussip to function in 
vivo. 
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Thus, the carboxy-terminal region of Ussip, although not essential for the activity of 
this polypeptide in vivo, is important when residues within the highly conserved 
amino-terminal snRNP core protein motif have been mutated. Most dramatically, 
UsslA proteins mutated in both conserved elements of the snRNP core protein motif, 
including mutations that do not cause dramatic growth defects when present in the 
full-length Ussi polypeptide, were non-functional as determined by the plate assay. 
Thus, in the absence of major perturbations to the conserved amino-terminal domain, 
Uss1ip is viable. However, mutations to the snRNP core protein motif of Ussip that 
might substantially alter the nature and/or structure of this region, can not be tolerated 
when domain II is significantly modified or absent. This implies that residues both 
within the snIRNP core protein motif and the unique carboxy-terminal domain of 
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Largely through genetic approaches, a number of yeast proteins have been 
identified in addition to Ussip, as integral components of U6-containing snRNP 
particles. Prp3 and Prp4 polypeptides are components of the U4/U6 snRNP 
(Banroques and Abelson, 1989; Abovich et al., 1990; Bordonné et al., 1990; Xu et 
al., 1990) and Prp6p is a U41U6.U5 tri-snRNP associated-protein required for the 
stability and accumulation of this complex (Galisson and Legrain, 1993). Prp24 
polypeptide has three RRMs and is associated with U6 snRNA (Shannon and Guthrie, 
1991; Ghetti etal., 1995; Jandrositz and Guthrie, 1995). 
The primary defect of cells metabolically depleted ofUssi polypeptide is a substantial 
reduction in the cellular level of U6 snRNA. This protein appears to associate with 
and stabilise free U6 snRNA. At present however, it is not known whether Ussip 
interacts with U6 snRNA directly, or associates indirectly through protein-protein 
interactions, possibly involving Prp24p or other, as yet unidentified U6-associated 
proteins. 
This chapter describes preliminary data that imply interactions between Ussi, known 
U6-associated polypeptides and U6 snRNA. 
7.1 Overexpression of U6 snRNA can Partially Compensate for the Loss 
of IJsslp 
To investigate whether Ussi polypeptide is only required for maintaining U6 
snRNA stability, MCY4 cells were transformed with a high copy-number plasmid 
bearing U6 snRNA with its own promoter (pU6; Table 2.1.9). Overexpression of this 
snRNA molecule partially rescued growth of MCY4 cells on glucose solid medium 
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(Figure 7. 1A). However, these cells did not grow as well as MCY4 cells transformed 
with a high copy-number plasmid encoding wild-type USSJ with its own promoter 
(YEp24-USS 1). 
When the growth rate of liquid cultures of MCY4 cells transformed with either 
plasmid YEp24-USS1 or pU6 was monitored following a shift to non-permissive 
glucose medium, the doubling times were almost indistinguishable for the first fifteen 
hours (Figure 7.1B). However, approximately twenty hours following the shift to 
glucose liquid medium, growth of MCY4-pU6 cells significantly slowed. In contrast, 
MCY4 cells transformed with YEp24-USS1 continued to grow at the same rate. 
Northern blot analysis on total RNA extracted from MCY4-pU6 cells at various times 
following a shift to glucose liquid medium, showed that the intracellular content of U6 
snRNA in these cells was substantially higher than that typically observed in MCY4 
cells (Figure 7.2A, compare lanes 1 and 7). In addition, the level of U6 snRNA in 
MCY4-pU6 cells was not especially reduced by metabolic depletion of Ussip to 
limiting levels (compare lanes 4 and 10), neither was the level of U6 substantially 
altered following the onset of reduced growth (lanes 11 and 12). 
To determine the splicing efficiency of MCY4-pU6 cells depleted of Ussip, Northern 
blots were probed with the yeast ribosomal protein gene RP28 (Figure 7.2B). As 
expected in MCY4 cells transformed with vector DNA, splicing was efficient for the 
first ten hours following a shift to glucose liquid medium (lanes 1-3). After fifteen 
hours, coinciding with the onset of reduced growth rate for these cells, the level of 
mature RP28 mRNA decreased substantially (lane 4). By twenty five hours in glucose 
medium only very low levels of mature RP28 transcript could be detected (lane 6). 
Splicing occurred in MCY4-pU6 cells (lanes 7-12), however, the level of mature 





and splicing appeared to be less efficient in these cells after prolonged growth in this 
medium (compare lanes 7-9 and 10-12). Thus, overexpression of U6 snRNA can only 
partially compensate for the absence ofUssip. 
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Figure 7.1. Overexpression of U6 snRINA can partially compensate for the loss of Ussip. 
(A) 10-fold serial dilutions of galactose-grown, mid-logarithmic cultures of MCY4 cells 
transformed with either vector (pBM125), YEp24-USS1, pGAL-USSI or pU6 were spotted 
onto selective galactose and glucose solid media. (B) Liquid cultures of transformed MCY4 
cells were grown to mid-logarithmic phase in galactose medium, harvested, washed and 
resuspended in sterile water. This suspension was used to inoculate fresh pre-warmed 
glucose liquid medium to an initial 0D600 of 0.05. Cultures were diluted to keep all 
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Figure 7.2. Overexpression of U6 snRNA only partially compensates for the loss of 
Ussip. (A) Total RNA was extracted from MCY4 cells transformed with either vector 
(pBMI25; MCY4, lanes 1-6) or pU6 (MCY4 + U6 snRNA, lanes 7-12) grown for 
various lengths of time in glucose liquid medium, fractionated on a 6% (w/v) 
denaturing polyacrylamide gel, blotted and probed with oligonucleotides specific for 
the snRNAs (Table 2.1.8 and Section 23.15). The positions ofUl, U2, U4, U5S, U51- 
and U6 snRNAs are indicated. (B) Total RNA was extracted from MCY4 cells 
transformed with either vector (pBM 125; MCY4, lanes 1-6) or pU6 (MCY4 ± U6 
snRNA, lanes 7-12) grown continuously in glucose liquid medium, resolved on a 
1.4% (w/v) denaturing agarose gel, blotted and probed with radiolabelled RP28 DNA 
(Section 2.3.15). The positions of pre-mRNA and mature mRNA are indicated. In 
addition, the level of U  snRNA is indicated to show the relative amounts of total 
RNA. 
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7.2 Overexpression of USS1 Enhances the Temperature-Sensitive 
Phenotype of Known PRP Mutants 
Immunoprecipitation studies have shown that Ussip is associated with both 
free U6 and U4/U6 snRNP particles. It is conceivable that this polypeptide associates 
with U6 snRNA by interacting with other U6-associated polypeptides, such as 
Prp24p. To test for genetic interactions that might support this prediction, 
temperature-sensitive prp3-1, prp4-1, prp6-1 and prp24-7 mutants were transformed 
with additional copies of USSJ. Either a high copy-number plasmid bearing USS1 
with its own promoter (YEp24-USS 1), or a low copy-number plasmid bearing USSJ 
under the control of the inducible GAL] promoter (pGAL-USS 1) were introduced 
into these mutants. These plasmids were also introduced into MCY4 and a 
temperature-sensitive prp2-1 strain; PRP2 encodes an essential, non-snRNP splicing 
factor that interacts transiently with the spliceosome during the splicing reaction. The 
ability of all these strains to grow on selective glucose and galactose solid media at a 
variety of temperatures was tested (Figure 7.3). In addition, the ability of extra copies 
of U6 snRNA to alleviate the temperature-sensitive phenotype caused by these pip 
mutations was checked. 
A high copy-number plasmid bearing USS] (YEp24-USS 1) had no significant affect 
on the temperature-sensitive growth of any of the prp mutants, but rescued growth of 
MCY4 on glucose medium. However, substantially elevated levels of Ussi 
polypeptide, encoded by pGAL-USS1, actually enhanced the temperature-sensitive 
phenotype due to prp3-1, prp4-1 and prp24-7 mutations (Figure 7.3). No difference 
in growth for the prp2-1 and prp6-1 strains was observed. Significantly, additional 
copies of U6 snRNA were only capable of partially relieving the growth defect on 
glucose medium shown by strain MCY4, and the temperature-sensitive phenotype 












Figure 7.4. Summary of potential interactions between USSJ, PRP3, PRP4 and PRP24 and 
SNR6 (U6 snRNA). 4, temperature-sensitive phenotype relieved; -I temperature-
sensitive phenotype enhanced. 
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Figure 7.3. Overexpression of USSJ enhances the temperature-sensitive phenotype of 
prp mutants. Galactose-grown, mid-logarithmic cultures of MCY4 cells transformed 
with either vector (pBMI25), YEp24-USS1, pGAL-USS1 or pU6 were spotted onto 
selective galactose and glucose solid media. For all other strains, glucose-grown, mid-
logarithmic cultures of cells transformed with either vector (pBM 125), YEp24-USSI, 
pGAL-USS1 or pU6 were spotted onto selective galactose and glucose solid media. 
All plates were incubated at either 23°C, 30°C, 34°C or 36°C for three to six days. 
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In yeast, U!, U2 and U5 snRNAs exist as monomeric snRNP particles, 
whereas the majority of U4 snRNA exists base-paired to U6 snRNA in the same 
particle (Fortner etal., 1994). U6 snRNA is normally present in excess over U4. This 
excess is believed to be a major factor in driving the formation of the U4/U6 snRNP 
particle, the favoured state of U6 snRNA. Metabolic depletion of Ussi polypeptide 
causes the relative amount of U6 snRNA to be substantially reduced, implying that 
one function of this protein may be to associate with and stabilise free U6 snRNA, 
until the formation of a more stable complex. The absence of Ussip appears to render 
this RNA molecule more susceptible to RNase degradation. 
Additional copies of U6 snRNA might partially rescue the growth of MCY4 on 
glucose medium by elevating the level of the intracellular pool of U6 snRNA, thus 
enhancing the interaction of U4 and U6 snRNAs and driving formation of the U41E.J6 
snRNP particle. However, Northern blot analysis of total RNA extracted form 
MCY4-pU6 cells, demonstrated that excess U6 can not frilly compensate for the 
absence of Ussi polypeptide. The reduced growth rate of these cells compared to 
those producing plasmid-encoded Ussi p, corresponded with reduced splicing 
efficiency as evidenced by significantly lower levels of mature RP28 transcript. This 
partial splicing defect is unlikely to be due to inadequate levels of U6 snlR.NA, since 
Northern blot analysis showed that the level of this snIRNA is vastly elevated in 
MCY4-pU6 cells, compared to that typically observed for MCY4. However, it can 
not be ruled out that plasmid-encoded U6 snRNA, in the absence of Ussip, can not 
be incorporated into active U6-containing snRNP particles that assemble into 
spliceosome complexes. 
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One function of Ussip appears to be maintaining U6 snRNA stability. However, the 
partial splicing defect observed in cells depleted of Ussip but saturated with U6 
snRNA, implies that this polypeptide performs some additional, as yet undetermined 
function. For example, Ussi protein may be required not only for maintaining the 
stability of U6 snRNA, but also for the incorporation of this molecule into the 
spliceosome. According to this model, one might predict that Ussip is present in the 
spliceosome. At present however, it is not known if this protein is a component of the 
spliceosome, since antibodies raised against Ussip do not detectably interact with the 
pre-mRNA-containing spliceosome complexes. This could be a consequence either of 
masking of the Ussip epitopes or the absence of this protein in these complexes. 
Vast overexpression of USSJ from the GAL] promoter, but not from its own 
promoter on a high copy-number plasmid, enhanced the temperature-sensitive 
phenotype caused by prp3, prp4 and prp24 mutations. However, additional copies of 
USSJ did not relieve the temperature-sensitive phenotype due to prp2 and prp6 
mutations. Significantly, overproduction of U6 snRNA partially relieved the 
temperature-sensitive phenotype caused by prp3, prp4 and prp24 mutations and 
rescued growth of MCY4 on glucose medium, but did not influence the growth of 
pip2 and prp6 mutants. 
These data imply that as yet undefined interactions, physical and/or functional, exist 
between Ussip, Prp3, 4 and 24 proteins and U6 snRNA. This prediction correlates 
with established genetic and biochemical links between Prp3, Prp4, Prp6 and Prp24 
polypeptides. For example, heat-inactivated prp3 and prp4 extracts fail to 
complement one another (Lustig et al., 1986), but a prp4-1 mutation can be 
suppressed by overexpression of PRP3 (Last et al., 1987; Hu et al., 1994). In 
addition, prp3, pip4 and prp24 mutations act synergistically with one another but not 
with prp6 (Ruby et al., 1993). 
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Prp3 and Prp4 polypeptides are components of the U4/U6 snRNP particle. Prp4 is 
believed to associate with the 5' stem-loop of U4 snRNA, although no direct RNA-
protein interaction has been demonstrated (Bordonné et al., 1990; Xu et al., 1990). 
This polypeptide is not required for maintaining the stability of U4 snRNA, however, 
heat-inactivation of a temperature-sensitive prp4-1 strain causes a substantial 
reduction in the level of U6 snRNA (Blanton et al., 1992 and references therein). 
Prp24 polypeptide is an RNA-binding protein which associates with free U6 snRNA 
(Jandrositz and Guthrie, 1995). Like Prp4p, this polypeptide is important for 
maintaining the stability of U6 snRNA and also plays a role in the dynamic interaction 
of U4 and U6 (Shannon and Guthrie, 1991; Ghetti et al., 1995). Prp6 polypeptide is a 
component of the U4/U6.U5 tri-snRNP particle. This protein is necessary for the in 
vivo stability of U6 snRNA, however, heat-inactivation of a temperature-sensitive 
pip6 strain does not cause a significant reduction in the level of this snRNA (Blanton 
et al., 1992). All of these factors are essential for nuclear pre-mRNA splicing and are 
components of the U6-containing particles. 
It is important to note in this experiment that the growth phenotype of all 
temperature-sensitive prp strains varied, depending on whether these cells were 
grown on glucose or galactose media. The efficiency of nuclear pre-mRNA splicing, 
indeed RNA processing in general, appears to be carbon-source dependent (this work; 
Tung and Hopper, 1995 and references therein). Temperature-sensitive prp mutants 
are capable of growing at elevated temperatures on non-glucose carbon sources. One 
model to explain this apparent carbon-source dependent growth links carbon 
metabolism, the cAMP pathway and RNA processing (Tung et al., 1992; Tung and 
Hopper, 1995). Significantly, REGJ (HEX21SRNJ) a negative regulator of glucose 
repressible genes, has been isolated as a suppressor of several prp mutant alleles 
(Tung et al., 1992). This gene may affect RNA processing indirectly, by negatively 





processing in the presence of glucose, but which enhance processing at elevated 
temperatures in alternative, non-glucose media. Alternatively and/or additionally the 
,.activities of components involved in RNA processing may be modulated in response 
to glucose by cAMP-dependent protein kinases and protein phosphatases. There is 
very strong evidence to suggest that the phosphorylation state of several components 
of the splicing machinery is critical for both steps of the splicing process (Mermoud et 
al., 1992; 1994; Tazi et al., 1992; 1993). Indeed, rather intriguingly a protein 
necessary for the processing of Neurospora mitochondrial pre-mRNAs has been 
identified, which is related to protein phosphatases involved in cell cycle regulation 
(Turcq etal., 1992). 
227 
CHAPTER EIGHT 
FINAL DISCUSSIONS AND FUTURE WORK 
CHAPTER EIGHT 	 FUTURE WORK 
USS] was isolated as a weak suppressor of a temperature-sensitive dbf2 mutant that 
has a cell cycle phenotype, being defective in late mitosis and in DNA synthesis 
(Parkes and Johnston, 1992). However, the nature of this suppression is not 
understood. This work has shown that USS] encodes an essential polypeptide, 
structurally related to the spliceosomal snRNP core proteins, necessary for nuclear 
pre-mRNA splicing both in vivo and in vitro (Cooper et al., 1995). Significantly, 
cells depleted of USSJ-encoded polypeptide do not have an obvious cell cycle 
phenotype and their primary defect is a dramatic reduction in the cellular content of 
U6 snRNA (Cooper et al., 1995). 
Uss ip represents a novel class of snRNP core protein. Unlike the canonical core 
proteins which associate with Ui, U2, U4 and US snRNP particles, Ussip 
specifically associates with free U6 and U4/U6 particles. In addition, Ussip is 
essential for maintaining U6 snRNA stability. In contrast to the other spliceosomal 
snRNAs, U6 has been evolutionarily well conserved and is believed to play a key 
role in the catalysis of splicing, possibly comprising part of the catalytic centre. 
However, in contrast to our knowledge concerning the complexity of the Ui, U2, U4 
and US snRNP particles (Luhrmann et al., 1990; Will et al., 1993; Kramer, 1995), 
very little is known about the proteins associated with U6 snRNA. To date, only 
three U6-associated polypeptides have been identified in yeast, Usslp, Uss2p and 
Prp24p (Cooper et al., 1995; Shannon and Guthrie, 1991; Ghetti et al., 1995; 
Jandrositz and Guthrie, 1995; Séraphin, 1995). 
Future analysis of Ussip will aim to clarify the role of this protein in the splicing 
process. In addition, the association of this protein with U6 and potentially other 
snRNAs will be investigated, as will the complexity of the U6 particle itself. 
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SnRNP-Specificity of Ussip. Alignment of the amino acid sequences of 
characterised mammalian and yeast core proteins with the sequence of Ussip 
revealed that the amino-terminal ninety amino acids of these proteins share a 
significant degree of sequence similarity. This conserved amino-terminal region has 
been termed the snRNP core protein motif (Cooper et al., 1995) or Sm domain 
(Hermann et al., 1995; Séraphin, 1995). In contrast, the carboxy-terminal sequence 
of the core proteins diverge considerably. Most strikingly, Ussip has an asparagine-
rich carboxy-terminus which distinguishes this protein from the canonical core 
polypeptides. Preliminary deletion analyses of the carboxy-terminal sequence of 
Ussip have indicated that residues within this region do not contribute to the snRNP-
specificity of Ussip. The carboxy-terminal sequence of Ussip will be further 
truncated, however, to determine the minimum amino acid sequence necessary for 
this protein to function in vivo, and retain its ability to specifically associate with U6-
containing snRNP particles. 
Highly conserved residues within the snRNP core protein motif itself are unlikely to 
contribute to the snRNP-specificity of Ussip. However, non-conserved residue(s) 
embedded within this motif may influence the specificity of this polypeptide. To test 
this prediction, domain swap experiments involving the exchange of region(s) of the 
conserved amino-terminal sequence of Ussip with the equivalent region(s) from the 
characterised yeast Smdl and Smd3 snRNP core polypeptides will be performed. 
Functional Significance of the SnRNP Core Protein Motf. Limited deletion and 
amino acid substitution analyses have demonstrated that the snRNP core protein 
motif is essential, and may be involved in mediating protein-protein interactions 
between individual core polypeptides (Rymond et al., 1993; Hermann et al., 1995; 
Séraphin, 1995). This work has shown that significantly altering the overall nature 
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and/or structure of Ussip, by introducing multiple mutations throughout the protein, 
disrupts the ability of this protein to function in vivo. However, highly conserved 
individual amino acids within the snRNP core protein motif are not essential for the 
function of Ussip. 
Mutagenesis of the USSJ gene, specifically sequence that encodes the conserved 
snRNP core protein motif, will be extended in an attempt to isolate conditional 
alleles of this gene. Defects caused as a result of these novel ussi mutations will be 
studied in vivo and in vitro, assaying the effect of the mutation on the splicing 
reaction itself, spliceosome assembly and on the ability of the mutant polypeptide to 
interact with U6-containing snRNP particles. In addition, these conditional ussi 
alleles will be used to screen for genetic suppressor and/or enhancer mutations to 
identify splicing factors that interact with Ussip (A. E. Mayes personal 
communication). The two-hybrid interaction assay (Beggs, 1995) will be used as an 
alternative approach to genetic screening to isolate factors that interact with Uss 1 p 
(S. Menart personal communication). 
Association of Ussip with U6 snRNA. It will be particularly interesting to establish 
how Ussip associates with U6 snRNA. At present, it seems unlikely that this 
polypeptide interacts directly with U6 snRNA since, like all the canonical core 
proteins, it does not contain a good match to any of the recognised RNA binding 
motifs (Burd and Dreyfuss, 1994 and references therein). However, Ussi protein 
may interact indirectly with U6 by associating with a protein which can bind to U6 
snRNA, for example Prp24p. Indeed, preliminary genetic data imply that as yet 
uncharacterised interactions, physical and/or functional, exist between Ussi and 
Prp24 polypeptides. These putative interactions, and those detected between Ussi, 
Prp3 and Prp4 proteins, will be investigated in more detail. Alternatively, Ussip may 
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associate with U6 snRNA through the assembly of an hetero-oligomeric protein 
complex, the formation of this complex resulting in the generation of a novel U6 
snRNA-binding site. These proteins may be additional U6-associated core-like 
polypeptides such as Uss2p. Genetic screens and physical-interaction assays for 
factors that interact with Uss 1 polypeptide will hopefully lead to the identification of 
novel U6-associated proteins. 
Presence of Ussip in Spliceosomes. At present it is unclear whether Ussip remains 
associated with U6 snRNA throughout the splicing reaction, or dissociates from the 
U6 snRNA-containing particles prior to spliceosome assembly. To date, antibodies 
raised against Ussip do not detectably interact with these spliceosome complexes. 
This could be a consequence either of masking of the Usslp epitopes or the absence 
of this protein in the spliceosome. To determine the extent of the involvement of 
Ussip in the splicing process it will be important to establish whether Ussi 
polypeptide is present in the spliceosome. Two approaches will be taken. 
The FLAG-epitope octapeptide sequence, which has been shown not to disrupt 
the ability of Uss lp to function in vivo, will be cloned immediately downstream of 
and in-frame with the wild-type USS] ORF. Splicing reactions will be assembled 
with an extract from MCY4 cells that contain wild-type, epitope-tagged Ussip and 
monoclonal anti-FLAG antibodies will be used to test for co-immunoprecipitation of 
splicing complexes containing pre-mRNA, splicing intermediates and products. 
An alternative, indirect method to determine whether Uss 1 p  is present in 
spliceosomal complexes exploits the ability of poly(A)-binding protein, endogenous 
to yeast cell extracts, to bind to polyadenylated transcripts. Splicing reactions will be 





intron-containing transcript. Spliceosomes will then be immunoaffinity purified 
using antibodies raised against poly(A)-binding protein, and the presence of Ussi 
polypeptide in these complexes determined by Western blotting (Whittaker et al., 
1990). However, due to the inability of antibodies raised against Ussip to recognise 
endogenous levels of this protein in yeast cell extracts, it may be necessary to 
assemble splicing reactions with an extract from MCY4 cells that contain wild-type, 
epitope-tagged Ussi polypeptide. Monoclonal anti-FLAG antibodies have been used 
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The SDB23 gene of Saccharomyces cerevisiae was 
isolated in a search for high copy-number suppressors 
of mutations in a cell cycle gene, DBF2. SDB23 encodes 
a 21 276 Da protein with significant sequence similarity 
to characterized mammalian snRNP core proteins. 
Examination of multiple sequence alignments of snRNP 
core proteins with Sdb23p indicates that all of these 
proteins share a number of highly conserved residues, 
and identifies a novel motif for snRNP core proteins. 
Sdb23p is essential for cell viability and is required 
for nuclear pre-mRNA splicing both in vivo and in vitro. 
Extracts prepared from Sdb23p-depleted cells are 
unable to support splicing and have vastly reduced 
levels of U6 snRNA. The stability of Ui, U2, U4 and 
U5 spliceosomal snRNAs is not affected by the loss of 
Sdb23p. Antibodies raised against Sdb23p strongly co-
immunoprecipitate free U6 snRNA and U41U6 base-
paired snRNAs. These results establish that SDB23 
encodes a novel U6 snRNA-associated protein that is 
essential for the stability of U6 snRNA. We therefore 
propose the more logical name USSJ (U-Six SnRNP) 
for this gene. 
Key words: core protein/RNA splicing/snRNPIU6 snRNAI 
yeast 
Introduction 
Nuclear pre-mRNA splicing involves two distinct, sequen-
tial trans-esterification reactions that occur within a large, 
highly dynamic complex termed the spliceosome. Splicing 
requires ATP and is dependent upon multiple trans-acting 
factors that interact and associate with one another and 
with conserved cis-elements within the pre-mRNA. The 
mechanism of the two-step splicing pathway is highly 
conserved from 'yeast to mammals (reviewed in Green, 
1991; Moore et at., 1993), as are at least some splicing 
factors. The major subunits of the spliceosome are five 
small nuclear ribonucleoprotein particles (snRNPs); UI, 
U2, U4, U5 and U6. These snRNPs, in conjunction with 
other protein factors, play critical roles in defining introns 
and folding pre-mRNAs into a conformation suitable for 
catalysis, and may play catalytic roles in the splicing 
reaction (reviewed in Moore et at., 1993). As characterized 
in metazoans each snRNP, with the exception of U6, is 
composed of a single small nuclear RNA (5nRNA) with 
a tri-methylguanosine (TMG) cap, a set of core proteins 
(B, B', Dl, D2, D3, E, F and G; in order of decreasing 
apparent molecular weight) and a variable number of 
snRNP-specific proteins (reviewed in Luhrmann et at., 
1990). Unlike the others, U6 snRNA is transcribed by 
RNA polymerase III, has a 'y-monomethyl guanosine cap 
structure and does not directly bind the core proteins since 
it lacks the appropriate structural motif, the Sm site 
(Branlant et at., 1982). 
The U6 snRNA associates with U4 snRNP and enters 
the spliceosome as a U41U6.U5 tri-snRNP complex. A 
number of yeast proteins associated with U6-containing 
particles have been identified. Prp24 protein has three 
RNA recognition motifs and is associated with U6 snRNA 
(Shannon and Guthrie, 1991). Prp3 and Prp4 proteins are 
components of the U4/U6 snRNP (Banroques and Abelson, 
1989; Abovich et at., 1990; Bordonné et at., 1990; Xu 
et at., 1990) and Prp6p is a U41U6.U5 tri-snRNP-associ-
ated protein required for the stability and accumulation of 
the tri-snRNP complex (Gallisson and Legrain, 1993). All 
these proteins are required for RNA splicing and their 
in vivo inactivation influences the cellular levels of U6 
snRNA (Blanton et at., 1992 and references therein; Hu 
et al., 1994). 
The binding of the core proteins to the Sm site is an 
important step in the biogenesis of snRNPs: cytoplasmic 
cap tri-methylation and nuclear localization of snRNPs 
are two core protein-dependent functions (Mattaj and De 
Robertis, 1985; Hamm et al., 1990; Fischer et at., 1993; 
Plessel et at., 1994). In addition, the core proteins (indi-
vidually or as a core complex) provide a flexible platform 
with which the snRNP-specific proteins can associate, 
adding stability to the snRNP (Nelissen et at., 1994). 
Focusing on the U  snRNP, Nelissen et at. (1994) detected 
direct protein—protein interactions between the Ul-
specific proteins (70K, A and C), and the core proteins 
B, B' and D2. These interactions occur in addition to 
established protein—RNA interactions between U! snRNA 
and the U1-70K and A proteins (Query et at., 1989; 
Scherly et at., 1989). 
With yeast, the ability to combine modem molecular 
biology and genetics with biochemistry has led to the 
relatively rapid identification and characterization of new 
factors involved in the nuclear pre-mRNA splicing reaction 
(reviewed in Ruby and Abelson, 1991; Rymond and 
Rosbash, 1992). However, conventional genetic screens 
for splicing mutants have been far from saturating. Most 
notable is the failure of these screens to isolate mutants 
affecting the homologues of the metazoan snRNP core 
proteins. All the evidence available suggests that yeast 
homologues of the Sn,bindi1!Ig  core proteins do exist. 
First, the yeast UI, U2, U4 and U5 snRNAs, although 
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not closely conserved in primary sequence, have retained 
Sm sites (Riedel et al., 1987). These sites are biologically 
functional (Riedel et aL, 1987) and required for snRNP 
stability (Jones and Guthrie, 1990). Secondly, the yeast 
snRNAs can be immunoprecipitated (albeit weakly) by 
human anti-Sm antisera (Siliciano et at., 1987; Tollervey 
and Mattaj, 1987), indicating that epitopes of the core 
'roteins have been conserved to some degree. Thirdly, 
I rge scale immunoaffinity purification of spliceosomal 
nRNPs from yeast has detected a number of candidates 
or snRNP core proteins (Fabrizio et at., 1994). Two 
east genes, SMDJ and SMD3, that encode polypeptides 
omologous to the human Dl and D3 proteins have now 
een identified fortuitously as neighbours of PRP38 and 
EP3 respectively (Rymond, 1993; Lehmeier et at., 1994; 
oy et at., 1995). 
A third yeast gene SDB23 has been identified (Parkes 
nd Johnston, 1992) that encodes a polypeptide with low 
Ut significant homology to the snRNP core proteins. 
db23p is only 25.1 and 26.8% identical to the yeast 
mdl and Smd3 proteins respectively, but significantly, 
all three proteins share a number of highly conserved 
residues within their N-terminal domains. All the snRNP 
core proteins sequenced to date contain these N-terminal 
conserved amino acids. We propose that these residues 
form a signature motif for snRNP core proteins. This 
paper describes the in vivo and in vitro characterization 
of SDB23, establishing a role for Sdb23p early in the 
splicing process, and demonstrating an absolute require-
ment for Sdb23p for U6 snRNA stability. This is the first 
identification, in any organism, of a U6 snRNP-associated 
core-like protein. 
Results 
Isolation of the SDB23 gene 
SDB23 was one of three genes isolated in a search for 
high copy-number suppressors of a mutation in DBF2, 
which encodes a cell cycle protein kinase (Parkes and 
Johnston, 1992). The suppressing activity of the comple-
mentingplasmid was localized by Tnl000 insertion muta-
genesis to a 1.4 kb HindIII fragment. This region was 
subjected to DNA sequence analysis and found to contain 
a single 561 nucleotide uninterrupted open reading frame 
(ORF) beginning with an ATG codon at position 1 (Figure 
IA) and terminating with TAA at positions 562-564. 
Sequences resembling the yeast transcriptional control 
consensus TATAA are located at positions - 178 
(TAATTA)and —78 (TATTA) 5' of the ORE Potential 3' 
processing sequences are located immediately downstream 
of the presumed termination codon (Figure 1). 
When the nucleotide sequence of the 1.4 kb Hindu! 
fragment was compared with sequences in the GenBank 
database, nucleotides —290 to —374 were identified as 
the SWI4 promoter sequence (Foster et at., 1993). Thus, 
the DNA fragment that complements the temperature-
sensitive defect of dbf2-I contains a single ORF (database 
accession number X82649) whose transcriptional control 
elements are adjacent to (if not overlapping) the SWI4 
promoter sequence (Figure IB). chromosome mapping of 
the SDB23 locus was performed by hybridizing 32P_ 
labelled SDB23 DNA to a yeast chromosome OFAGE 
blot. A single band corresponding to chromosome V 
A 
-374 TCATAGTGAT.6/.GTAATTTTAAATG7GTTTAAAGTACTACTTTTCCTTTACCGCCAGTT 315 
-314 CCD13TACTA1AAAAAGCCAAATTCC13CATTGTAGCCCCCCJ.cACGGCATTTTGATCATC 255 
-254 AATTACGAAATTTGCCGCACACGTGTCACGTGATAAGCACTCTTACTATCATGTTTTACG 195 
- 194 GAGTAGCAATGATGTTTAATTATTGCAGCTTTCTTTCGTGAAPTCGTAGTATCATAGACC 135 
-134 TTCCTAPTGATGG?.AGCGGTAAAGAAGGAAATCGTAAMGTAAATTAACGAAGTAGTATT -75 
-74 AGTP.AAACAGAGTTGAAAAACTGATAAATCTTCAACTCGAACTGAAAAGAAACACAATAG -15 
-14 AATATTTTTCCTCAATGCTACCTTTATATCTTTTAACAAATGCGAAGGGACAACAAATGC 46 
ML PLY L L TN A K GO 0 HO 
47 AAATAGAATTGAAAAACGGTGAAATTATACR.AGGGATATTGACCAACGTAGATAACTGGA 106 
I ELK N GE 110 C I I. TN V D P1W H 
107 TGAACCTTACTTTATCTAATGTAACCGAATATAGTGAJ,GAAAGCGCAATTAATTCAGAAG 166 
N I. T L 5 	VT ED SEES A INS ED 
167 ACAATGCTGAGAGCAGTAAAGCCGTAAAATTGAACGAMTTTATATTAGAGGGACTTTTA 226 
N A ES S 	AV K L N ElY I PG T F I 
227 TCAAGTTTATCAAATTGCAAGATR.ATATAATTGACAAGGTCAAGCAGCAAATTAACTCCA 286 
K F 1K L 0 D NIl D K 	K 000 N S  
287 ACAATAACTCTAATAGTAACGGCCCTGGGCATAAAAGATACTACAACAATAGGGATTCAA 346 
N N S N 5MG PG 8K R Y 	N N R D S  
347 ACAACAATAGAGGTAACTACAACAGAAGAAATAATAATAACGGCAACAGCAACCGCCGTC 406 
N N R G N DM99 N N N N G N SNRR P 
407 CATACTCTCAAAACCGTCAATACAACAACAGCAACAGCAGTAACATTAACAACAGTATCA 466 
S SON ROY N NSNS0NINNSI N 
467 ACAGTATCAATAGCAACAACCAP.AATATGAACAATGGTTTACGTGGGTCCGTCCAACATC 526 
SINS N N OHM N N G L G G S VON H 
527 ATTTTAACAGCTCTTCTCCACAAAAGGTCGAATTTTMACAAATTTTGTATTATAATAAT 586 
F N 555 P OK V IF 
587 TATGTACATATATAAATATATTGGTACATATGTACTGTCTGTGATGTGAATGTTGATTAC 646 
647 CGTTTTCTTT 
B 	




Fig. 1. Sequence of SDB23 and a physical map of the SDB23 
chromosomal locus. (A) SDB23 nucleotide and predicted polypeptide 
sequences (database accession number X82649). Potential TATAA 
elements are underlined, the presumed initiation codon is in bold. The 
region corresponding to part of the SW14 promoter sequence is 
italicized. (B) Restriction map of the SDB23 chromosomal locus 
isolated on a BamHI fragment showing the SDB23 gene (hatched box), 
SWI4 promoter (open box) and gene (black box). Arrows indicate 
direction of transcription. Restriction sites: B, BamHl; H, HindilI; 
Rv, EcoRV. 
was detected (data not shown). Complete sequencing of 
chromosome V has identified the precise location of 
SDB23 on the right arm of this chromosome (database 
accession number Sc9781). 
SDB23 encodes a polypeptide with low but 
significant homology to snRNP core proteins 
The SDB23 gene encodes a predicted 187 amino acid 
protein with a calculated molecular weight of 21 276 Da. 
An initial comparison of the SDB23-encoded ORF with 
protein sequences in the GenIEMBL database revealed 
that Sdb23p is an uncharacterized protein with low but 
significant sequence similarity to two snRNP core proteins, 
human Dl polypeptide (Rokeach et at., 1988) and its 
yeast homologue Smdlp (Rymond, 1993). 
A more extensive search of protein databases available 
on the EMBL-Heidelberg and NCBI network file-servers, 
using the BLITZ (Sturrock and Collins, 1993) and BLAST 
(Altschul et at., 1990) search programs respectively with 
varied search-sensitivity levels, found that the proteins 
most closely related to the predicted yeast polypeptide are 
snRNP core proteins, known to play a critical role in the 
structure and function of the spliceosome (reviewed in 
Ltihrmann et at., 1990). The amino-terminal halves of 
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Fig. 2. Alignment of N-terminal domains of multiple snRNP core proteins identifying a novel snRNP protein motif. (A) snRNP proteins were 
aligned using the program PILEUP in the GCG7 Suite of sequence analysis programs. The snRNP motif was identified visually. Alignment gaps are 
indicated by dots. The alignment is numbered above using the methionine codon of human E protein as position 1. Protein names are given 
alongside the sequence. Boxed text indicates positions in which residues belonging to a single conservative grouping are present in at least 50% of 
the sequences. The degree of conservation is indicated by the following symbols: * , indicates positions which are absolutely invariant; f, indicates 
positions where a single conservative grouping represents 100% of the sequences; 1, indicates positions where the nature of the residue is conserved 
in at least 83% of the sequences. Accepted conservative groupings were I = V = L, D = E, R = K, T = S, N = Q, F = Y = W. The Swissprot, 
EMBL or Genbank accession number for the protein sequences, or for the nucleotide sequences from which the peptide sequence was derived, are as 
follows: human DI, P13641; yeast Smdl, L04669; yeast Smd3, M65144; yeast Sdb23, X82649; human B, P14678; human E, P08578. 
(B) Consensus snRNP motif derived from the alignment of multiple published snRNP core protein sequences. During the revision of this manuscript 
the sequences of core polypeptides D2 and p3 from HeLa were published (Lehmeier et al., 1994). Incorporation of these sequences into Figure 2A 
supports the consensus derived from this alignment with the exception of the C-terminal conserved hydrophobic residue at position 115. This has 
been considered in deriving the 5nRNP core protein motif shown in B. The font size reflects the degree of conservation at any position with 
absolutely invariant residues highlighted in enlarged, bold text. At positions where alternative residues within a conserved grouping do occur, these 
residues are listed in order of preference below the most commonly used residue. x represents any residue and the spacing parameters are shown by 
numbers; + indicates that this number is variable. 
these proteins share the greatest degree of sequence 
similarity (Figure 2A), the carboxy-terminal portions 
diverging considerably. 
The amino-terminal conserved sequence of all the 
snRNP core proteins and Sdb23p can be split into two 
highly conserved regions. The first contains four invariant 
residues; G1y45, Met54, Asn55 and Leu58 (numbered 
according to alignment, Figure 2A). In addition, there 
appears to be a preference for an acidic residue, either 
aspartate or glutamate, two positions upstream of the 
conserved methionine residue. The first conserved region 
is separated from the second by a variable number of 
amino acids, typically 14-25. The yeast Smdlp is atypical 
in its longer amino-terminal sequence and introduces the 
only major gap in the alignment (Figure 2A, residues 
72-98). The second region consists of only one invariant 
residue, glycine at position 107. However, immediately  
prior to the conserved glycine, there is a clear preference 
for a basic residue (ArglLys 106), which is preceded by a 
hydrophobic residue, either isoleucine, leucine or valine. 
At three additional positions hydrophobic residues are 
preferred (Leu 100, llefLeufVal 103 and IlelLeu 110). A 
novel motif characteristic of the snRNP core protein 
family has been derived from the alignment of published 
snRNP core protein sequences (Figure 213). 
Sdb23 is a small hydrophilic protein that has an overall 
positive charge (p1 = 10.31) in common with the majority 
of snRNP proteins. However, the nature of this charge 
distribution is uneven; the amino'Ierminal half of the 
protein is essentially neutral with an approximately equal 
number of basic and acidic residues. In contrast the 
carboxy-terminal half contains a preponderance of basic 
amino acids, its most notable feature being the presence 
of a particularly asparagine-rich segment; 85% of the 
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ca rboxy-terminal 97 amino acids are hydrophilic with 
3 % of these being asparagine residues. This asparagine-
ri h segment distinguishes Sdb23p from all the other 
sr RNP core proteins, which tend to have an abundance 
o arginine and glcine residues. 
S DB23 is an essential gene 
T determine whether SDB23 encodes an essential func-
tipn a heterozygous diploid strain (MCY5) was con-
structed in which one SDB23 locus had LEU2 integrated 
at the presumed initiation codon, disrupting read-through 
from the promoter sequence. After sporulation of the 
sdb23::LEU21SDB23 diploid, 10 independent tetrads were 
dissected, all of which contained only two viable spores; 
in each case the viable cells were auxotrophic for leucine, 
indicating that disruption of the SDB23 gene results in loss 
of viability. Genomic Southern blot analyses confirmed the 
chromosomal configurations of the sdb23::LEU2/SDB23 
diploid and of the haploid progeny (data not shown). Thus 
SDB23 encodes a novel activity essential for cell viability. 
In vivo depletion of Sdb23p arrests cell growth 
To address the potential function of Sdb23p, a haploid 
strain, MCY4, was constructed in which the sole chromo-
somal copy of SDB23 was under the control of the 
inducible GAL] promoter (GAL] —SDB23; see Materials 
and methods). The growth of strain MCY4 is galactose-
dependent; the cells grew on galactose as the sole carbon 
source but not on glucose (Figure 3A). A plasmid bearing 
the entire SDB23 gene with its own promoter (pSDB23- 1) 
 capable of rescuing lethality on glucose medium 
(Figure 3A). 
When the growth rate of MCY4 cells was monitored 
ollowing a shift to non-permissive glucose medium, the 
oubling times in galactose or glucose media were almost 
ndistinguishable for the first 10 h (Figure 313). However, 
rowth began to slow after approximately 11-12 h follow -
ng the shift to glucose medium and stopped after 15-17 h 
n glucose. It is possible that over-production of Sdb23p 
as toxic to MCY4 cells since they grew slower than wild- 
ype (MCY2) cells in galactose medium (data not shown). 
Sdb23p is required for nuclear pre-mRNA splicing 
o investigate the effect on pre-mRNA splicing of deplet-
ing cells of Sdb23p, total RNA was extracted from wild-
type and MCY4 cells grown continuously in galactose or 
shifted to glucose medium for various lengths of time. 
Splicing efficiency was determined by probing Northern 
blots with the yeast ribosomal protein gene RP28 (Figure 
4). In the wild-type control cells splicing of the RP28 
transcript was efficient and carbon source independent. 
Interestingly, unspliced RP28 pre-mRNA was detected in 
MCY4 cells grown continuously in galactose medium 
(lanes 4-6), although mature mRNA was the predominant 
species. This partial splicing defect was no longer apparent 
when MCY4 cells had been in glucose medium for 5 h; 
only mature mRNA was detected at this time (lane 10). 
This indicates that over-production of Sdb23p is in some 
way detrimental to splicing and could explain the poor 
growth noted for this strain in galactose medium. However, 
10 h following the shift to glucose medium, immediately 
prior to the onset of reduced growth rate, the ratio of 
spliced RP28 mRNA to unspliced RP28 pre-mRNA had 
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Fig. 3. Depletion of Sdb23p leads to growth arrest. (A) Ten-fold serial 
dilutions of galactose-grown, mid-logarithmic cultures of MCY4 cells, 
transformed with either pFL39 (row A) or pSDB23-1 (row B) were 
spotted onto selective galactose (I) and glucose (2) media and 
incubated at 30°C for 3 days. (B) A culture of untransformed MCY4 
cells was grown to mid-logarithmic phase in galactose medium, 
harvested, washed and resuspended in sterile water. Half of this 
suspension was used to inoculate either fresh pre-warmed galactose or 
glucose media to an initial OD600 of 0.05. Cultures were diluted to 
keep all 0D600 readings below 0.6, maintaining the cells in 
logarithmic growth. 
decreased 18-fold (lane 11; data quantified by Phosphor-
Imager analysis). By 20 h, when the cells were no longer 
capable of further growth, the ratio was dramatically 
reduced although mature RP28 mRNA could still be 
detected (lane 12). ACT] transcripts, which also contain 
an intron, behaved similarly, whereas the level of tran-
scripts of the intronless URA3 gene-was unaffected by 
repression of SDB23, indicating that this effect was specific 
to intron-containing transcripts (data not shown). 
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Fig. 4. Sdb23p is required for nuclear pre-mRNA splicing. Total RNA 
was extracted from wild-type and MCY4 cells grown continuously in 
galactose or at various times following a shift to glucose medium, 
resolved on a 1.4% denaturing agarose gel, blotted and probed with 
radiolabelled RP28 DNA. The positions of pre-mRNA and mature 
mRNA are indicated. 
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Sdb23p is required prior to step 1 of splicing 
in vitro 
The in vivo depletion of Sdb23p demonstrated a role for 
this protein in nuclear pre-mRNA splicing. To determine 
whether Sdb23p is also required for splicing in vitro, 
extracts prepared from MCY4 cells either grown continu-
ously in galactose or transferred to glucose for 13 h (i.e. 
just prior to the point of complete growth arrest) were 
tested for their ability to splice RP28 transcript. Extracts 
derived from cells grown in galactose efficiently spliced 
RP28 transcript to mature mRNA (Figure 5A, lanes 1-3). 
In contrast, Sdb23p-depleted extracts failed to support 
splicing (lanes 4-6). 
The ability of Sdb23p-depleted extract to form spliceo-
some complexes was analysed by non-denaturing gel 
electrophoresis (Pikielny et al., 1986). This gel system 
resolves three spliceosome complexes, termed I, II and 
III, from yeast splicing reactions on the basis of their 
electrophoretic mobility. These complexes assemble in the 
order III, I and II; splicing reaction intermediates and 
products are detected in complex II. Figure 5B shows 
that complex II rapidly formed in extract derived from 
galactose-grown MCY4 cells. The formation of complex 
II in these extracts coincided with the detection of mature 
mRNA and splicing intermediates in the corresponding 
in vitro splicing reaction (Figure 5A, lane 3, compared 
with Figure 5B, lane 3). In the Sdb23p-depleted extract, 
the complex assembly stalled following the formation of 
the pre-spliceosome, complex III (Figure 513, lanes 4-6). 
The absence of complex I in the Sdb23p-depleted reaction 
is consistent with Sdb23p being required for the addition 




Fig. 5. In vitro splicing inactivation following depletion of Sdb23p. 
(A) Extracts prepared from MCY4 cells grown in galactose or in 
glucose for 13 h were assayed for their ability to splice RP28 
transcript and form spliceosome complexes. Splicing reactions (10 p.sl) 
containing radiolabelled RP28 pre-mRNA were incubated at 25°C for 
5, 10 and 20 mm, RNA recovered and analysed on a 6% (w/v) 
denaturing polyacrylamide gel. IVS-E2, lariat intron—exon 2; IVS, 
lariat excised intron; pre-mRNA, RP28 substrate RNA; El-E2, spliced 
exons. (B) For analysis of splicing complex formation, 5 Ill aliquots of 
the splicing reactions shown in (A) were fractionated on a non-
denaturing gel; splicing complexes 1, II and Ill as defined by Pikielny 
etal. (1986). 
Sdb23p is essential for the stability of U6 snRNA 
To investigate the possibility that the stability of the 
spliceosomal snRNAs was affected by in vivo depletion 
of Sdb23p, total RNA was extracted at various times from 
MCY4 cells grown in glucose medium. Northern analysis 
showed that depletion of Sdb23p resulted in a dramatic 
reduction in the level of U6 snRNA (Figure 6). After 10 h 
growth in glucose medium, when growth still appeared to 
be normal, U6 snRNA was reduced to 40-50% of its 
original level. After 20 h, the level of U6 snRNA was 
further reduced to 10-20% of the original level. In a 
control experiment, the level of U6 snRNA in a wild-type 
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Fig. 6. Effect of in vivo depletion of Sdb23p on snRNA stability. 
(A) Total RNA was extracted from MCY4 cells grown for various 
lengths of time in glucose medium, fractionated on a 6% denaturing 
polyacrylamide gel, blotted and probed with oligonucleotides specific 
for the snRNAs (Materials and methods). (B) Levels of snRNAs were 
quantified, values normalized against UI snRNA and plotted as a 
percentage of the starting amount as 100%. U5L and U5S data were 
combined and plotted as a single value. Probing with the intron-less 
URA3 validated using UI snRNA as a standard (data not shown). 
Note: the variability observed in this experiment for the level of U2 
snRNA is not due to depletion of Sdb23p. In several identical 
experiments the only reproducible significant effect observed was the 
reduction in the level of U6 snRNA. 
strain was not affected by carbon source (data not shown). 
Although the levels of UI, U2, U4 and US snRNAs in 
both wild-type and mutant cells fluctuated, this was not 
significant compared with the reproducible effect on U6 
of depleting Sdb23p (Figure 6 and data not shown). 
Immunoprecipitation of the spliceosome-associated 
snRNAs with antibodies raised against either the 1MG-
cap of the snRNAs, or the U5 snRNP-specific protein 
Fig. 7. Immunoprecipitation of snRNAs with antibodies against TMG 
or Prp8p. Extract derived from cells grown either continuously in 
galactose (GAL) or in glucose (GLU) for 13 It was subjected to 
immunoprecipitation with either anti-TMG (lanes 2 and 3) or Prp8 
(lanes 4 and 5) antibodies. Incubation of the extract with antibodies 
and subsequent washes were in 150 mM salt. The RNAs were 
recovered and analysed as described for Figure 6A. Lane I shows total 
RNA from galactose-grown MCY4 extract. 
Prp8 confirmed that Sdb23p is not required for the 
maintenance of Ul, U2, U4 and US snRNA stability 
(Figure 7). However, the amount of U4 snRNA associated 
with US snRNA (and thereby co-precipitated by anti-Prp8 
antibodies) was significantly reduced in Sdb23p-depleted 
extracts (compare lanes 4 and 5), suggesting that the 
association of U4 with US is affected by the reduced level 
of U6 snRNA. 
Association of Sdb23p with U6 snRNA 
To facilitate the further characterization of Sdb23p, poly-
clonal antibodies were generated against a -galacto-
sidase—Sdb23 fusion protein. Immunoblot analysis of 
wild-type yeast splicing extracts probed with immune 
serum specifically recognized a polypeptide with an appar-
ent molecular weight of 21-22 kDa. This polypeptide was 
not detected by pre-immune serum, nor by immune serum 
when probing cell extracts depleted of Sdb23p (data not 
shown). To determine whether any spliceosomal snRNAs 
were associated with Sdb23p, RNAs co-immunoprecipi-
tated with Sdb23p polyclonal antibodies were analysed by 
Northern blotting. Pre-immune serum did not immuno-
precipitate any RNA species above background level, 
whereas at low salt concentrations U 1, U2 (albeit weakly), 
plus U4, U5 and U6 snRNAs were detected in the immune 
pellet (Figure 8A, lanes 2-5). After extensive washing at 
moderate to high salt concentrations (500 and 750 mM 
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SDB23 was isolated as a weak suppressor of a d!4f12 
mutation that has a cell cycle phenotype, being defective 
in late mitosis and in DNA synthesis (Parkes and Johnston, 
1992). DBF2 encodes a cell cycle protein kinase that 
functions late in the mitotic cycle and is probably require1l 
for the G 1 /S transition. The nature of this, suppression is 
not understood nor is it certain that suppression is mediate1 
by SDB23. Cells depleted of the SDB23-encoded polypep 
tide do not have an obvious cell cycle phenotype and thei 
primary defect is a reduction in the cellular content o 
U6 snRNA. 
On the basis of sequence similarity to human and yeas 
snRNP core proteins, this polypeptidé is a core-like snRN 
protein. Unlike the known core proteins, however, it onl 
associates with free U6 and U6-containing particles. W 
therefore propose the more logical name USSI (U Si 
SnRNP) for this gene, as its original name SDB23 wa 
based on its uncharacterized suppressor activity (Parke 
and Johnston, 1992). 
USSJ/SDB23 has been shown to be essential for via-
bility. The long lag after shifting cells to glucose mediu 
before a substantial effect is seen on the growth may 
indicate slow turnover of this protein. Typically, shutting 
off the synthesis of essential, stable proteins or snRNAs 
results in a lag before growth rate slows, since dilution to 
limiting levels requires several generations (e.g. Strauss 
and Guthrie, 1991). 
The decreased growth rate of MCY4 cells depleted 
of Usslp/Sdb23p corresponded with reduced splicing 
efficiency in these cells, as evidenced by a decrease 
in the mRNA:pre-mRNA ratio for the two transcripts 
examined. The partial splicing defect observed with MCY4 
cells grown continuously in galactose could be a con-
sequence of Usslp/Sdb23p overproductiori. Excess Usslp/ 
Sdb23p could potentially interact with and titrate out other 
factors (possibly U6-associated proteins) that are required 
for nuclear pre-mRNA splicing. 
In vitro, extracts depleted of Usslp failed to support 
splicing. Spliceosome complex assembly in these extracts 
was blocked at an early stage, after formation of the U1/U2 
snRNP-containing pre-spliceosome complex. These data 
are consistent with Usslo being required for the assembly 
of the U41U6.U5 tri-snRNP into the spliceosomes, or for 
the stable formation of the U41U6.U5 tri-snRNP itself. 
Indeed, the level of U4/U6.U5 tri-snRNP complex is 
reduced in the Usslp-depleted extract. 
Point mutations and deletions in the Sm site of yeast 
spliceosomal snRNAs can have a marked effect on snRNP 
assembly and snRNA stability, and may block splicing 
both in vivo and in vitro (McPheeters et al., 1989; Jones 
and Guthrie, 1990; Siliciano et al., 1991). In yeast, the 
spliceosomal snRNAs are extremely sensitive to in vivo 
depletion of Smdlp or Smd3p. The removal of either of 
these proteins causes a dramatic reduction in the levels of 
UI, U2, U4 and U5 snRNAs but leaves the level of 
B 	OLIGO U6A OLIGO U413 
a - Sdb23 	a - Sdb23 
TOTALI 	 TOTAL I 	I 




Fig. 8. Co-immunoprecipitation of U4, U5 and U6 snRNAs with 
Sdb23p. (A) Wild-type splicing extract was subjected to 
immunoprecipitation with pre-immune serum (lane 3) or anti-Sdb23 
antibodies (lanes 4-7). Incubation of the extract with antibodies was in 
150 mM salt; washes were performed using various concentrations of 
salt (lane 4, 150 mM; 5, 300 mM; 6, 500 mM; 7, 750 mM). The 
RNA5 were recovered and analysed as described for Figure 6A. Lane I 
shows total RNA from the same extract. Lane 2 indicates background 
precipitation due to non-specific binding of the snRNAs to protein 
A—Sepharose (PAS). (B) For analysis of free U6 and U41U6 snRNPs, 
half the RNA samples immunoprecipitated from wild-type splicing 
extract with anti-Sdb23 antibodies were resolved on a non-denaturing 
polyacrylamide gel (Zairong and Brow, 1993), blotted and probed 
successively with oligonucleotides complementary to U6 snRNA 
(lanes 1-3) and U4 snRNA (lanes 4-6). Lanes 2 and 5 correspond to 
samples shown in lanes 4 and 6 respectively in (A). 
NaCI) the precipitate with the immune serum contained 
U4 and U6 snRNA (lanes 6 and 7). These results indicated 
an association between Sdb23p and the U4/1J6 snRNP 
and perhaps to a lesser extent the U41U6.U5 tri-snRNP. 
To determine whether Sdb23p was associated with 
free U6, the snRNAs co-immunoprecipitated by Sdb23 
antibodies were fractionated on a non-denaturing poly- 
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U6 snRNA relatively unaffected (Rymond, 1993; Roy 
et al., 1995). U6 snRNA differs from the other spliceo-
somal snRNAs in that it lacks an Sin site and, by itself, 
does not associate with core proteins. In contrast to the 
in viva depletion of Smdlp or Smd3p, depletion of Ussip 
resulted in a vast reduction in the level of U6 snRNA 
without causing significant changes to the levels of U 1, 
U2, U4 and US snRNAs. Thus, although Usslp resembles 
the core proteins in terms of sequence similarity and in 
being required for the stability of an snRNA molecule, it 
differs in terms of its functional specificity. This is the 
first identification of a U6-specific protein that is related 
to the snRNP core proteins. 
Depletion of Ussip could affect the abundance of U6 
snRNA through decreased U6 snRNA synthesis or by 
rendering, the RNA more susceptible to decay. U6 snRNA 
is unique amongst the spliceosomal snRNAs in that it 
is transcribed by RNA polymerase III (RNA Pol III). 
Alterations in the intracellular content of Usslp could 
pecifically affect RNA Pol III transcription without 
ffecting the transcription, and hence levels, of snRNAs 
roduced by RNA polymerase II. Both ethidium bromide 
taming of RNA fractionated in polyacrylamide gels and 
end-labelling of total RNA isolated from Ussip-depleted 
xtrácts showed that the steady state levels of 5S rRNA 
and of tRNAs (also produced by RNA Pol III) were not 
affected by the reduction in cellular content of Usslp 
(data not shown). This implies that in the absence of 
Ussip, the rate of decay of U6 snRNA is accelerated. 
Usslp may influence the rate of U6 snRNA decay directly 
by associating with and stabilizing this RNA. Alternatively, 
Usslp could affect other factors required for U6 stability. 
Anti-Uss 1 p  antibodies strongly co-immunoprecipitated 
U4 and U6 snRNAs from a wild-type splicing extract 
which suggests that Usslp is associated with the U411J6 
snRNP. UI, U2 and U5 snRNAs were only weakly co-
immunoprecipitated with Ussip at low salt concentrations. 
The inability to detect U5 snRNA above 300 mM NaCl 
may reflect the sensitivity of the U41U6.U5 tri-snRNP 
complex to high salt concentrations (Abovich etal., 1990; 
Banroques and Abelson, 1990). However, bearing in mind 
the high degree of sequence similarity between Smdlp, 
Smd3pand Usslp, polyclonal anti-Usslp antibodies may 
recognize epitopes shared by all three proteins. Thus, 
weak immunoprecipitation of UI, U2 and U5 snRNAs 
could be attributed to the immunoprecipitation of low 
amounts of Smdlp and Smd3p. 
Non-denaturing gel electrophoresis demonstrated a clear 
association between Uss I  and free U6, in addition to its 
association with 'U4/U6 snRNP. These data indicate a 
direct or indirect interaction between Uss 1 p  and U6 snRNA 
that is maintained following the physical association of 
U4 and U6 snRNAs in the U4/U6 snRNP (Madhani and 
Guthrie, 1994). At present, however, it is not known 
whether Usslp is a component of spliceosomes, since 
antibodies to Uss Ip do not detectably interact with the 
pre-mRNA-containing spliceosome complexes (data not 
shown). This could be a consequence of masking of 
the Usslp epitopes or the absence of Usslp in these 
complexes. 
U6 snRNA is normally present in excess over U4 
snRNA. This excess is believed to be a major factor in 
driving the formation of U41U6 snRNP, the favoured state  
of U6 snRNA. The intracellular content of U6 snRNA 
drops in response to heat inactivation of prp3, prp4, prp6 
and prp24 temperature-sensitive strains (Blanton et al., 
1992 and references within). All these factors are essential 
for nuclear pre-mRNA splicing and are components of 
U6-containing particles. Prp4p is a component of the U4/ 
U6 snRNP, thought to associate with the 5' stem—loop 
of U4 snRNA, although no direct RNA—protein interaction 
has been demonstrated (Bordonné etal., 1990; Xu et al., 
1990). Prp4p is not required for maintaining the stability 
of U4 snRNA since heat inactivation of a temperature-
sensitive prp4-1 strain significantly reduced the level of 
U6 but not U4 snRNA (Galisson and Legrain, 1993). 
Glycerol gradient analysis of prp4-1 snRNP fractions 
showed the presence of a free U4 snRNP particle in 
the absence of functional Prp4 protein and U6 snRNA. 
Immunoprecipitation of snRNPs from Ussip-depleted 
extracts, using antibodies against the TMG-cap, similarly 
showed that the total cellular level of U4 snRNA was not 
affected by reduced levels of U6 snRNA. The association 
of U4 snRNP with US snRNP was affected however, as 
indicated by immunoprecipitations with antibodies raised 
against the US snRNP-specific protein, Prp8. 
It is not known whether Usslp interacts with U6 snRNA 
directly, or associates indirectly through protein—protein 
interactions possibly involving Prp24p or other (as yet 
unidentified) U6-associated proteins. Unlike Prp24p, 
which has three RNA recognition motifs (RRM) (Shannon 
and Guthrie, 1991), Usslp does not contain a good match 
to any of the characterized RNA-binding motifs (Birney 
et al., 1993 and references within; Burd and Dreyfuss, 
.1994). The amino-terminal 80 amino acids of Usslp do 
include a potential RNP2 motif, but have a very poor 
match to the degenerate RNPI consensus motif (Bimey 
et al., 1993). 
USSJ encodes a small, basic protein with an apparent 
p1 value of 10.31. This value is in common with most Of 
the snRNP core proteins which have apparent p1 values 
ranging between 8 and 10. The multiple alignment of 
published snRNP core protein sequences with Ussip 
revealed that the amino-terminal regions of these proteins 
share a significant degree of similarity and identified a 
signature motif for snRNP core proteins. This motif 
consists of five invariant residues, one residue where the 
consensus is either arginine or lysine, and another position 
where the consensus is split between aspartate, glutamate 
and serine, with a clear preference for an acidic residue. 
There are a number of other highly conserved residues, 
and in particular three positions are always occupied by 
hydrophobic residues, either isoleucine, leucine or valine. 
Compared with the human Dl protein, yeast Smdlp 
contains an additional 27 amino acids. Rymond et al. 
(1993) demonstrated that Smdlp lacking the yeast 
Dl-specific sequence (residues 80-99, Figure 2A) is fully 
functional. However, extending this deletion by six amino 
acids (residues 79-105, Figure 2A) knocks out Smdlp 
function (Rymond etal., 1993). The larger deletion encom-
passes three highly conserved positions in the core protein 
motif, amino acids LeulOO, 11e103 and IlelOS, which 
indicates that residues within this motif are indeed essential 
for core protein function. 
The conserved residues may be required for the correct 
folding, stability or function of the individual core protein. 
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In addition, or alternatively, they may mediate 
protein—protein interactions between individual core pro-
teins. In mammalian cells, snRNP assembly begins with 
the interaction of core proteins to form an snRNA-free 
protein complex (Fisher et al., 1985; Lehmeier et al., 
1994; R.Luhnnann, personal communication) which then 
associates with the Sm site of the snRNA molecule. The 
ability of snRNP core proteins to form stable complexes 
in the absence of an snRNA molecule implies that 
protein - protein interactions are dominant over 
RNA—protein interactions in the snRNA—core protein 
complex. To date, a direct interaction between a core 
protein and an snRNA within a snRNP has been demon-
strated only for the snRNP-G polypeptide and the Sm site 
of Ui snRNA (Heinrichs et al., 1992). 
The amino-terminal domain alignment (Figure 2A) 
identifies two small sub-motifs that are very highly con-
served among the D proteins (VTIELKNG, residues 33-40; 
ILPD, residues 114-117 of human Dl). On the basis of 
extremely similar regions to these in Ussip, Usslp would 
appear to be structurally most similar to the D proteins. 
However, the homology between Ussip and the mam-
malian Dl (25.1% identical) is much less than that 
observed between mammalian Dl and the yeast functional 
homologue, Smdlp (48.7% identical). Ussip differs most 
noticeably from the D proteins in two ways. First, the 
carboxy-terminal domain of Ussip is extended by 41 and 
68 amino acids compared with the human Dl and yeast 
Smdl proteins, respectively. Secondly, the carboxy-ter -
minal domain is extremely asparagine-rich. At present, 
the functional importance of the Uss 1 p  asparagine-rich 
carboxy-tail is unclear. It is possible that this domain of 
Ussip is required for the U6-specificity of this protein. 
Conceivably, U6 snRNA could be complexed with as 
many 'core' proteins as the other spliceosomalsnRNAs. 
Indeed, another yeast gene, SMX4, has now been identified 
which encodes a core protein-like polypeptide that also 
associates with U6 snRNA particles (Séraphin, 1995). As 
rapid sequencing of the yeast genome reveals novel open-
reading frames, the proposed consensus should aid in 
the identification of other members of this apparently 
expanding family of proteins. 
Materials and methods 
Strains, plasmids and RNA substrates 
The Escherichia coli Strain DH5ceF' (GIBCO BRL) was used for cloning 
and propagation of plasmid DNAs. The following Saccharomyces 
cerevisiae strains were used: MCYI (MATa/(x adel-JOJIADE], leu2-
3,-1121leu2 his3-A l/HIS3, trpI-2891TRP1, ura3-521ura3-52); MCY2 
(MATa, adel-101, leu2-3,112, trpl-289, ura3-52); MCY3 (MATaJ(x 
adel-JOJIADEJ, leu2-3, - 11211eu2 his3- l/HIS3, trpl-2891TRPI, ura3-
521ura3-52 SDB23ILE(J2-GALJ-SDB23); MCY4 (MATes, adel- 101, 
his3-Al, trpI-289, ura3-52, LEU2-GALI-SDB23); MCY5 (MATa/a 
adel- I0I/ADEJ, leu2-3,-1121leu2 his3-E l/HIS3, trpl-2891TRPJ, ura3-
521ura3-52, sdb23::LEU21SDB23). Yeast cells were grown on rich 
YPGaIA [1% (wlv) yeast extract, 2% (w/v) Bacto-tryptone and 2% 
(w/v) galactose, 0.003% (wlv) adenine] or selective YMGaICas [0.67% 
(w/v) yeast nitrogen base w/o amino acids, 1% (w/v) vitamin-free 
casamino acids, 2% (wlv) galactose] inducing media; non-inducing 
media were as for YPGaIA and YMGaICas except that galactose was 
replaced by 2% (w/v) glucose. Yeast transformations were performed as 
described by Gietz et al. (1992). 
Plasmids YEp24-SDB23 and pBS-SDB23 contain the entire dbJ2-1-
complementing BamHl fragment (Figure IB) subcloned into the BamHl 
site of YEp24 and pBluescript (Stratagene) respectively. Plasmid 
pSDB23-1 is the 1.4 kb Hindlil fragment encoding SDB23 and SWI4  
promoter cloned into the Hindul of pFL39 (Bonneaud etal., 1991). ihe 
GALl —SDB23 conditional allele of SDB23 was constructed as follows: 
a 648 nt fragment encoding the SDB23 gene was generated by PCR 
using pBS-SDB23 as template, incorporating BamHl and Sail restriction 
sites 5' and 3' of the gene respectively. This fragment was cloned 
between the BamHl and Sail restriction sites of pBM 125, placing SD823 
under control of the GALl promoter. The EcoRl site 5' of the GAL) 
promoter in pBM 125 was converted to Xhol by linker insertion. The 
GALI—SDB23 fusion was isolated on an Xhol—Sall fragment and 
subcloned into the unique Sail site of a pUC 19-based vector containing 
the yeast LEU2 gene and 5' non-transcribed SDB23 sequence: the I kb 
fragment containing 5' non-transcribed SDB23 sequence was generated 
by PCR amplification of pBS-SDB23. MCY4 was derived from MCY3 
which has one wild-type 5DB23 locus replaced with the 
LEU2—GALJ—SDB23 (one-step gene disruption of MCYI by the 
method of Rothstein, 1983). Sporulation and tetrad dissection (Rose 
et al., 1990) of MCY3, followed by a screen for galactose-dependent 
growth identified strain MCY4 as containing the chromosomal 
LEU2—GALJ-5DB23 allele. Southern blot analysis was used to confirm 
the correct chromosomal configurations of MCY3 and MCY4. 
Plasmid pT7rp28 was linearized by digestion with EcoRI to provide 
a template for in vitro transcription (Lossky et al., 1987) with T7 RN4 
polymerase. The transcripts were uniformly 32P-labelled by using 60 i.tqi 
[a- 32P]UTP (Amersham, UK) in a 18 j.il transcription reaction containin 
a total concentration of 8 l.tM UTP, according to the protocol of th 
manufacturer (Pharmacia LKB). 
Growth curves 
Growth of MCY4 cells in galactose-containing medium or after a shi 
to glucose medium was assayed as follows: cells were grown to mi 
logarithmic phase in galactose medium, pelleted, washed and resuspenth 
in sterile water. Half of this suspension was used to inoculate fresh pr 
warmed galactose or glucose media to an initial OD600  of 0.05. Cultur 
were diluted to keep all OD600 readings below 0.6, maintaining the eel 
in logarithmic growth. 
Nucleic acid methods 
Nucleotide sequence of USSI was determined by using the Sequenase 
Version 2.0 DNA sequencing system (United States Biochemical). For 
Northern blot analysis of mRNA, total RNA was extracted by the 
method of Hopper et al. (1978), followed by denaturing agarose gel 
electrophoresis and transfer Onto Hybond N nylon membrane according 
to the manufacturer's instructions (Amersham). Hybridizations were 
performed at 60°C using SES I buffer [0.5 M sodium phosphate buffer 
pH 7.2, I mM EDTA pH 8.0, 7% (w/v) SDS; Church and Gilbert, 19841. 
Filters were washed three times for 30 min at 60°C in SES2 buffer 
[40 m!vl sodium phosphate buffer pH 7.2, I mM EDTA pH 8.0, 5% 
(w/v) SDS]. DNA fragments of cloned genes were radiolabelled by the 
random priming method (Feinberg and Vogelstein, 1984). For denaturing 
Northern analysis of snRNAs, RNA samples were fractionated on 6% 
(wlv) polyacrylamide-8 M urea gels. For the detection of U41U6 snRNA 
complex, RNA was resolved on a 9% non-denaturing aèrylamide gel 
(30:1 acrylamide to bisacrylamide) in 50 mM Iris—borate pH 8.3 and 
I mM EDTA according to Zairong and Brow (1993). The gels were 
transferred electrophoretically to Hybond N nylon membrane at 60 V 
for 30 mm. All hybridizations were performed as described for mRNA 
Northerns in SES I buffer, except that the hybridization temperature was 
adjusted to 5°C below the calculated melting temperature of the 
oligonucleotide/snRNA hybrid. Filters were washed three times for 
30 min at 35°C in SES3 buffer [0.5 M sodium phosphate buffer pH 7.2, 
1 mM EDTA pH 8.0, 5% (w/v) SDS]. snRNA probes were prepared by 
end-labelling the following snRNA oligonucleotides with 60 l.tCi 
[y-32P]ATP (Amersham, UK) using T4 polynucleotide kinase (New 
England Biolabs): UI, CACGCCTFCCGCGCCG'f; U2, CTACACTITG-
ATCTAAGCCAAAAGGC; U4,CCGTGCATAAGGAT; US, AATATG-
GCAAGCCC; U6, TC(A/T)VrCTCTGTATFG (obtained from D.Brow); 
U4B, AGGTATI'CCAAAAATFCCC; U6A, AAAACGAAATAAAT-
CTCTVI'G. The sequences for U4B and U6A oligonucleotides were as 
in Zairong and Brow (1993) where U6A corresponds to oligonucleotide 
U61). Unless stated otherwise, all oligonucleotides were synthesized by 
Oswell DNA services, Edinburgh University. Blots were analysed by 
autoradiography, and on a Phosphorlmager (Molecular Dynamics, UK) 
for quantification. 
Splicing extract preparation and in vitro splicing reactions 
Yeast whole cell extracts were prepared as described by Lin et al. (1985). 
Extracts from strain MCY4 were depleted of Sdb23p by growth in 
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glucose medium for 13 hat 30°C, maintaining the cells in logarithmic 
giowth by diluting the cells to keep all 0D600 readings below 0.6. In 
vi ro splicing reactions were performed as described (Lin et al., 1985). 
The reaction products were fractionated on a 6% (w/v) polyacrylamide-
8 M urea gel and visualized by autoradiography. Non-denaturing gel 
el ectrophoresis of splicing reactions was performed as described (Pikielny 
el al., 1986), except that 10 mM EDTA was present in both the 
e ectrophoresis buffer and the acrylamide/agarose gel. 
bodies against the TMG-cap were a kind gift from R.Luhrmann. 
-Prp8 antibodies were from anti-8.6 serum against a 35 amino acid 
htic peptide corresponding to the amino-terminal sequence of Prp8. 
it polyclonal anti-Sdb23p antibodies (sera 756 and 763) were raised 
nat a 3-galactosidase fusion protein containing the entire 187 amino 
Sdb23 polypeptide. Antibodies were bound to protein A—Sepharose 
Is (PAS; Sigma) in NTN buffer (150 mM NaCl, 50 mM Tris—HCI 
7.5, 0.1% v/v Nonidet P-40). For snRNA analysis, PAS-bound 
iodies were then incubated for 1 h in NTN-B (NTN plus 100 IgJml 
of glycogen, E.coli tRNA and BSA) before washing four times 
NTN. Splicing extracts were incubated at 4°C with PAS-bound 
)odies for 2 h with rotation. The antibody complexes were washed 
times with NTN, varying the salt concentration according to the 
igency of the wash required, and once with NT (NTN without 
idet P-40). Immunoprecipitated snRNAs were recovered by treatment 
proteinase IC (Boehringer Mannheim, prepared according to manu-
irer's instructions) for 30 min at 37°C, followed by successive 
actions with phenol and phenol/chloroform, then precipitated with 
nol in the presence of 10 jig E.coli tRNA as carrier. 
number 
nucleotide sequence data reported in this paper will appear in the 
IL, Genbank and DDBJ Nucleotide Sequence Databases under the 
ssion number X82649. 
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